EOS Med Chem Impurity Stock 20201029-24

   

EOS Med Chem is serving more than 100 Pharma companies, we have the original Drug Discovery Compounds, Like Impurity, small molecule and inhibitor.

Impurity we keep stock more than 80000, most in stock, we are World Sole Original Supplier, Each impurity we could supply: Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA.

EOS Med Chem Quotation include: Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, COA, MSDS.

Welcome to visit: our youtube:  https://youtu.be/r5cJdXKNXHk 

Contact:

EOS Med Chem, Medicinal Chemical is Big

執大象，天下往，往而無害，安平泰

Ms Nina

Youtube: https://youtu.be/r5cJdXKNXHk 

E: info@eosmedchem.com 

W: www.eosmedchem.com 

Tel: 0086-531-69905422

SALE OFFICE: 16F, China Overseas Plaza, Jinan City, China

(3-Bromophenyl)(2,3,5-trimethylphenyl)methanone, CAS: /, stock: 5.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₅BrO.

(R)-(-)-Ketoprofen, CAS: 56105-81-8, stock: 5.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄O₃.

(R)-(-)-Ketoprofen-13C,d3, CAS: 1329496-52-7, stock: 9.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅¹³CH₁₁D₃O₃.

(R)-4-Methyl Ketoprofen, CAS: /, stock: 4.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₆O₃.

(R)-4-Methyl Ketoprofen-d3, CAS: /, stock: 6.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₃D₃O₃.

(R)-Ketoprofen Acyl-β-D-glucuronide, CAS: 140148-25-0, stock: 9.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₂O₉.

(R)-Ketoprofen β-D-Glucuronide Allyl Ester, CAS: /, stock: 9.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₆O₉.

(S)-(+)-Ketoprofen, CAS: 22161-81-5, stock: 6.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄O₃.

(S)-(+)-Ketoprofen-13C,d3, CAS: 1330260-99-5, stock: 2.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅¹³CH₁₁D₃O₃.

(S)-Ketoprofen Acyl-β-D-glucuronide, CAS: 140148-26-1, stock: 4.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₂O₉.

(S)-Ketoprofen β-D-Glucuronide Allyl Ester, CAS: /, stock: 2.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₆O₉.

2,3,5-Trimethylbenzonitrile, CAS: 88166-75-0, stock: 4.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁N.

2,3,5-Trimethylphenyl Trifluoromethanesulfonate, CAS: 209684-76-4, stock: 2.4g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁F₃O₃S.

2-(3-Bromophenyl)propanoic Acid, CAS: 53086-52-5, stock: 5.3g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉BrO₂.

3-Benzoyl-α-methylbenzeneacetonitrile, CAS: 42872-30-0, stock: 7.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₃NO.

3-Bromo-β-methylbenzeneethanol, CAS: 81310-68-1, stock: 5.3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁BrO.

3-Carboxy-α-methylbenzeneacetic Acid(Ketoprofen Impurity), CAS: 68432-95-1, stock: 5.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀O₄.

3-Carboxy-α-methylbenzeneacetic Acid-d3, CAS: 1330265-71-8, stock: 9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₇D₃O₄.

Deoxy Ketoprofen, CAS: 73913-48-1, stock: 7.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆O₂.

Desmethyl Ketoprofen, CAS: 22071-22-3, stock: 5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂O₃.

Desmethyl Ketoprofen Methyl Ester, CAS: 24021-44-1, stock: 5.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄O₃.

Dexketoprofen Trometamol, CAS: 156604-79-4, stock: 4.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₅NO₆.

Dihydro Ketoprofen(Mixture of Diastereomers), CAS: 59960-32-6, stock: 1.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆O₃.

Dihydro Ketoprofen β-D-Glucuronide (Mixture of Diastereomers), CAS: 849104-47-8, stock: 3.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₄O₉.

Dihydro Ketoprofen-13C,d3(Mixture of Diastereomers), CAS: 1189722-51-7, stock: 9.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅¹³CH₁₃D₃O₃.

Isopropyl Palmitate, CAS: 142-91-6, stock: 1.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₃₈O₂.

Isopropyl-d7 Palmitate, CAS: /, stock: 5.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₃₁D₇O₂.

Ketoprofen 1,4-Sorbitan Ester, CAS: /, stock: 5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₄O₇.

Ketoprofen Ethyl Ester, CAS: 60658-04-0, stock: 8.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₈O₃.

Ketoprofen Methyl Ester, CAS: 47087-07-0, stock: 5.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₆O₃.

Ketoprofen Sorbitol Monoester {Mixture of Diasteromers), CAS: /, stock: 8.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₆O₈.

Ketoprofen-13CD3 Methyl Ester, CAS: 1190007-27-2, stock: 6.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆¹³CH₁₃D₃O₃.

Ketoprofen-d3 Methyl Ester, CAS: 1189950-12-6, stock: 9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₃D₃O₃.

Morpholino(2,3,5-trimethylphenyl)methanone, CAS: /, stock: 3.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉NO₂.

Pentadecanolide, CAS: 106-02-5, stock: 1.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₈O₂.

rac Ketoprofen, CAS: 22071-15-4, stock: 6.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄O₃.

rac Ketoprofen Acyl-β-D-glucuronide, CAS: 76690-94-3, stock: 4.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₂O₉.

rac Ketoprofen Amide, CAS: 59512-16-2, stock: 4.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₅NO₂.

rac Ketoprofen Amide-13C,d3, CAS: 1346603-74-4, stock: 9.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅¹³CH₁₂D₃NO₂.

rac Ketoprofen Glucuronide Allyl Ester-13CD3, CAS: /, stock: 2.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄¹³CH₂₃D₃O₉.

rac Ketoprofen β-D-Glucuronide Allyl Ester, CAS: /, stock: 1.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₆O₉.

rac Ketoprofen β-D-Glucuronide Benzyl Ester, CAS: /, stock: 4.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₈O₉.

rac Ketoprofen PEG 400 Ester, CAS: /, stock: 1.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  n/a.

rac Ketoprofen-13C,d3, CAS: 1189508-77-7, stock: 3.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅¹³CH₁₁D₃O₃.

rac Ketoprofen-13C,d3 Acyl-β-D-glucuronide(Mixture of diastereomers), CAS: /, stock: 2.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁¹³CH₁₉D₃O₉.

rac Ketoprofen-d3, CAS: 159490-55-8, stock: 7.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₁D₃O₃.

rac-2’,3’,5’-Trimethyl Ketoprofen, CAS: /, stock: 1.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₀O₃.

rac-2’,3’4’-Trimethyl Ketoprofen, CAS: 1785760-29-3, stock: 5.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₀O₃.

rac-2’,4’,5’-Trimethyl Ketoprofen, CAS: 1797984-80-5, stock: 3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₀O₃.

rac-2’,4’-Dimethyl Ketoprofen, CAS: 1785759-59-2, stock: 1.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₈O₃.

rac-4’-Methyl Ketoprofen, CAS: 107257-20-5, stock: 8.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₆O₃.

rac-4’-Methyl Ketoprofen-d3, CAS: 1346600-04-1, stock: 7.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₃D₃O₃.

rac-Ketoprofen Tris Base Amide, CAS: 1777830-05-3, stock: 4.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₃NO₅.

rac-Ketoprofen-13C,d3 Tris Base Amide, CAS: /, stock: 6.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₀D₃NO₅.

rac-Trimethyl Ketoprofen (Mixture of (2’,3’4’) and (3’,4’,5’) Isomers), CAS: /, stock: 7.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₀O₃.

(+)-Ketoconazole, CAS: 142128-59-4, stock: 8.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₈Cl₂N₄O₄.

(-)-Ketoconazole, CAS: 142128-57-2, stock: 2.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₈Cl₂N₄O₄.

(2R,4R)-2-(2,4-Dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolane-4-methanol 4-(4-Methylbenzenesulfonate), CAS: 1610851-15-4, stock: 4.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₀Cl₂N₂O₅S.

(2R,4R)-trans-Ketoconazole, CAS: 142128-58-3, stock: 7.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₈Cl₂N₄O₄.

(2R,4R)-trans-Ketoconazole-d8, CAS: /, stock: 9.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₀D₈Cl₂N₄O₄.

1-Acetyl-4-(4-hydroxyphenyl)piperazine, CAS: 67914-60-7, stock: 6.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆N₂O₂.

1-[3,4-Dihydro-4-(4-hydroxyphenyl)-1(2H)-pyrazinyl]ethanone, CAS: 581806-59-9, stock: 9.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄N₂O₂.

1-[4-[4-(Acetyloxy)phenyl]-3,4-dihydro-1(2H)-pyrazinyl]-ethanone, CAS: 581806-58-8, stock: 9.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₆N₂O₃.

2,3-Dehydro Ketoconazole, CAS: 254912-63-5, stock: 9.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₆Cl₂N₄O₄.

2,3-Piperazinedione, CAS: 13092-86-9, stock: 8.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₆N₂O₂.

4-((2-(N-(2-((tert-Butyldimethylsilyl)oxy)ethyl)acetamido)ethyl)amino)phenyl Acetate, CAS: /, stock: 5.2g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₄N₂O₄Si.

4-Acetoxyaniline, CAS: 13871-68-6, stock: 7.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉NO₂.

cis-2-(2,4-Dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolane-4-methanol Benzoate (Ester), CAS: 70894-66-5, stock: 7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₈Cl₂N₂O₄.

cis-[2-(2,4-Dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methyl p-Tolylsulfonate, CAS: 134071-44-6, stock: 3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₀Cl₂N₂O₅S.

Deacetyl Ketoconazole, CAS: 67914-61-8, stock: 4.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₆Cl₂N₄O₃.

Deacetyl Ketoconazole-d8, CAS: 1346602-18-3, stock: 1.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₁₈D₈Cl₂N₄O₃.

Difluoromethanesulfonyl Chloride, CAS: 1512-30-7, stock: 4.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  CHClF₂O₂S.

Steviol, CAS: 471-80-7, stock: 9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₀O₃.

Steviol-13CD2, CAS: /, stock: 4.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉¹³CH₂₈D₂O₃.

Ketoconazole, CAS: 65277-42-1, stock: 4.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₈Cl₂N₄O₄.

Ketoconazole N-​Oxide, CAS: 1392277-16-5, stock: 2.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₈Cl₂N₄O₅.

Ketoconazole-d3, CAS: 1217766-70-5, stock: 9.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₅D₃Cl₂N₄O₄.

Ketoconazole-d4, CAS: /, stock: 2.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₄D₄Cl₂N₄O₄.

Ketoconazole-d8, CAS: 1217706-96-1, stock: 9.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₀D₈Cl₂N₄O₄.

Mirodenafil Dihydrochloride, CAS: 862189-96-6, stock: 2.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₉Cl₂N₅O₅S.

Mirodenafil-d7 Dihydrochloride, CAS: 1329651-11-7, stock: 8.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₂D₇Cl₂N₅O₅S.

N,N-Bis(2-((tert-butyldimethylsilyl)oxy)ethyl)acetamide, CAS: /, stock: 4.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₄₁NO₃Si₂.

N-Acetyldiethanolamine, CAS: 7435-67-8, stock: 3.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃NO₃.

N-Acetylpiperazine-N’-(4-phenol) Ketoconazole, CAS: 1346598-39-7, stock: 9.1g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₄₂Cl₂N₆O₆.

2-PMDQ, CAS: 139047-55-5, stock: 3.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₃N₅O.

N-[2-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]ethyl]-N-(2-hydroxyethyl)-acetamide, CAS: 581806-55-5, stock: 9.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₇NO₃Si.

DV 7028 Hydrochloride, CAS: 133364-62-2, stock: 6.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₅FN₄O₃ • HCl.

Ketanserin, CAS: 74050-98-9, stock: 3.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₂FN₃O₃.

N-[2-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]ethyl]-N-(2-oxoethyl)-acetamide, CAS: 581806-56-6, stock: 6.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₅NO₃Si.

N-[2-[[4-(Acetyloxy)phenyl]amino]ethyl]-N-(2-hydroxyethyl)-acetamide, CAS: 581806-57-7, stock: 5.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₀N₂O₄.

Ketanserin Tartrate, CAS: 83846-83-7, stock: 9.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₈FN₃O₉.

rac-trans-Ketoconazole, CAS: 83374-59-8, stock: 2.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₈Cl₂N₄O₄.

trans-2-​(2,​4-​Dichlorophenyl)​-​2-​(1H-​imidazol-​1-​ylmethyl)​-​1,​3-​dioxolane-​4-​methanol, CAS: 61441-65-4, stock: 8.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₄Cl₂N₂O₃.

(3S)-10-(4-Ethyl-1-piperazinyl)-9-fluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid(Levofloxacin Impurity), CAS: 106939-30-4, stock: 7.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₂FN₃O₄.

(3S)-10-(4-Ethyl-1-piperazinyl)-9-fluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid-d5(Levofloxacin Impurity), CAS: /, stock: 6.3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₇D₅FN₃O₄.

(3S)-10-Fluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid, CAS: 117620-84-5, stock: 9.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₀FNO₄.

(3S)-10-Fluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid Methyl Ester, CAS: /, stock: 5.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₂FNO₄.

(R)-Ofloxacin, CAS: 100986-86-5, stock: 8.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₀FN₃O₄.

(R)-Ofloxacin Carboxylic Acid (Dextrofloxacin Difluoro Impurity), CAS: 110548-07-7, stock: 3.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₉F₂NO₄.

(R)-Ofloxacin-d3, CAS: 1346617-10-4, stock: 9.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₇D₃FN₃O₄.

(S)-(7,8-difluoro-3-methyl-2H-benzo[b][1,4]oxazin-4(3H)-yl)methanesulfonamide (Levofloxacin Impurity), CAS: /, stock: 8.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂F₂N₂O₃S.

(S)-7,8-Difluoro-1-(1-hydroxypropan-2-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic Acid Ethyl Ester, CAS: /, stock: 9.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₅F₂NO₄.

(S)-7,8-Difluoro-3-methyl-3,4-dihydro-2H-benzo[b][1,4]oxazine Hydrogen Sulfate (Levofloxacin Impurity), CAS: /, stock: 9.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉F₂NO.H₂SO₄.

(S)-9,10-Difluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid Ethyl Ester, CAS: 106939-34-8, stock: 4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₃F₂NO₄.

(S)-9,10-Difluoro-3-methyl-2,3,5,6-tetrahydro-7,7-O-ethylidene-7H-pyrido[1,2,3-de]-1,4-benzoxazin-7,7-diol, CAS: 1798887-79-2, stock: 8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₅F₂NO₃.

(S)-9,10-Difluoro-3-methyl-2,3,5,6-tetrahydro-7H-pyrido[1,2,3-de]-1,4-benzoxazin-7-one, CAS: 1798902-76-7, stock: 7.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₁F₂NO₂.

2,3,4,5-Tetrafluoro-α-[[[(1S)-2-hydroxy-1-methylethyl]amino]methylene]-β-oxo-benzenepropanoic Acid Ethyl Ester, CAS: 110548-02-2, stock: 4.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₅F₄NO₄.

2,3,4,5-Tetrafluoro-α-[[[(1S)-2-hydroxy-1-methylethyl]amino]methylene]-β-oxo-benzenepropanoic Acid Methyl Ester, CAS: 1213269-48-7, stock: 7.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₃F₄NO₄.

2,3,4-Trifluoro-α-[[[(1S)-2-hydroxy-1-methylethyl]amino]methylene]-β-oxo-benzenepropanoic Acid Ethyl Ester, CAS: 601490-35-1, stock: 3.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₆F₃NO₄.

2,3,4-Trifluorobenzoyl Chloride, CAS: 157373-08-5, stock: 6.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₂ClF₃O.

2,3,5-trifluoro-4-(4-methyl-1-piperazinyl)-β-oxo-benzenepropanoic Acid, CAS: 108860-30-6, stock: 9.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₉F₃N₂O₃.

6,7,8-Trifluoro-1,4-dihydro-1-[(1S)-2-hydroxy-1-methylethyl]-4-oxo-3-quinolinecarboxylic Acid Ethyl Ester, CAS: 110548-03-3, stock: 5.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄F₃NO₄.

9-Defluoro-9-(4-methyl-1-piperazinyl) Levofloxacin, CAS: 1329833-82-0, stock: 1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₁N₅O₄.

Chloromethyl Laurate, CAS: 61413-67-0, stock: 6.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₅ClO₂.

Defluoro Levofloxacin, CAS: 117620-85-6, stock: 9.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₁N₃O₄.

Defluoro Levofloxacin-d3, CAS: 1329836-14-7, stock: 3.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₈D₃N₃O₄.

Kanosamine, CAS: 576-44-3, stock: 5.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃NO₅.

Descarboxyl Levofloxacin, CAS: 178964-53-9, stock: 3.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀FN₃O₂.

Desmethyl Levofloxacin Hydrochloride, CAS: /, stock: 1.7g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉ClFN₃O₄.

Desmethyl Levofloxacin-d8 Hydrochloride, CAS: 1217677-38-7, stock: 8.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₁D₈ClFN₃O₄.

Ethyl (3R)-9-Fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylate, CAS: /, stock: 3.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₄FN₃O₄.

Ethyl (S)-2-(Benzyloxy)propionate, CAS: 54783-72-1, stock: 9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆O₃.

Ethyl 3-Oxo-3-(2,3,4-trifluorophenyl)propanoate, CAS: 157766-27-3, stock: 1.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₉F₃O₃.

α-[(Dimethylamino)methylene]-2,3,4,5-tetrafluoro-β-oxo-benzenepropanoic Acid Ethyl Ester, CAS: 138998-47-7, stock: 8.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₃F₄NO₃.

Levofloxacin, CAS: 100986-85-4, stock: 9.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₀FN₃O₄.

Levofloxacin Acyl-2,3,4-tri-O-acetyl-β-D-glucuronide Methyl Ester, CAS: /, stock: 6.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₆FN₃O₁₃.

Levofloxacin Acyl-β-D-glucuronide 80%, CAS: 160962-46-9, stock: 1.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₈FN₃O₁₀.

Levofloxacin Acyl-β-D-glucuronide Methyl Ester, CAS: /, stock: 4.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₀FN₃O₁₀.

Levofloxacin Carboxylic Acid (Levofloxacin Difluoro Impurity), CAS: 100986-89-8, stock: 9.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₉F₂NO₄.

Levofloxacin Chloromethyl Ester, CAS: /, stock: 7.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₁ClFN₃O₄.

Levofloxacin Difluoroboryl Ester-d3, CAS: /, stock: 3.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₆D₃BF₃N₃O₄.

Levofloxacin Ethyl Ester, CAS: 177472-30-9, stock: 5.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₄FN₃O₄.

Levofloxacin Hemihydrate, CAS: 138199-71-0, stock: 3.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₀FN₃O₄ •1/2 H ₂O.

Levofloxacin Hydrochloride, CAS: 177325-13-2, stock: 5.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₀FN₃O₄ • (HCl).

Levofloxacin Hydroxy Acid, CAS: 1036016-10-0, stock: 1.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₁F₂N₃O₄.

Levofloxacin mesylate, CAS: 226578-51-4, stock: 3.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₄FN₃O₇S.

Levofloxacin Methyl Ester, CAS: 862690-19-5, stock: 8.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₂FN₃O₄.

Levofloxacin N-oxide, CAS: 117678-38-3, stock: 5.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₀FN₃O₅.

Levofloxacin N-oxide Acetic Acid Salt, CAS: /, stock: 8.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₄FN₃O₇.

Levofloxacin Q-Acid Difluoroboryl Ester, CAS: 129306-33-8, stock: 3.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₈BF₄NO₄.

Levofloxacin-d3, CAS: /, stock: 1.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₇D₃FN₃O₄.

Levofloxacin-d3 Sodium Salt, CAS: /, stock: 7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₆D₃FN₃NaO₄.

Levofloxacin-d8, CAS: 1217716-71-6, stock: 9.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₂D₈FN₃O₄.

Levofloxacin-d8 Acyl-β-D-glucuronide, CAS: /, stock: 9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₀D₈FN₃O₁₀.

Levofloxacin-d8 Chloromethyl Ester, CAS: /, stock: 6.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₃D₈ClFN₃O₄.

Methyl (R)-2-(Benzyloxy)propionate, CAS: 115458-99-6, stock: 5.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄O₃.

N,N-Didesethylene Levofloxacin Hydrochloride, CAS: 1797099-76-3, stock: 7.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₇ClFN₃O₄.

N,N’-Desethylene Levofloxacin Hydrochloride, CAS: 1346603-62-0, stock: 5.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₉ClFN₃O₄.

N,N’-Desethylene-N,N’-diformyl Levofloxacin, CAS: 151377-74-1, stock: 2.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₈FN₃O₆.

N,N’-Desethylene-N,N’-diformyl Levofloxacin-d3, CAS: 1346598-04-6, stock: 1.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₅D₃FN₃O₆.

N-Boc N,N-Didesthylene Levofloxacin, CAS: /, stock: 9.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₄FN₃O₆.

N-tert-Butoxycarbonyl Desmethyl Levofloxacin, CAS: 1330277-19-4, stock: 5.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₆FN₃O₆.

rac Ethyl 2-(Benzyloxy)propionate, CAS: 2040-44-0, stock: 3.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆O₃.

3-N-[(S)-4-Amino-2-hydroxybutyryl]kanamycin B, CAS: /, stock: 8.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₄₄N₆O₁₂.

6-O-[3-Acetamido-3-deoxy-α-D-glucopyranosyl]-4-O-(6-acetamido-3,6-dideoxy-3-nitrohexopyranosyl)-N,N’-diacetyl-2-deoxy-D-streptamine, CAS: 20971-00-0, stock: 2.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₄₃N₅O₁₆.

BB-K 6 N-(Benzyloxy) Carbamate, CAS: /, stock: 1.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₄₉N₅O₁₅.

Carbonochloridic Acid Octadecyl Ester, CAS: 51637-93-5, stock: 7.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₃₇ClO₂.

Gentamicin Deuterated  (C Complex) Pentaacetate Salt(Contains d0), CAS: /, stock: 3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  NA.

Gentamicin Sulfate Salt (C Complex), CAS: 1405-41-0, stock: 5.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  NA.

Hexanoyl Chloride, CAS: 142-61-0, stock: 8.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁ClO.

Hexanoyl Chloride-d11, CAS: /, stock: 6.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆D₁₁ClO.

Kanamycin, CAS: 08/07/8063, stock: 2.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₆N₄O₁₁.

Kanamycin A, CAS: 59-01-8, stock: 1.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₆N₄O₁₁.

Kanamycin A Deuterated, CAS: 1174286-24-8, stock: 3.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₆N₄O₁₁ for undeuterated.

Kanamycin Acid Sulfate, CAS: 64013-70-3, stock: 5.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₆N₄O₁₁ •  x(H₂O₄S).

Kanamycin B, CAS: 4696-76-8, stock: 3.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₇N₅O₁₀.

Kanamycin B Sulfate, CAS: 29701-07-3, stock: 3.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₇N₅O₁₀•  x(H₂O₄S).

Kanamycin Sulfate, CAS: 70560-51-9, stock: 4.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₆N₄O₁₁ • ( H₂O₄S).

L(-)-γ-(Benzyloxycarbonylamino)-α-hydroxybutyric Acid N-Hydroxysuccinimide Ester, CAS: 40371-52-6, stock: 6.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈N₂O₇.

Tetra-N-acetyl Kanamycin A, CAS: 20399-23-9, stock: 5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₄₄N₄O₁₅.

Tetra-N-acetyl Seco-kanamycin A Dialdehyde, CAS: /, stock: 5.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₄₀N₄O₁₄.

(±)-Dihydrokaempferol, CAS: 104486-98-8, stock: 6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂O₆.

Engeletin, CAS: 572-31-6, stock: 2.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₂O₁₀.

Kaempferitrin, CAS: 482-38-2, stock: 5.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₀O₁₄.

Kaempferol 3-O-α-L-Rhamnoside, CAS: 482-39-3, stock: 3.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₀O₁₀.

Kaempferol 3-O-β -Rutinoside (Nicotiflorin), CAS: 17650-84-9, stock: 6.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₀O₁₅.

Kaempferol-3-O-robinoside-7-O-glucoside, CAS: 114924-89-9, stock: 4.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₄₀O₂₀.

Kaempferol-7,4’-dimethoxy-8-butyryl Ester, CAS: 1284229-43-1, stock: 3.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₀O₇.

SL0101, CAS: 77307-50-7, stock: 6.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₄O₁₂.

Tiliroside, CAS: 20316-62-5, stock: 2.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₂₆O₁₃.

Jatrorrhizine Chloride, CAS: 6681-15-8, stock: 4.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₀ClNO₄.

Jatrorrhizine Hydroxide, CAS: 483-43-2, stock: 5.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₁NO₅.

Jatrorrhizine Iodide, CAS: 1168-00-9, stock: 7.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₀NO₄.

Desmethyl Jaboticabin Ethyl Carboxylate, CAS: 1404192-74-0, stock: 9.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₆O₈.

Jaboticabin, CAS: 911315-93-0, stock: 7.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄O₈.

2,3-Dehydro-3,4-dihydro Ivermectin (Mixture of Diastereomers), CAS: 1135339-49-9, stock: 1.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₈H₇₄O₁₄.

28-Oxo Ivermectin B1a (Impurity), CAS: 102190-55-6, stock: 8.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₈H₇₂O₁₅.

3,4-Dihydro Ivermectin (Mixture of Diastereomers), CAS: 74567-01-4, stock: 1.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₈H₇₆O₁₄.

5-O-Demethyl-4’’,5-bis-O-[(1,1-dimethylethyl)dimethylsilyl]-22,23-dihydro-28-oxo-Avermectin A1a, CAS: 102190-51-2, stock: 5.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₀H₁₀₀O₁₅Si₂.

5-O-Demethyl-4’’,5-bis-O-[(1,1-dimethylethyl)dimethylsilyl]-22,23-dihydro-Avermectin A1a, CAS: 82590-57-6, stock: 9.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₀H₁₀₂O₁₄Si₂.

7-O-Methyl Ivermectin B1a, CAS: /, stock: 2.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₉H₇₆O₁₄.

Ivermectin 8α-Hydroperoxide, CAS: /, stock: 9.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₈H₇₄O₁₆.

Ivermectin B1 Aglycon, CAS: 73162-95-5, stock: 9.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₅₀O₈.

Ivermectin B1 Monosaccharide, CAS: 71837-27-9, stock: 4.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₁H₆₂O₁₁.

(1S)-4,5-Dimethoxy-1-[(methylamino)methyl]benzocyclobutane Hydrochloride, CAS: 866783-13-3, stock: 9.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈ClNO₂.

(7R)-3,4-Dimethoxy-N-methyl-bicyclo[4.2.0]octa-1,3,5-triene-7-methanamine Hydrochloride, CAS: 1204612-29-2, stock: 6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈ClNO₂.

(R)-1-(3,4-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)-N,N-dimethylmethanamine, CAS: /, stock: 5.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₉NO₂.

(R)-1-(3,4-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)-N-methylmethanamine, CAS: 1132667-04-9, stock: 4.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇NO₂.

(S)-N-((3,4-Dimethoxybicyclo[4.2.0]octa-1(6),2,4-trien-7-yl)methyl)-N-methylacetamide, CAS: /, stock: 9.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉NO₃.

1,3,4,5-Tetrahydro-3-(3-hydroxypropyl)-7,8-dimethoxy-2H-3-benzazepin-2-one, CAS: 1235547-07-5, stock: 9.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₁NO₄.

1,3,4,5-Tetrahydro-7,8-dimethoxy-3-[3-(methylamino)propyl]-2H-3-benzazepin-2-one, CAS: 85175-77-5, stock: 7.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₄N₂O₃.

2-Oxo-ivabradine Hydrochloride, CAS: 1616710-50-9, stock: 6.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₅ClN₂O₆.

3,3’-(Propane-1,3-diyl)bis(7,8-dimethoxy-1H-benzo[d]azepin-2(3H)-one), CAS: /, stock: 7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₀N₂O₆.

3,3’-(Propane-1,3-diyl)bis(7,8-dimethoxy-4,5-dihydro-1H-benzo[d]azepin-2(3H)-one), CAS: /, stock: 2.7g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₄N₂O₆.

3,3’-(Propane-1,3-diyl)bis(7,8-dimethoxy-4,5-dihydro-1H-benzo[d]azepin-2(3H)-one), CAS: /, stock: 3.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₄N₂O₆.

3,3’-(Propane-1,3-diyl)bis(7,8-dimethoxy-4,5-dihydro-1H-benzo[d]azepin-2(3H)-one)-d6, CAS: /, stock: 6.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₈D₆N₂O₆.

3-(3-Chloropropyl)-1,3,4,5-tetrahydro-7,8-dimethoxy-2H-3-benzazepin-2-one, CAS: 85175-65-1, stock: 2.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₀ClNO₃.

3-(3-Chloropropyl)-1,3,4,5-tetrahydro-7,8-dimethoxy-2H-3-benzazepin-2-one-d6, CAS: /, stock: 5.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄D₆ClNO₃.

4,5-Dimethoxy-1,2-benzenacetic Acid, CAS: 1000517-77-0, stock: 9.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂O₄.

4,5-Dimethoxy-1-(aminomethyl)benzocyclobutane, CAS: 73344-75-9, stock: 5.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅NO₂.

7,8-Dimethoxy-1H-3-benzazepine-2,4(3H,5H)-dione, CAS: 85175-49-1, stock: 6.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃NO₄.

7-Demethyl Ivabradine, CAS: 304462-60-0, stock: 9.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₄N₂O₅.

8-Demethyl Ivabradine, CAS: 304464-97-9, stock: 8.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₄N₂O₅.

Dehydro Ivabradine, CAS: 1086026-31-4, stock: 6.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₄N₂O₅.

Dehydro Ivabradine-d3, CAS: 1795787-01-7, stock: 1.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₁D₃N₂O₅.

ent-Ivabradine Hydrochloride, CAS: 148849-68-7, stock: 9.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₇ClN₂O₅.

Ivabradine Hydrochloride, CAS: 148849-67-6, stock: 3.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₇ClN₂O₅.

Ivabradine N-oxide, CAS: /, stock: 1.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₆N₂O₆.

Ivabradine-d3 Hydrochloride, CAS: 1217809-61-4, stock: 8.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₄D₃ClN₂O₅.

Ivabradine-d3 N-oxide, CAS: /, stock: 9.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₃D₃N₂O₆.

Ivabradine-d4 Hydrochloride, CAS: /, stock: 4.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₃D₄ClN₂O₅.

N-(2,2-Dimethoxyethyl)-3,4-dimethoxybenzeneacetamide(Ivabradine Impurity), CAS: 73954-34-4, stock: 9.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₁NO₅.

N-Demethyl Ivabradine Hydrochloride, CAS: 1246638-08-3, stock: 3.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₅ClN₂O₅.

N-Demethyl Ivabradine-d4 Hydrochloride, CAS: 1346600-74-5, stock: 2.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₁D₄ClN₂O₅.

N-Demethylivabradine, CAS: 215935-23-2, stock: 7.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₄N₂O₅.

N-Propyl-7,8-dimethoxy-1,3,4,5-tetrahydro-2H-3-benzazepin-2-one, CAS: /, stock: 1.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₁NO₃.

rac-4-O-Desmethyl Ivabradine Hydrochloride, CAS: /, stock: 1.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₅ClN₂O₅.

[[(7S)-3,4-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl]-carbamic Acid Ethyl Ester, CAS: /, stock: 1.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉NO₄.

((2R,4R)-2-(Chloromethyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methyl 4-Methylbenzenesulfonate, CAS: /, stock: 5.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₇Cl₃O₅S.

((2R,4S)-2-(Chloromethyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methyl 4-Methylbenzenesulfonate, CAS: /, stock: 4.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₇Cl₃O₅S.

((2S,4R)-2-(Chloromethyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methyl 4-Methylbenzenesulfonate, CAS: /, stock: 2.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₇Cl₃O₅S.

((2S,4S)-2-(Chloromethyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methyl 4-Methylbenzenesulfonate, CAS: /, stock: 1.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₇Cl₃O₅S.

(1,2,4-Triazol-4-yl) Itraconazole, CAS: 854372-77-3, stock: 2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₃₈Cl₂N₈O₄.

(2R,4R)-Itraconazole (Mixture of Diastereomers), CAS: /, stock: 5.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₃₈Cl₂N₈O₄.

(2R,4R)-Itraconazole-d5 (Mixture of Diastereomers), CAS: /, stock: 1.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₃₃D₅Cl₂N₈O₄.

(2R,4S)-Itraconazole (Mixture of Diastereomers), CAS: 873066-43-4, stock: 6.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₃₈Cl₂N₈O₄.

(2R,4S)-Itraconazole-d5 (Mixture of Diastereomers), CAS: /, stock: 5.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₃₃D₅Cl₂N₈O₄.

(2S,4R)-Itraconazole (Mixture of Diastereomers), CAS: 939027-87-9, stock: 9.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₃₈Cl₂N₈O₄.

(2S,4R)-Itraconazole-d5 (Mixture of Diastereomers), CAS: /, stock: 7.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₃₃D₅Cl₂N₈O₄.

(2S,4S)-Itraconazole (Mixture of Diastereomers), CAS: 916910-37-7, stock: 2.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₃₈Cl₂N₈O₄.

(2S,4S)-Itraconazole-d5 (Mixture of Diastereomers), CAS: /, stock: 8.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₃₃D₅Cl₂N₈O₄.

(4-(4-(4-(((2R,4S)-2-((1H-1,2,4-Triazol-1-yl)methyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methoxy)phenyl)piperazin-1-yl)phenyl)carbamic Acid Phenyl Ester, CAS: 89848-11-3, stock: 6.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₃₄Cl₂N₆O₅.

1-(3-Hydroxybutan-2-yl)-4-(4-(4-(4-hydroxyphenyl)piperazin-1-yl)phenyl)-1H-1,2,4-triazol-5(4H)-one, CAS: 125272-25-5, stock: 2.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₇N₅O₃.

1-(4-(((2R,4S)-2-((1H-1,2,4-Triazol-1-yl)methyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methoxy)phenyl)-4-(4-(4H-1,2,4-triazol-4-yl)phenyl)piperazine, CAS: /, stock: 3.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₀Cl₂N₈O₃.

1-(4-Methoxyphenyl)piperazine Hydrochloride, CAS: 84145-43-7, stock: 8.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₇ClN₂O.

1-(4-Methoxyphenyl)piperazine-d8, CAS: /, stock: 1.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₈D₈N₂O.

1-(4-Nitrophenyl)piperazine, CAS: 6269-89-2, stock: 1.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃N₃O₂.

1-(sec-Butyl)-4-(4-(4-(4-(((2R,4R)-2-(chloromethyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-1H-1,2,4-triazol-5(4H)-one, CAS: /, stock: 6.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₆Cl₃N₅O₄.

1-(sec-Butyl)-4-(4-(4-(4-(((2R,4S)-2-(chloromethyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-1H-1,2,4-triazol-5(4H)-one, CAS: /, stock: 1.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₆Cl₃N₅O₄.

1-(sec-Butyl)-4-(4-(4-(4-(((2S,4R)-2-(chloromethyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-1H-1,2,4-triazol-5(4H)-one, CAS: /, stock: 2.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₆Cl₃N₅O₄.

1-(sec-Butyl)-4-(4-(4-(4-(((2S,4S)-2-(chloromethyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-1H-1,2,4-triazol-5(4H)-one, CAS: /, stock: 5.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₆Cl₃N₅O₄.

1-Boc-4-(4-aminophenyl)piperazine, CAS: 170911-92-9, stock: 1.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₃N₃O₂.

1-[4-[[(2R,4S)-2-(2,4-Dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-4-(4-nitrophenyl)piperazine, CAS: 1437468-92-2, stock: 7.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₈Cl₂N₆O₅.

2,4-Dihydro-4-[4-[4-(4-hydroxyphenyl]-1-piperazinyl]phenyl]-2-(1-methylpropyl)-3H-1,2,4-triazol-3-one, CAS: 106461-41-0, stock: 2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₇N₅O₂.

2-(2,4-Dichlorophenyl)-2-(1H-1,2,4-triazol-1-yl-methyl)-1,3-dioxolan-4-yl]methyloxy-phenylformamide, CAS: /, stock: 3.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₈Cl₂N₄O₄.

2-(2-Butyl)-4-{4-[4-(4-methyloxy-phenyl)-piperazin-1-yl]-phenyl}-2,4-dihydro-[1,2,4]-triazol-3-one, CAS: 252964-68-4, stock: 3.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₉N₅O₂.

2-(2-Butyl-d3)-4-{4-[4-(4-methyloxy-phenyl)-piperazin-1-yl]-phenyl}-2,4-dihydro-[1,2,4]-triazol-3-one, CAS: /, stock: 7.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₆D₃N₅O₂.

2-Desbutyl-2-isopentyl-5-methyl Itraconazole, CAS: 1217692-26-6, stock: 7.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₄₂Cl₂N₈O₄.

2-sec-Butyl-4-[(Piperazinyl-1-yl)-phenyl]-1,2,4-triazol-3-one Dihydrochloride, CAS: 146091-05-6, stock: 1.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₅Cl₂N₅O.

4,5-Dimethyl-1,3,2-dioxathiolane 2,2-dioxide, CAS: 4440-89-5, stock: 5.5g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₈O₄S.

4-(4-(4-(4-Hydroxyphenyl)piperazin-1-yl)phenyl)-1-(prop-1-en-2-yl)-1H-1,2,4-triazol-5(4H)-one, CAS: /, stock: 6.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₃N₅O₂.

4-(4-(4-(4H-1,2,4-Triazol-4-yl)phenyl)piperazin-1-yl)phenol, CAS: /, stock: 4.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₉N₅O.

4-(4-(4-(4H-1,2,4-Triazol-4-yl)phenyl)piperazin-1-yl)phenyl Acetate, CAS: /, stock: 5.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₁N₅O₂.

4-(4-(7-(((2R,4S)-2-((1H-1,2,4-Triazol-1-yl)methyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methoxy)-2,3-dihydro-1H-benzo[e][1,4]diazepin-4(5H)-yl)phenyl)-1-(sec-butyl)-1H-1,2,4-triazol-5(4H)-one, CAS: /, stock: 3.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₃₆Cl₂N₈O₄.

4-[4-(4-Methyloxy-phenyl)-piperazin-1-yl]-phenylamine, CAS: 74852-62-3, stock: 4.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₁N₃O.

4-[4-(4-Nitrophenyl)-1-piperazinyl]phenol, CAS: 112559-81-6, stock: 8.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇N₃O₃.

4-{[4-(4-Methyloxyphenyl)-piperazin-1-yl]-phenyl}-2,4-dihydro-[1,2,4]-triazol-3-one, CAS: 74853-07-9, stock: 3.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₁N₅O₂.

Butyl Itraconazole, CAS: 89848-51-1, stock: 9.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₃₈Cl₂N₈O₄.

cis-2-(2,4-Dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolane-4-methanol, CAS: 67914-85-6, stock: 1.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₃Cl₂N₃O₃.

cis-2-(2,4-Dichlorophenyl)-2-(4H-1,2,4-triazol-4-ylmethyl)-1,3-dioxolane-4-methanol, CAS: 84499-45-6, stock: 1.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₃Cl₂N₃O₃.

cis-[2-(2,4-Dichlorophenyl)-2-(1H-1,2,4-triazol-1-yl-methyl)-1,3-dioxolan-4-yl]methyl Methanesulfonate, CAS: 67914-86-7, stock: 9.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₅Cl₂N₃O₅S.

cis-[2-(2,4-Dichlorophenyl)-2-(1H-1,2,4-triazol-4-yl-methyl)-1,3-dioxolan-4-yl]methyl Methanesulfonate, CAS: 103661-14-9, stock: 2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₅Cl₂N₃O₅S.

De-1-((2-(2,4-dichlorophenyl)-1,3-dioxolan-2-yl)methyl)-1H-1,2,4-triazole Itraconazole Sulfate, CAS: 765882-88-0, stock: 6.3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₉N₅O₆S.

Deoxo Anhydro Itraconazole Bromide, CAS: /, stock: 8.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₃₉BrCl₂N₈O₃.

Des-(1-(sec-butyl)-1H-1,2,4-triazol-5(4H)-one) Itraconazole, CAS: 1437468-62-6, stock: 4.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₀Cl₂N₆O₃.

Des-(2-butyl) N-Allyl Itraconazole, CAS: 89848-54-4, stock: 2.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₃₄Cl₂N₈O₄.

Des-(2-butyl) N-Allyl Itraconazole-D5, CAS: /, stock: 5.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₂₉D₅Cl₂N₈O₄.

Deshydroxypentanyl Posaconazole, CAS: 161532-56-5, stock: 6.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₂F₂N₈O₃.

Deshydroxypentanyl Posaconazole-d4, CAS: /, stock: 5.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₂₈D₄F₂N₈O₃.

Des[2-(1,2,4-triazolyl)] Itraconazole-2-isocyanate, CAS: 1246812-37-2, stock: 2.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₃₆Cl₂N₆O₅.

Hydroxy Itraconazole, CAS: 112559-91-8, stock: 5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₃₈Cl₂N₈O₅.

Hydroxy Itraconazole O-β-D-Glucuronide Sodium Salt, CAS: /, stock: 4.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₁H₄₅Cl₂N₈NaO₁₁.

Hydroxy Itraconazole-d5, CAS: 1217524-77-0, stock: 1.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₃₃D₅Cl₂N₈O₅.

Hydroxy Itraconazole-d8, CAS: 1217516-26-1, stock: 9.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₃₀D₈Cl₂N₈O₅.

Isopropyl Itraconazole, CAS: 89848-49-7, stock: 5.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₃₆Cl₂N₈O₄.

Itraconazole, CAS: 84625-61-6, stock: 1.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₃₈Cl₂N₈O₄.

Itraconazole Desethylene-seco-piperazine, CAS: /, stock: 1.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₆Cl₂N₈O₄.

Itraconazole Desethylene-seco-piperazine Di-N-formyl Impurity, CAS: 1199350-02-1, stock: 9.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₃₆Cl₂N₈O₆.

Itraconazole Desethylene-seco-piperazine Mono-N-formyl Impurity, CAS: 1199350-00-9, stock: 4.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₃₆Cl₂N₈O₅.

Itraconazole Didioxolonyl Impurity, CAS: /, stock: 7.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₄₁Cl₄N₁₁O₆.

Itraconazole Imidazolium Impurity, CAS: /, stock: 2.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₃₅Cl₃N₈O₄.

Itraconazole N,N-Dioxide, CAS: /, stock: 3.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₃₈Cl₂N₈O₆.

Itraconazole-d3, CAS: 1217512-35-0, stock: 7.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₃₅D₃Cl₂N₈O₄.

Itraconazole-d5 (major), CAS: 1217510-38-7, stock: 4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₃₃D₅Cl₂N₈O₄.

Itraconazole-d9, CAS: /, stock: 5.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₂₉D₉Cl₂N₈O₄.

Keto Itraconazole, CAS: 112560-33-5, stock: 1.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₃₆Cl₂N₈O₅.

Keto Itraconazole-d8, CAS: /, stock: 1.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₂₈D₈Cl₂N₈O₅.

N-(Desisobutyl) N-[(4-Carboxymethyl)phenyl] Itraconazole, CAS: /, stock: 2.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₃₆Cl₂N₈O₆.

N-Desalkyl Itraconazole, CAS: 89848-41-9, stock: 4.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₀Cl₂N₈O₄.

N-Desalkyl Itraconazole-d8, CAS: /, stock: 2.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₂₂D₈Cl₂N₈O₄.

Propyl Itraconazole, CAS: 74855-91-7, stock: 6.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₃₆Cl₂N₈O₄.

rel-4-(4-(4-(4-(((2R,4S)-2-((1H-1,2,4-Triazol-1-yl)methyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-1-(prop-1-en-2-yl)-1H-1,2,4-triazol-5(4H)-one, CAS: /, stock: 7.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₃₄Cl₂N₈O₄.

trans-Itraconazole, CAS: 252964-65-1, stock: 7.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₃₈Cl₂N₈O₄.

trans-[2-(2,4-Dichlorophenyl)-2-(1H-1,2,4-triazol-1-yl-methyl)-1,3-dioxolan-4-yl]methyl Methanesulfonate, CAS: 854372-78-4, stock: 9.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₅Cl₂N₃O₅S.

(3S,6R,7S,8S)-11-((2R,3S)-3-((S,E)-2-Azido-3-methyl-4-(2-methylthiazol-4-yl)but-3-en-1-yl)-2-methyloxiran-2-yl)-3,7-dihydroxy-4,4,6,8-tetramethyl-5-oxoundecanoic Acid, CAS: /, stock: 8.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₂N₄O₆S.

(4S,7R,8S,9S,13R,14R)-14-((S,E)-2-Amino-3-methyl-4-(2-methylthiazol-4-yl)but-3-en-1-yl)-4,8,13-trihydroxy-5,5,7,9,13-pentamethyloxacyclotetradecane-2,6-dione, CAS: /, stock: 2.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₄N₂O₆S.

(Z)-Ixabepilone, CAS: 1220999-07-4, stock: 2.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₂N₂O₅S.

BMS 249798, CAS: 444197-71-1, stock: 1.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₂N₂O₅S.

BMS 326412, CAS: 1220999-09-6, stock: 6.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₄N₂O₆S.

BMS 567637, CAS: 1220999-08-5, stock: 1.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₂N₂O₅S.

Ixabepilone, CAS: 219989-84-1, stock: 7.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₂N₂O₅S.

4-Desmethyl Istradefylline, CAS: 160434-48-0, stock: 8.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₂N₄O₄.

4-Desmethyl Istradefylline-d3,13C, CAS: /, stock: 8.9g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈¹³CH₁₉D₃N₄O₄.

Istradefylline, CAS: 155270-99-8, stock: 4.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₄N₄O₄.

Istradefylline Dimer, CAS: /, stock: 9.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₅₀N₈O₈.

Istradefylline M8, CAS: 1798429-54-5, stock: 7.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₄N₄O₅.

Istradefylline M8-d3,13C, CAS: /, stock: 9.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉¹³CH₂₁D₃N₄O₅.

Istradefylline-d3,13C, CAS: /, stock: 9.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉¹³CH₂₁D₃N₄O₄.

4-Benzofurazancarboxaldehyde, CAS: 32863-32-4, stock: 2.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₄N₂O₂.

Dehydro Isradipine, CAS: 116169-18-7, stock: 3.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₉N₃O₅.

Isradipine Lactone, CAS: 1076198-34-9, stock: 3.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₇N₃O₅.

11-cis,13-cis-Retinoic Acid >90%, CAS: 3555-80-4, stock: 5.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₈O₂.

11-cis-Retinoic Acid, CAS: 68070-35-9, stock: 4.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₈O₂.

13-cis Retinoyl β-D-Glucuronide, >85% By HPLC, CAS: 78147-42-9, stock: 2.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₆O₈.

13-cis-Retinoic Acid, CAS: 4759-48-2, stock: 6.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₈O₂.

13-cis-Retinoic Acid-13C3, CAS: /, stock: 5.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇¹³C₃H₂₈O₂.

13-cis-Retinoic Acid-d5, CAS: 78996-15-3, stock: 2.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₃D₅O₂.

13-cis-Retinoic Acid-d5, CAS: /, stock: 5.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₃D₅O₂.

4-Hydroxy-13-cis-retinoic Acid, CAS: 75281-25-3, stock: 9.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₈O₃.

4-Keto 13-cis-Retinoic Acid, CAS: 71748-58-8, stock: 5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₆O₃.

4-Keto 13-cis-Retinoic Acid-d3, CAS: 1185241-31-9, stock: 5.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₃D₃O₃.

4-Keto 13-cis-Retinoic Acid-d6, CAS: /, stock: 5.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₀D₆O₃.

5,6-Epoxy-13-cis Retinoic Acid, CAS: 81444-57-7, stock: 7.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₈O₃.

9-cis,13-cis-Retinoic Acid, ~85%, CAS: 5352-74-9, stock: 3.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₈O₂.

9-cis-Retinoic Acid, CAS: 08/03/5300, stock: 4.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₈O₂.

all-trans-Retinoic Acid, CAS: 302-79-4, stock: 2.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₈O₂.

Isothipendyl Hydrochloride, CAS: 1225-60-1, stock: 9.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₀ClN₃S.

Isothipendyl-d6, CAS: 1330265-10-5, stock: 6.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₃D₆N₃S.

2-Methyl-3-isothiazolone-d3 Hydrochloride, CAS: 1329509-49-0, stock: 8.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₃D₃ClNOS.

2-Methyl-4-isothiazolin-3-one Hydrochloride, CAS: 26172-54-3, stock: 6.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₆ClNOS.

2-Methyl-4-isothiazolin-3-one-d3 Hydrochloride, CAS: /, stock: 7.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₂D₃NOS  • (HCl).

4,5-Dichloro-2-methylisothiazol-3-one, CAS: 26542-23-4, stock: 1.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₃Cl₂NOS.

4,5-Dichloro-2-methylisothiazol-3-one-d3, CAS: /, stock: 1.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄D₃Cl₂NOS.

5-Chloro-2-methyl-3-isothiazolone, CAS: 26172-55-4, stock: 4.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₄ClNOS.

5-Chloro-2-methyl-3-isothiazolone-d3, CAS: 1329611-34-8, stock: 4.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄HD₃ClNOS.

Isosorbide, CAS: 652-67-5, stock: 7.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₀O₄.

Isosorbide 2-Mononitrate 5-β-D-Glucuronide, CAS: 89576-61-4, stock: 5.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇NO₁₂.

Isosorbide 2-Mononitrate 5-β-D-Glucuronide-13C6, CAS: /, stock: 3.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆¹³C₆H₁₇NO₁₂.

Isosorbide 2-Nitrate, CAS: 16106-20-0, stock: 6.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉NO₆.

Isosorbide 5-β-D-Glucuronide, CAS: 29542-01-6, stock: 6.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈O₁₀.

Isosorbide 5-β-D-Glucuronide-13C6, CAS: /, stock: 7.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆¹³C₆H₁₈O₁₀.

Isosorbide 5-Mononitrate, CAS: 16051-77-7, stock: 2.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉NO₆.

Isosorbide 5-Mononitrate (1.0 mg/mL in Dimethyl Sulfoxide), CAS: 16051-77-7, stock: 8.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉NO₆.

Isosorbide 5-Mononitrate 2-β-D-Glucuronide, CAS: 32871-20-8, stock: 6.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇NO₁₂.

Isosorbide 5-Mononitrate-13C6 2-β-D-Glucuronide, CAS: /, stock: 3.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆¹³C₆H₁₇NO₁₂.

Isosorbide Dinitrate, CAS: 87-33-2, stock: 5.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₈N₂O₈.

Isosorbide-13C6, CAS: 1322623-36-8, stock: 3.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₆H₁₀O₄.

Isosorbide-13C6 2-Nitrate (>90%), CAS: 1391051-97-0, stock: 3.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₆H₉NO₆.

Isosorbide-13C6 5-Mononitrate, 90%, CAS: 1217604-00-6, stock: 8.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₆H₉NO₆.

Isosorbide-13C6 Dinitrate, CAS: 1246815-45-1, stock: 5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₆H₈N₂O₈.

Isosorbide-D8, CAS: /, stock: 5.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₂D₈O₄.

4-Isopropylaniline, CAS: 99-88-7, stock: 8.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₃N.

Isoproturon, CAS: 34123-59-6, stock: 9.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈N₂O.

Isoproturon-13C6, CAS: /, stock: 8.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆¹³C₆H₁₈N₂O.

Isoproturon-d3, CAS: 352438-80-3, stock: 3.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅D₃N₂O.

Isoproturon-d6, CAS: 217487-17-7, stock: 6.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₂D₆N₂O.

(+/-)-Pronethalol, CAS: 54-80-8, stock: 1.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₉NO.

(+/-)-Pronethalol-d6, CAS: 1329805-79-9, stock: 1.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₃D₆NO.

5,5’,6,6’-Tetrakis(methoxymethoxy)-indigotin, CAS: 858230-17-8, stock: 4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₆N₂O₁₀.

5,5’,6,6’-Tetrakis(methoxymethoxy)-indigotin N,N’-Diisopropyl, CAS: /, stock: 9.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₈N₂O₁₀.

5,5’,6,6’-Tetrakis(methoxymethoxy)-indigotin N-Isopropyl, CAS: /, stock: 9.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₂N₂O₁₀.

Cetamolol, CAS: 34919-98-7, stock: 3.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₆N₂O₄.

Cetamolol-d9, CAS: /, stock: 1.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇D₉N₂O₄.

Isoproterenol-d7 Hydrochloride, CAS: /, stock: 6.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁D₇ClNO₃.

N,N’-Diisopropyl-5,6,5’,6’-tetrahydroxy Indigo, 90%, CAS: /, stock: 2.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₂N₂O₆.

N,N’-Diisopropyl-5,6,5’,6’-tetrahydroxy Indigo-d14, CAS: /, stock: 6.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₈D₁₄N₂O₆.

p-O-Methyl-isoproterenol Hydrochloride, CAS: /, stock: 7.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₉NO₃ •HCl.

p-O-Methyl-isoproterenol-d3 Hydrochloride, CAS: /, stock: 7.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆D₃NO₃  •HCl.

p-O-Methyl-isoproterenol-d7 Hydrochloride, CAS: /, stock: 4.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₂D₇NO₃ •HCl.

Isoprenaline Sulphate, CAS: 299-95-6, stock: 6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ₂[C₁₁H₁₇NO₃].H₂O₄S.

N-Isopropyldopamine Hydrochloride, CAS: 5178-52-9, stock: 6.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₈ClNO₂.

(+)-(S)-Tylophorine, CAS: 482-20-2, stock: 6.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₇NO₄.

(+)-(S)-Tylophorine-d8, CAS: 1795785-68-0, stock: 1.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₁₉D₈NO₄.

(+)-Erythraline, CAS: 466-77-3, stock: 1.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₉NO₃.

(+)-Papaveroxinoline, CAS: 106982-93-8, stock: 5.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₉NO₈.

(+)-Papaveroxinoline Acetate, CAS: 106982-95-0, stock: 2.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₁NO₉.

(+)-Rheadine, CAS: 2718-25-4, stock: 8.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₁NO₆.

(+)-Tubocurarine Dichloride, CAS: 57-94-3, stock: 3.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₄₁N₂O₆ • HCl • Cl.

(-)-Isocorypalmine, CAS: 483-34-1, stock: 4.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₃NO₄.

(-)-α-Narcotinediol, CAS: 23942-99-6, stock: 9.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₇NO₇.

(1-(Aminomethyl)cyclobutyl)methanol, CAS: 45513-32-4, stock: 5.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₃NO.

(13aS)​-13,​13a-​Dihydro-​2,​3,​6,​7-​tetramethoxydibenzo[f,​h]​pyrrolo[1,​2-​b]​isoquinoline-​11,​14(9H,​12H)​-​dione, CAS: 87227-03-0, stock: 5.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₃NO₆.

(1R)-1-[[3-(Trifluoromethyl)phenyl]methyl]-2-oxo-2-(1-pyrrolidinyl)ethyl]1,2,3,4-tetrahydro-6-isoquinolinesulfonamide Hydrochloride, CAS: 1627607-87-7, stock: 1.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₅F₄N₃O₃S •  x(HCl).

(1R,2S)-1-Amino-N-(cyclopropylsulfonyl)-2-vinylcyclopropanecarboxamide 4-methylbenzenesulfonate, CAS: 1028252-16-5, stock: 5.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₄N₂O₃S • (C  ₇H₈O₃S).

(1R,3S)-Solifenacin Hydrochloride, CAS: 180468-40-0, stock: 9.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₇ClN₂O₂.

(1R,3S-)Solifenacin-d5 Hydrochloride, CAS: 1217810-85-9, stock: 2.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₂D₅ClN₂O₂.

(1S)-3,4-Dihydro-1-phenyl-2(1H)-isoquinolinecarbonyl Chloride, CAS: 1195949-26-8, stock: 4.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄ClNO.

(1S)-3,4-Dihydro-1-phenyl-2(1H)-isoquinolinecarboxylic Acid 1-Methylethyl Ester, CAS: 1353274-25-5, stock: 7.1g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₁NO₂.

(1S)-3,4-Dihydro-1-phenyl-2(1H)-isoquinolinecarboxylic Acid 2,5-Dioxo-1-pyrrolidinyl Ester, CAS: 1534326-80-1, stock: 7.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₈N₂O₄.

(1S,3’S)-Solifenacin Succinate, CAS: 862207-71-4, stock: 7.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₂N₂O₆.

(1S,3S)-Solifenacin, CAS: 732228-02-3, stock: 9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₆N₂O₂.

(1S,3S)-Solifenacin Hydrochloride, CAS: 180468-38-6, stock: 4.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₇ClN₂O₂.

(1S,3S-)Solifenacin Hydrochloride-d5, CAS: /, stock: 8.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₂D₅ClN₂O₂.

(1S,4R)-(1R,3S,4R)-Quinuclidin-3-yl 4-hydroxy-1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate, CAS: /, stock: 4.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₆N₂O₃.

(2’R,5’S,11’S,14’S)-2’,11’,17’,17’-Tetramethyl-14’-{2-[4-(pyridin-2-yl)-1H-1’,2’,3’-triazol-1-yl]ethyl}-3’-oxa-9’,12’,15’,21’,29’-pentaazatetracyclo[18.5.3.15,9.023,²⁷]nonacosa-1’(26’),18’,20’,22’,24’,27’-hexaene-4’,10’,13’,16’-tetrone, CAS: 1510841-23-2, stock: 1.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₄₁N₉O₅.

(3-Oxopropyl)carbamic Acid tert-Butyl Ester, CAS: 58885-60-2, stock: 5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₅NO₃.

(3R)-1,2,3,4-Tetrahydro-3-isoquinolinemethanol, CAS: 62855-02-1, stock: 5.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃NO.

(3R)-2-Carbobenzoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid, CAS: 146684-74-4, stock: 8.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₇NO₄.

(3R)-N-[(1R)-1-[(4-Chlorophenyl)methyl]-2-[4-cyclohexyl-4-(1H-1,2,4-triazol-1-ylmethyl)-1-piperidinyl]-2-oxoethyl]-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide, CAS: 312637-48-2, stock: 6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₄₁ClN₆O₂.

(3S)-1,2,3,4-Tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic Acid, CAS: 103733-66-0, stock: 7.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅NO₄.

(3S)-1,2,3,4-Tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic Acid Hydrochloride, CAS: 82586-62-7, stock: 2.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆ClNO₄.

(3S)-1,2,3,4-Tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic Acid Phenylmethyl Ester Hydrochloride, CAS: 103733-32-0, stock: 1.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₂ClNO₄.

(3S)-1,2,3,4-Tetrahydroisoquinoline-3-(N-tert-Butylcarboxamide), CAS: 149182-72-9, stock: 8.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₀N₂O.

(3S)-2-(2,2-Diphenylacetyl)-1,2,3,4-tetrahydro-6-methoxy-5-(phenylmethoxy)-3-isoquinolinecarboxylic Acid Sodium Salt Dihydrate, CAS: 1356460-29-1, stock: 4.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₃NNaO₇.

(3S)-2-Carbobenzoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic Acid, CAS: 79261-58-8, stock: 9.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₇NO₄.

(3S,4aS,8aS)-2-Carbobenzyloxy-decahydro-3-isoquinolinecarboxylic Acid, CAS: 136465-85-5, stock: 4.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₃NO₄.

(3S,4aS,8aS)-2-Carbobenzyloxy-decahydro-N-(2-hydroxy-1,1-dimethylethyl)-3-isoquinolinecarboxamide, CAS: 213135-53-6, stock: 4.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₂N₂O₄.

(3S,4aS,8aS)-2-[(2R,3R)-3-Amino-2-hydroxy-4-(phenylthio)butyl]-N-(1,1-dimethylethyl)decahydro-3-isoquinolinecarboxamide, CAS: 159878-05-4, stock: 5.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₉N₃O₂S.

(3S,4aS,8aS)-2-[(2R,3R)-3-Amino-2-hydroxy-4-phenythiobutyl]-decahydro-3-isoquinolinecarboxylic Acid, CAS: 1221793-34-5, stock: 3.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₀N₂O₃S.

(3S,4aS,8aS)-2-[(2R,3R)-3-[(3-Acetoxy-2-methylbenzoyl)amino]-4-phenythiobutyl]-decahydro-N-(2-hydroxy-1,1-dimethylethyl)-3-isoquinolinecarboxamide, CAS: 1217807-30-1, stock: 3.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₄₇N₃O₆S.

(3S,4aS,8aS)-2-[(2R,3R)-3-[(3-Amino-2-hydroxy-4-phenythiobutyl]-decahydro-N-(2-hydroxy-1,1-dimethylethyl)-3-isoquinolinecarboxamide, CAS: 252186-41-7, stock: 5.3g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₉N₃O₃S.

(3S,4aS,8aS)-2-[(2R,3S)-3-Amino-2-hydroxy-4-phenylbutyl]-N-(1,1-dimethylethyl)decahydro-3-isoquinolinecarboxamide, CAS: 136522-17-3, stock: 8.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₉N₃O₂.

(3S,4aS,8aS)-2-[(2R,3S)-3-Amino-2-hydroxy-4-phenylbutyl]-N-(1,1-dimethylethyl)decahydro-3-isoquinolinecarboxamide-d9, CAS: /, stock: 1.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₀D₉N₃O₂.

(3S,4aS,8aS)-2-[(2R,3S)-3-tert-Butyloxycarbonylamino-2-hydroxy-4-phenylbutyl]-N-(1,1-dimethylethyl)decahydro-3-isoquinolinecarboxamide, CAS: 142580-65-2, stock: 10g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₄₇N₃O₄.

(3S,4aS,8aS)-Decahydro-N-(2-hydroxy-1,1-dimethylethyl)-2-[(2R,3R)-2-hydroxy-3-carbobenzyloxyamino-4-phenylthiobutyl]-3-isoquinolinecarboxamide, CAS: 213135-55-8, stock: 3.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₅N₃O₅S.

(3S,4aS,8aS)-Decahydro-N-(2-hydroxy-1,1-dimethylethyl)-3-isoquinolinecarboxamide, CAS: 213135-54-7, stock: 3.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₆N₂O₂.

(3S,4aS,8aS)-Decahydro-N-t-butyl-3-isoquinolinecarboxamide, CAS: 136465-81-1, stock: 1.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₆N₂O.

(3S,4aS,8aS)-Decahydroisoquinolinecarboxylic Acid, Hydrochloride Salt (90%), CAS: 115238-58-9, stock: 5.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₈ClNO₂.

(3S,4aS,8aS)-N-(1-Hydroxy-2-methylpropan-2-yl)-2-(((4R,5R)-2-oxo-4-((phenylthio)methyl)oxazolidin-5-yl)methyl)decahydroisoquinoline-3-carboxamide, CAS: /, stock: 4.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₇N₃O₄S.

(4R)-1,2-Dimethyl-1,2,3,4-tetrahydroisoquinoline-4,6-diol, CAS: /, stock: 3.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅NO₂.

(4R)-1,2-Dimethyl-1,2,3,4-tetrahydroisoquinoline-4,8-diol, CAS: /, stock: 7.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅NO₂.

(4R)-1,2-Dimethyl-1,2,3,4-tetrahydroisoquinoline-4,8-diol Hydrochloride, CAS: /, stock: 6.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅NO₂•HCl.

(4R)-4,6-Dihydroxy-2-methyl-1,2,3,4-tetrahydroisoquinoline-1-carboxylic Acid (Impurity)  (Mixture of 2 Diastereomers), CAS: /, stock: 9.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃NO₄.

(4R)-4,6-Dihydroxy-2-methyl-1-(3-methoxy-4-hydroxyphenyl)-1,2,3,4-tetrahydroisoquinoline, CAS: /, stock: 3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉NO₄.

(4R)-4,6-Dihydroxy-2-methyl-1-(3-methoxy-4-hydroxyphenyl)-1,2,3,4-tetrahydroisoquinoline-d3, CAS: /, stock: 7.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₆D₃NO₄.

1-Isonicotinoyl-4-piperidinone Hydrochloride, CAS: 1269199-40-7, stock: 7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂N₂O₂ • HCl.

(4R)-4,6-Dihydroxy-2-methyl-1-phenyl-1,2,3,4-tetrahydroisoquinoline, CAS: /, stock: 9.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇NO₂.

(4R)-4,6-Dihydroxy-2-methyl-1-phenyl-1,2,3,4-tetrahydroisoquinoline-d5, CAS: /, stock: 7.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₂D₅NO₂.

1-Isonicotinoylpiperazine DiHCl, CAS: 39640-04-5, stock: 2.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃N₃O.

1-Isonicotinoylpiperazine Trihydrochloride, CAS: 1185303-34-7, stock: 7.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃N₃O  •  3HCl.

1-Isonicotinoylpiperidine-4-carboxylic Acid, CAS: 67691-60-5, stock: 4.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄N₂O₃.

(±)-Mcn 5652, CAS: 96795-89-0, stock: 8.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₁NS.

(±)-Salsolidine, CAS: 5784-74-7, stock: 5.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇NO₂.

3-Bromo-5-iodophenol, CAS: 570391-20-7, stock: 5.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄BrIO.

3-Isonicotinoyl-1-vinylazepan-2-one, CAS: 878209-04-2, stock: 9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₆N₂O₂.

(R)-(+)-Higenamine Hydrobromide, CAS: 106032-52-4, stock: 7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇NO₃•HBr.

(R)-(-)-Norlaudanosine Hydrochloride, CAS: 54417-53-7, stock: 6.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₆ClNO₄.

(R)-(1,2,3,4-Tetrahydroisoquinolin-3-yl)methanol, CAS: /, stock: 3.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃NO.

(R)-1,2,3,4-Tetrahydro-6-methoxy-1-[[4-methoxy-3-(phenylmethoxy)phenyl]methyl]-7-(phenylmethoxy)isoquinoline, CAS: 47792-50-7, stock: 1.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₃NO₄.

(R)-1,2,3,4-Tetrahydroisoquinoline-3-carboxylic Acid, CAS: 103733-65-9, stock: 6.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁NO₂.

(R)-1-Phenyl-1,2,3,4-tetrahydroisoquinoline, CAS: 180272-45-1, stock: 4.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₅N.

Itacitinib, CAS: 1334298-90-6, stock: 3.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₃F₄N₉O.

(R)-3-(2-(Dimethylamino)ethyl)-6-(hydroxymethyl)-5,6-dihydro-1H-pyrrolo[3,2-g]isoquinoline-7(8H)-carboxylic Acid tert-Butyl Ester, CAS: /, stock: 9.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₁N₃O₃.

(R)-Fmoc-1,2,3,4-tetrahydroisoquinoline-1-carboxylic acid, CAS: 204317-98-6, stock: 4.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₁NO₄.

(R)-N-Cbz-3,4-dihydro-1h-isoquinolinecarboxylic acid, CAS: 151004-88-5, stock: 3.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₇NO₄.

(R)-Phenyl 1-Phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate, CAS: /, stock: 1.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₉NO₂.

(R)-Reticuline (>80% ee), CAS: 3968-19-2, stock: 5.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₃NO₄.

(R)-Reticuline-d3, CAS: 1243291-26-0, stock: 1.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₀D₃NO₄.

(R, R)-rel-2-Benzyloxycarbonyl-1-(tetrahydro-5-oxo-2-furanyl)-2(1H)-Isoquinoline, CAS: 335158-33-3, stock: 6.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₉NO₄.

(R,R)-Solifenacin Succinate, CAS: 862207-70-3, stock: 2.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₂N₂O₆.

(R,S)-Solifenacin Succinate, CAS: 1262506-09-1, stock: 8.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₆N₂O₂ • C₄H₆O₄.

(R,S)-Stylopine, CAS: 4312-32-7, stock: 1.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₇NO₄.

(S)-1,2,3,4-Tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic Acid 1,1-Dimethylethyl Ester, CAS: 103733-31-9, stock: 2.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₃NO₄.

(S)-1,2,3,4-Tetrahydroisoquinoline-3-carboxylic Acid, CAS: 74163-81-8, stock: 7.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁NO₂.

(S)-1,2,3,4-Tetrahydroisoquinoline-3-carboxylic Acid Benzyl Ester Hydrochloride, CAS: 103733-30-8, stock: 6.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₈ClNO₂.

(S)-1-(4-Methoxybenzyl)-1,2,3,4,5,6,7,8-octahydroisoquinoline Acetate Salt, CAS: 103573-39-3, stock: 9.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₇NO₃.

(S)-1-Phenyl-1,2,3,4-tetrahydroisoquinoline, CAS: 118864-75-8, stock: 7.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₅N.

(S)-1-Phenyl-1,2,3,4-tetrahydroisoquinoline-d5, CAS: 1217607-42-5, stock: 8.7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₀D₅N.

(S)-3-(Acetoxymethyl)-9-(2-(dimethylamino)ethyl)-3,4-dihydro-1H-pyrrolo[2,3-h]isoquinoline-2(7H)-carboxylic Acid tert-Butyl Ester, CAS: /, stock: 8.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₃N₃O₄.

(S)-3-Boc-aminomethyl-1,2,3,4-tetrahydro-isoquinoline, CAS: 1187933-37-4, stock: 2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₂N₂O₂.

2-Aminoisonicotinic Acid, CAS: 13362-28-2, stock: 3.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆N₂O₂.

(S)-4-Nitrophenyl 1-Phenyl-3,4-dihydroisoquinoline-2(1H)-carboxylate, CAS: 1229227-22-8, stock: 5.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₈N₂O₄.

2-Methylheptanoic Acid, CAS: 1188-02-9, stock: 1.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₆O₂.

(S)-4-Nitrophenyl 1-Phenyl-d5-3,4-dihydroisoquinoline-2(1H)-carboxylate, CAS: /, stock: 2.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₃D₅N₂O₄.

(S)-9-(2-(Dimethylamino)ethyl)-3-(hydroxymethyl)-3,4-dihydro-1H-pyrrolo[2,3-h]isoquinoline-2(7H)-carboxylic Acid tert-Butyl Ester, CAS: /, stock: 9.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₁N₃O₃.

(S)-Benzyl 2-Amino-3-(3-(methylsulfonyl)phenyl)propanoate Hydrochloride, CAS: 1194550-59-8, stock: 8.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉NO₄S • (HCl).

(S)-Decanhydroisoquinoline-3-carboxylic Acid Hydrochloride, CAS: 1221793-35-6, stock: 8.6g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₇NO₂ • HCl.

Acetohydrazide-D3, CAS: 1028333-41-6, stock: 3.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂H₃D₃N₂O.

(S)-Nor Laudanine, CAS: 1206614-00-7, stock: 3.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₃NO₄.

(S)-Nor Laudanosine, CAS: 4747-98-2, stock: 2.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₅NO₄.

(S)-PFI-2 Hydrochloride, CAS: 1627607-88-8, stock: 3.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₆ClF₄N₃O₃S.

Isonicotinic Acid Vanillylidenehydrazide, CAS: 149-17-7, stock: 3.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₃N₃O₃.

1,11-Undecanedicarboxylic Acid, CAS: 505-52-2, stock: 9.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₄O₄.

1,2,3,4,5,6,7,8-Octahydro-1-[(4-methoxyphenyl)methyl]-isoquinoline, CAS: 51072-36-7, stock: 7.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₃NO.

1,2,3,4-Tetrahydro-1,2-dimethyl-4,6-isoquinolinediol, CAS: 102830-16-0, stock: 1.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅NO₂.

1,2,3,4-Tetrahydro-1,2-dimethyl-4,6-isoquinolinediol-d3, CAS: /, stock: 5.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂D₃NO₂.

1,2,3,4-tetrahydro-1,2-dimethyl-4,8-isoquinolinediol, CAS: 102830-20-6, stock: 8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅NO₂.

1,2,3,4-tetrahydro-1,2-dimethyl-4,8-isoquinolinediol-d3, CAS: /, stock: 7.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂D₃NO₂.

1,2,3,4-Tetrahydro-2-(trifluoroacetyl)isoquinoline-7-sulfonyl Chloride, CAS: 74291-57-9, stock: 5.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₉ClF₃NO₃S.

1,2,3,4-Tetrahydro-2-methyl-4,8-isoquinolinediol Hydrochloride, CAS: /, stock: 2.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄ClNO₂.

1,2,3,4-Tetrahydro-3,3-dimethyl-2-[(4-methylphenyl)sulfonyl]isoquinoline, CAS: 200631-40-9, stock: 7.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₁NO₂S.

1,2,3,4-Tetrahydro-3-methylisoquinoline Hydrochloride, CAS: 112794-28-2, stock: 2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄ClN.

1,2,3,4-Tetrahydro-4,6-dihydroxy-2-methyl-isoquinoline, CAS: 23824-24-0, stock: 8.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃NO₂.

1,2,3,4-Tetrahydro-4,6-isoquinolinediol Hydrochloride, CAS: 72511-88-7, stock: 6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂ClNO₂.

1,2,3,4-Tetrahydro-4,8-dihydroxy-2-methyl-isoquinoline, CAS: 23824-25-1, stock: 4.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃NO₂.

1,2,3,4-Tetrahydro-4,8-isoquinolinediol Hydrochloride, CAS: 72511-87-6, stock: 3.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂ClNO₂.

1,2,3,4-Tetrahydro-4-methylisoquinoline Hydrochloride, CAS: 111661-47-3, stock: 1.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄ClN.

1,2,3,4-Tetrahydro-5-isoquinolinol Acetate, CAS: 164653-60-5, stock: 4.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅NO₃.

1,2,3,4-Tetrahydro-5-methylisoquinoline Hydrochloride, CAS: 41565-80-4, stock: 4.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄ClN.

1,2,3,4-Tetrahydro-6,7-dimethoxy-1-(p-methoxybenzyl)isoquinoline Hydrobromide, CAS: 31804-72-5, stock: 1.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₄BrNO₃.

1,2,3,4-Tetrahydro-6,7-dimethoxy-2-[(2E)-3-(1-methyl-2-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)-1-oxo-2-propenyl]-isoquinoline Monohydrochloride, CAS: 521984-48-5, stock: 3.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₈ClN₃O₃.

1,2,3,4-Tetrahydro-6,7-dimethoxy-2-[2-(4-nitrophenyl)ethyl]isoquinoline, CAS: 82925-01-7, stock: 9.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₂N₂O₄.

1,2,3,4-Tetrahydro-6-isoquinolin-6-ol Hydrobromide, CAS: 59839-23-5, stock: 4.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁NO•HBr.

1,2,3,4-Tetrahydro-7-(trifluoromethyl)isoquinoline Hydrochloride, CAS: 220247-87-0, stock: 3.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀F₃N•HCl.

1,2,3,4-Tetrahydro-7-methylisoquinoline Hydrochloride, CAS: 41565-82-6, stock: 4.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄ClN.

1,2,3,4-Tetrahydro-8-isoquinolinol Hydrochloride, CAS: 32999-38-5, stock: 9.8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂ClNO.

1,2,3,4-Tetrahydro-isoquinoline-1-carboxylic Acid, CAS: 41034-52-0, stock: 1.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁NO₂.

1,2,3,4-Tetrahydro-isoquinoline-1-carboxylic Acid Ethyl Ester Hydrochloride, CAS: 103733-33-1, stock: 8.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅NO₂ • HCl.

1,2,3,4-Tetrahydro-isoquinoline-4-ol, CAS: 51641-23-7, stock: 5.5g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁NO.

1,2,3,4-Tetrahydro-N-hydroxy-2-[(1-methyl-1H-pyrrol-2-yl)carbonyl]-6-isoquinolinecarboxamide, CAS: 1259296-46-2, stock: 2.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇N₃O₃.

1,2,3,4-Tetrahydroisoquinolin-6-ol, CAS: 14446-24-3, stock: 4.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁NO.

1,2,3,4-Tetrahydroisoquinoline, CAS: 91-21-4, stock: 7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁N.

1,2,3,4-Tetrahydroisoquinoline Hydrochloride, CAS: 14099-81-1, stock: 1.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁N  • HCl.

1,2,3,4-Tetrahydroisoquinoline-3-carboxamide, CAS: 112794-29-3, stock: 7.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₂O.

1,2,3,4-Tetrahydroisoquinoline-3-carboxylic Acid Ethyl Ester, CAS: 41234-43-9, stock: 8.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅NO₂.

1,2,3,4-Tetrahydroisoquinoline-4-carboxylic Acid, CAS: 116140-19-3, stock: 9.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁NO₂.

1,2,3,4-Tetrahydroisoquinoline-5-carbonitrile Hydrochloride, CAS: 1165924-13-9, stock: 9.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀N₂ •  HCl.

1,2-Dihydro-1-phenyl-3,4-Isoquinolinedione 4-Oxime, CAS: 90861-76-0, stock: 1.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂N₂O₂.

1,3-Dibromoisoquinoline, CAS: 53987-60-3, stock: 8.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₅Br₂N.

1,3-Dichloro-6-ethylisoquinoline, CAS: 1150271-19-4, stock: 2.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₉NCl₂.

1,3-Dichloro-7-fluoroisoquinoline, CAS: 941294-25-3, stock: 8.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₄NFCl₂.

1,3-Dichloroisoquinoline, CAS: 7742-73-6, stock: 8.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₅NCl₂.

1,4-Dibromoisoquinoline, CAS: 51206-40-7, stock: 1.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₅NBr₂.

1,4-Dichloro-7-isoquinolinesulfonyl Chloride, CAS: 223671-80-5, stock: 9.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₄Cl₃NO₂S.

1,4-Dichloroisoquinoline, CAS: 15298-58-5, stock: 4.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₅NCl₂.

1,4-Dihydro-1-phenyl-3(2H)-isoquinolinone, CAS: 17507-05-0, stock: 8.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₃NO.

1,5-Isoquinolinediol, CAS: 09/02/5154, stock: 3.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇NO₂.

1,6-Dichloroisoquinoline, CAS: 630421-73-7, stock: 7.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₅NCl₂.

1,7-Dichloro-4-methoxyisoquinoline, CAS: 630423-36-8, stock: 6.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₇Cl₂NO.

1,7-Dichloroisoquinoline, CAS: 70810-24-1, stock: 8.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₅NCl₂.

1,​2,​3,​4-​Tetrahydro-​2-​[2-​(4-​hydroxyphenyl)​-​1-​methylethyl]​-4,​6,​8-​isoquinolinetriol, CAS: 161040-25-1, stock: 7.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₁NO₄.

1,​2-​Dihydro-​1-​phenylisoquinoline, CAS: 134021-15-1, stock: 2.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₃N.

1-(1-Chloro-5-isoquinolinesulfonyl)homopiperazine, CAS: 105628-70-4, stock: 9.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₆ClN₃O₂S.

1-(2,2,2-Trifluoroethoxy)isoquinoline-3-carboxylic Acid, CAS: 1096982-79-4, stock: 8.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₈NO₃F₃.

1-(2-Bromo-4,5-dimethoxyphenyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline Hydrochloride, CAS: 1049758-71-5, stock: 1.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₂NO₄Br • HCl.

1-(2-Fluorophenyl)-1,2,3,4-tetrahydroisoquinoline, CAS: 1017125-85-7, stock: 2.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄NF.

1-(2-Methoxyethoxy)isoquinoline-3-carboxylic Acid, CAS: 1094758-42-5, stock: 5.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₃NO₄.

1-(3,4-Dimethoxyphenyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline hydrochloride, CAS: 251306-32-8, stock: 1.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₃NO₄ •HCl.

1-(4-Fluorophenyl)-1,2,3,4-tetrahydroisoquinoline, CAS: 120086-34-2, stock: 5.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄NF.

1-(5-Isoquinolinesulfonyl)-2-methyl-4-trityl-piperazine, CAS: 1798013-99-6, stock: 9.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₁N₃O₂S.

1-(5-Isoquinolinesulfonyl)-2-methylpiperazine Dihydrochloride, CAS: 108930-17-2, stock: 2.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉Cl₂N₃O₂S.

1-(5-Isoquinolinesulfonyl)-3-methylpiperazine Hydrochloride, CAS: 141543-65-9, stock: 5.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈ClN₃O₂S.

1-(5-Isoquinolinesulfonyl)-4-tert-butyloxycarbonyl-2-methylpiperazine, CAS: 1796933-25-9, stock: 8.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₅N₃O₄S.

1-(5-Isoquinolinesulfonyl)piperazine Hydrochloride, CAS: 141543-63-7, stock: 7.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆ClN₃O₂S.

1-(7,8-Dihydro-1,3-dioxolo[4,5-g]isoquinolin-6(5H)-yl)-2,2-dimethyl-1-propanone, CAS: 104270-86-2, stock: 9.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₉NO₃.

Isometamidium Bromide Hydrobromide, CAS: 4174-69-0, stock: 9.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₇Br₂N₇.

1-(8-Chloro-5-isoquinolinesulfonyl)piperazine Dihydrochloride, CAS: 355115-40-1, stock: 2.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆Cl₃N₃O₂S.

1-(Chloromethyl)-3,3-dimethyl-3,4-dihydroisoquinoline, CAS: 146304-90-7, stock: 8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄NCl.

Isometamidium Chloride Hydrochloride, CAS: 6798-24-9, stock: 8.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₇Cl₂N₇.

Isometamidium-d5 Bromide Hydrobromide, CAS: /, stock: 1.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₂D₅Br₂N₇.

1-(Cyclopropylmethoxy)isoquinoline-3-carboxylic Acid, CAS: 1097166-34-1, stock: 8.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₃NO₃.

1-(p-Methoxybenzyl)-3,4,5,6,7,8-hexahydroisoquinoline, CAS: 51072-35-6, stock: 4.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₁NO.

Isometamidium-d5 Chloride Hydrochloride, CAS: /, stock: 9.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₂D₅Cl₂N₇.

1-(Thiophen-2-yl)-1,2,3,4-tetrahydroisoquinoline, CAS: 120086-35-3, stock: 6.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₃NS.

1-Acetamido-4-cyano-3-methylisoquinoline, CAS: 179985-52-5, stock: 4.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₁N₃O.

1-Acetonylhydrohydrastinine, CAS: 51254-37-6, stock: 5.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₇NO₃.

1-Amino-3-methylisoquinoline-4-carbonitrile, CAS: 161468-33-3, stock: 2.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₉N₃.

1-Amino-6,7,8,9-tetrahydrothieno[2,3-c]isoquinoline-2-carboxamide, CAS: 155412-95-6, stock: 9.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃N₃OS.

1-Bromo-5-chloroisoquinoline, CAS: 1207448-41-6, stock: 3.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₅NClBr.

1-Bromo-6-chloroisoquinoline, CAS: 1196146-81-2, stock: 7.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₅NClBr.

1-Bromo-6-nitro-isoquinoline, CAS: 1368380-95-3, stock: 6.6g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₅BrN₂O₂.

1-Bromo-7-chloroisoquinoline, CAS: 1196155-73-3, stock: 1.4g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₅NClBr.

1-Bromo-7-fluoroisoquinoline, CAS: 1207448-24-5, stock: 8.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₅NFBr.

1-Bromoisoquinoline, CAS: 1532-71-4, stock: 6.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₆NBr.

1-Chloro-3-(morpholin-4-yl)isoquinoline, CAS: 1050885-07-8, stock: 2.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₃N₂OCl.

1-Chloro-3-(pyrrolidin-1-yl)isoquinoline, CAS: 1050909-85-7, stock: 6.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₃N₂Cl.

1-Chloro-5-isoquinolinesulfonic Acid, CAS: 105627-80-3, stock: 1.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₆ClNO₃S.

1-Chloro-5-isoquinolinesulfonyl Chloride, CAS: 141519-77-9, stock: 9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₅Cl₂NO₂S.

1-Chloro-5-methoxyisoquinoline, CAS: 106462-85-5, stock: 9.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈NOCl.

1-Chloro-5-nitroisoquinoline, CAS: 58142-97-5, stock: 3.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₅N₂O₂Cl.

1-Chloro-6-isoquinolinecarboxaldehyde, CAS: 1211528-19-6, stock: 4.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₆ClNO.

1-Chloro-6-nitro-isoquinoline, CAS: 1367810-55-6, stock: 4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₅ClN₂O₂.

1-Chloro-7-(trifluoromethyl)isoquinoline, CAS: 1196154-02-5, stock: 2.5g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₅NF₃Cl.

1-Chloro-isoquinoline-6-boronic acid, CAS: 1800484-01-8, stock: 5.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇BClNO₂.

1-Chloroisoquinolin-6-amine, CAS: 347146-33-2, stock: 9.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇ClN₂.

1-Chloroisoquinoline-3-carboxamide, CAS: 1152888-86-2, stock: 7.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₇N₂OCl.

1-Chloroisoquinoline-3-carboxylic Acid, CAS: 1049606-80-5, stock: 1.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₆NO₂Cl.

1-Chloroisoquinoline-4-carbonitrile, CAS: 53491-80-8, stock: 8.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₅ClN₂.

1-Chloroisoquinoline-5-carbonitrile, CAS: 1231761-23-1, stock: 2.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₅N₂Cl.

1-Chloroisoquinoline-7-boronic acid, CAS: 370864-49-6, stock: 1.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇BClNO₂.

1-Chloroisoquinoline-8-carbonitrile, CAS: 1231761-24-2, stock: 6.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₅N₂Cl.

1-Chloroisoquinone, CAS: 19493-44-8, stock: 10g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₆ClN.

1-Des(3,4-dimethoxybenzyl) 1-Methoxymethyl 3,4-Dihydropapaverine, CAS: 107415-83-8, stock: 5.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇NO₃.

1-Ethoxyisoquinoline-3-carboxylic Acid, CAS: 1094758-39-0, stock: 7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₁NO₃.

1-Ethyl-1,2,3,4-tetrahydroisoquinoline Hydrochloride, CAS: 103861-49-0, stock: 2.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅N  •  HCl.

1-Hydroxyisoquinoline, CAS: 491-30-5, stock: 2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇NO.

1-Iodoisoquinoline, CAS: 19658-77-6, stock: 3.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₆NI.

1-Methoxyisoquinoline-3-carboxylic Acid, CAS: 1094553-95-3, stock: 9.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₉NO₃.

1-Methyl-1,2,3,4-tetrahydroisoquinoline, CAS: 07/09/4965, stock: 9.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃N.

1-Methyl-1,2,3,4-tetrahydroisoquinoline Hydrochloride, CAS: 111635-08-6, stock: 4.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃N • HCl.

1-Phenyl-2,3-dihydroisoquinolin-4(1H)-one Hydrochloride, CAS: /, stock: 8.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄ClNO.

1-Phenylisoquinoline, CAS: 3297-72-1, stock: 4.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₁N.

1-Propoxyisoquinoline-3-carboxylic Acid, CAS: 1094509-81-5, stock: 8.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₃NO₃.

1-[(1E)-2-Phenylethenyl]-2(1H)-pyridinone, CAS: 61259-55-0, stock: 7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₁NO.

1-[(1E)-2-Phenylethenyl]-2(1H)-pyridinone-d5, CAS: /, stock: 2.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₆D₅NO.

1-[(S)-O-(5-Isoquinolinesulfonyl)-N-methyltyrosyl]-4-phenyl-piperazine, CAS: 1391068-10-2, stock: 7.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₀N₄O₄S.

1-[(S)-O-(5-Isoquinolinesulfonyl)-N-tert-boc-N-methyltyrosyl]-4-phenyl-piperazine, CAS: 1391068-28-2, stock: 5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₃₈N₄O₆S.

1-[5-(Hydroxymethyl)-2-furyl]-2-methyl-1,2,3,4-tetrahydroisochinolin-4,6-diol, CAS: 1312706-19-6, stock: 6.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₇NO₄.

1-[5-(Hydroxymethyl)-2-furyl]-2-methyl-1,2,3,4-tetrahydroisochinolin-4,8-diol, CAS: 1312706-18-5, stock: 5.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₇NO₄.

1-[7-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]-1,2,3,4-tetrahydro-2-methyl-4-isoquinolinyl]-cyclohexanol, CAS: 1187948-69-1, stock: 2.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₇NO₂Si.

1H-Isoquinoline-2,4-dicarboxylic acid 2-tert-butyl ester 4-methyl ester, CAS: 1187830-86-9, stock: 2.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₉NO₄.

2(1H)-Isoquinolinecarboxylic acid, 3,4-dihydro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-, 1,1-dimethylethyl ester, CAS: 1035235-26-7, stock: 8.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₀BNO₄.

2,3-Dihydroxyphenethylamine, CAS: 579-59-9, stock: 6.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₁NO₂.

2,4-Diphenylpyrylium Tetrafluoroborate, CAS: /, stock: 7.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₃BF₄O.

2,​3-​Cyclopentenopyridine, CAS: 533-37-9, stock: 3.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉N.

2-((S)-Quinuclidin-3-yl)-2,3,3a,4,5,6-hexahydro-1H-benzo[de]isoquinoline, CAS: 1796933-62-4, stock: 2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₆N₂.

2-(1,1-Dimethylethyl)-1,2,3,4-tetrahydro-4,6,8-Isoquinolinetriol-d9 Hydrochloride, CAS: /, stock: 2.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₁D₉ClNO₃.

2-(1-Phenoxypropan-2-yl)-1,2,3,4-tetrahydroisoquinoline, CAS: /, stock: 8.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₁NO.

2-(1H-Benzotriazol-1-ylmethyl)-1,2,3,4-tetrahydro-7-methoxy-isoquinoline, CAS: 221656-41-3, stock: 3.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₈N₄O.

2-(2,6-Dichlorobenzenesulfonyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic Acid, CAS: 1009520-26-6, stock: 2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₃NO₄SCl₂.

2-(2-Chloroacetyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic Acid, CAS: 1009185-81-2, stock: 8.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₂NO₃Cl.

2-(2-Chlorobenzoyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic Acid, CAS: 1009695-46-8, stock: 6.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₄NO₃Cl.

2-(2-Methoxyphenyl)-1,2,3,4-tetrahydroisoquinoline-1,3-dione, CAS: 106128-44-3, stock: 1.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₃NO₃.

2-(2-Methylbutanoyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic Acid, CAS: 1104734-29-3, stock: 1.1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₉NO₃.

2-(2-Methylphenyl)-1,2,3,4-tetrahydroisoquinoline-1,3-dione, CAS: 101273-81-8, stock: 7.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₃NO₂.

2-(2-Nitrobenzenesulfonyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic Acid, CAS: 1008002-08-1, stock: 1.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄N₂O₆S.

2-(3-Chloropropanoyl)-1,2,3,4-tetrahydroisoquinoline, CAS: 10579-67-6, stock: 6.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄NOCl.

2-(3-Chloropropyl)-3-(3,4-dimethoxyphenyl)-1-oxo-1,2,3,4-tetrahydroisoquinoline-4-carboxylic Acid, CAS: 1011412-52-4, stock: 1.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁ H₂₄ Cl N O ₅.

2-(3-Methylbutanoyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic Acid, CAS: 1103531-38-9, stock: 8.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₉NO₃.

2-(3-Methylphenyl)-1,2,3,4-tetrahydroisoquinoline-1,3-dione, CAS: 106110-70-7, stock: 3.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₃NO₂.

2-(3-Pyrrolidinylmethyl)-1,2,3,4-tetrahydroisoquinoline Dihydrochloride, CAS: 1220021-26-0, stock: 4.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₀N₂ • 2HCl.

2-(4-Aminophenyl)-1,2-dihydro-1-oxo-7-(2-pyridinylmethoxy)-4-(3,4,5-trimethoxyphenyl)-3-isoquinolinecarboxylic Acid Methyl Ester Dihydrochloride, CAS: 212498-37-8, stock: 5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₁Cl₂N₃O₇.

2-(4-Aminophenyl)-1,2-dihydro-7-[(1-oxido-2-pyridinyl)methoxy]-1-oxo-4-(3,4,5-trimethoxyphenyl)-3-isoquinolinecarboxylic Acid methyl Ester Monohydrochloride, CAS: 260414-73-1, stock: 5.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₀ClN₃O₈.

2-(4-Bromophenyl)-1,2,3,4-tetrahydroisoquinoline, CAS: 1057279-05-6, stock: 1.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄BrN.

2-(4-Nitro-2-(trifluoromethyl)phenyl)-1,2,3,4-tetrahydroisoquinoline, CAS: 914348-89-3, stock: 7.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₃F₃N₂O₂.

2-(4-Piperidylmethyl)-3,4-dihydro-1H-isoquinoline Dihydrochloride, CAS: 120847-08-7, stock: 7.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₂N₂ • 2HCl.

2-(6-Methacryloyloxyhexyl)thioxantheno[2,1,9-dej]isoquinoline-1,3-dione Monomer, CAS: 450387-14-1, stock: 1.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₅NO₄S.

2-(Benzenesulfonyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic Acid, CAS: 1009266-12-9, stock: 1.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₅NO₄S.

2-(Benzenesulfonyl)-1,2-dihydroisoquinoline-1-carbonitrile, CAS: 1035-19-4, stock: 6.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₂N₂O₂S.

2-(Bromomethyl)-7-methoxy-1,2,3,4-tetrahydroisoquinoline, CAS: /, stock: 8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄BrNO.

2-(Chloroacetyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline, CAS: 111631-72-2, stock: 9.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆NO₃Cl.

2-(Ethanesulfonyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic Acid, CAS: 1008987-50-5, stock: 7.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅NO₄S.

2-(Fluoromethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-pyridine, CAS: 1220696-61-6, stock: 9.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇BFNO₂.

2-(Fmoc-amino)ethyl Bromide, CAS: 340187-12-4, stock: 4.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₆BrNO₂.

2-(Furan-2-carbonyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic Acid, CAS: 1007979-03-4, stock: 2.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₃NO₄.

2-(Piperidin-4-yl)-1,2,3,4-tetrahydroisoquinoline, CAS: 200413-62-3, stock: 2.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₀N₂.

2-(Pyrrolidin-3-yl)-1,2,3,4-tetrahydroisoquinoline Dihydrochloride, CAS: 1220017-74-2, stock: 3.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈N₂ • 2 HCl.

2-(tert-Butoxycarbonyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic Acid, CAS: 151838-62-9, stock: 9.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₉NO₄.

2-Acetyl-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic acid, CAS: 143767-54-8, stock: 5.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃NO₃.

2-Acetyl-1,2,3,4-tetrahydro-8-isoquinolinol, CAS: 140865-97-0, stock: 3.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃NO₂.

2-Acetyl-3-dehydro-8-isoquinolinol, CAS: 1346598-26-2, stock: 1.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁NO₂.

2-Amino-2-oxo-acetic Acid Ethyl Ester, CAS: 617-36-7, stock: 9.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₇NO₃.

2-Amino-3-methyl-3H-imidazo[4,5-f]isoquinoline, CAS: 147293-15-0, stock: 9.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀N₄.

2-Amino-3-methyl-3H-imidazo[4,5-F]isoquinoline Hydrobromide, CAS: 1246819-52-2, stock: 9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁BrN₄.

2-Amino-3-methyl-3H-imidazo[4,5-h]isoquinoline, CAS: 147293-14-9, stock: 2.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀N₄.

2-Amino-benzo[de]isoquinoline-1,3-dione, CAS: 5690-46-0, stock: 5.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₈N₂O₂.

2-Azepan-4-yl-1,2,3,4-tetrahydroisoquinoline, CAS: 1069473-59-1, stock: 1.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₂N₂.

2-Benzoyl-1,2,3,4-tetrahydro-isoquinoline-3-carboxylic acid, CAS: 93316-40-6, stock: 5.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₅NO₃.

2-Boc-6-acetyl-1,2,3,4-tetrahydroisoquinoline, CAS: 1008518-35-1, stock: 9.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₁NO₃.

2-Boc-6-chloro-3,4-dihydro-1H-isoquinoline-1-carboxylic Acid, CAS: 871730-33-5, stock: 7.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₈ClNO₄.

2-Boc-6-hydroxy-1,2,3,4-tetrahydro-isoquinoline-1-carboxylic acid, CAS: 362492-00-0, stock: 5.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₉NO₅.

2-Bromo-5-methoxypyridine, CAS: 105170-27-2, stock: 2.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₆BrNO.

2-Bromo-5-methoxypyridine-d3, CAS: 1185315-90-5, stock: 7.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃D₃BrNO.

2-Bromoveratryl Alcohol, CAS: 72912-38-0, stock: 1.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁BrO₃.

2-Bromoveratryl-d3 Alcohol, CAS: 1795029-54-7, stock: 3.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈D₃BrO₃.

2-Butynoic Acid, CAS: 590-93-2, stock: 9.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₄O₂.

2-CBZ-1,2,3,4-tetrahydroisoquinoline-1-carboxylic Acid, CAS: 22914-95-0, stock: 8.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₇NO₄.

2-Chloro-4,5-dimethoxyphenylacetic Acid, CAS: 2898-63-7, stock: 5.7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁ClO₄.

(2,2,2-Trifluoroethoxy)difluoroacetic Acid, CAS: 152538-73-3, stock: 1.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₃F₅O₃.

2-Ethyl-1,2,3,4-tetrahydroisoquinoline-3-carboxylic Acid Hydrochloride, CAS: 1101199-16-9, stock: 7.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅NO₂ • HCl.

2-Fluoro-5-(ethoxycarbonylmethyl)phenylboronic Acid, Pinacol Ester, CAS: 1198615-88-1, stock: 4.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₂BFO₄.

2-Hydroxyisoquinoline-1,3(2H,4H)-dione, CAS: 6890-08-0, stock: 1.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇NO₃.

2-Methyl-1-oxo-1,2,3,4-tetrahydroisoquinoline-4-carboxylic Acid, CAS: 1134335-04-8, stock: 3.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁NO₃.

2-Methyl-1-phenylprop-2-en-1-one, CAS: 769-60-8, stock: 6.5g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀O.

2-Methylphenylacetonitrile, CAS: 22364-68-7, stock: 3.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉N.

2-Phenyl-1,2,3,4-tetrahydroisoquinoline, CAS: 3340-78-1, stock: 7.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₅N.

2-[(1,2,3,4-Tetrahydroisoquinoline-2-carbonyl)amino]acetic Acid, CAS: 1018299-34-7, stock: 7.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄N₂O₃.

2-[4-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-Yl)-benzyl]-1,2,3,4-tetrahydro-isoquinoline, CAS: 1315281-49-2, stock: 2.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₈BNO₂.

2-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]-N-[2-[[(1,1-dimethylethyl)dimethylsilyl]oxy]ethyl]-ethanamine, CAS: 169527-49-5, stock: 7.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₃₉NO₂Si₂.

2’,3’-Dihydro-1’H-spiro[cyclopropane-1,4’-isoquinoline] Hydrochloride, CAS: 1203682-08-9, stock: 7.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃N • HCl.

3,4,5-Tribenzyloxybenzyl Chloride, CAS: 96277-83-7, stock: 8.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₅ClO₃.

3,4,5-Trichloroaniline, CAS: 634-91-3, stock: 8.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄Cl₃N.

3,4-Dibenzyloxyphenylacetic Acid, CAS: 1699-61-2, stock: 3.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₀O₄.

3,4-Dihydro-1-phenylisoquinoline Hydrochloride, CAS: 52250-51-8, stock: 8.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄ClN.

3,4-Dihydro-3,3-dimethylisoquinoline, CAS: 28460-55-1, stock: 4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃N.

3,4-Dihydro-5,8-dimethoxyisoquinoline Hydrochloride, CAS: 29983-76-4, stock: 6.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃NO₂ •HCl.

3,4-Dihydro-5-methoxyisoquinoline, CAS: 1355060-40-0, stock: 1.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃NO₂.

3,4-Dihydro-6,7-dimethoxy-1-(p-methoxybenzyl)isoquinoline Hydrochloride, CAS: 13233-00-6, stock: 3.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₂ClNO₃.

3,4-Dihydro-6-methoxyisoquinoline Hydrochloride, CAS: 93549-15-6, stock: 3.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁NO  •HCl.

3,4-Dihydro-7-methoxy-isoquinoline Hydrochloride, CAS: 1216775-99-3, stock: 6.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁NO  •HCl.

3,4-Dihydroisoquinoline, CAS: 3230-65-7, stock: 4.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉N.

3,4-Dihydroisoquinoline-2(1H)-carboximidamide, CAS: 1131-64-2, stock: 1.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃N₃.

3,4-Dihydroisoquinoline-6,7-diol, CAS: 4602-83-9, stock: 5.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉NO₂.

3,4-Dihydropapaverine, CAS: 6957-27-3, stock: 5.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₃NO₄.

3-(1,2,3,4-Tetrahydroisoquinoline-2-carbonyl)phenol, CAS: 1019438-49-3, stock: 7.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₅NO₂.

3-(1H-Imidazol-2-yl)-1,2,3,4-tetrahydroisoquinoline, CAS: 1027595-67-0, stock: 8.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃N₃.

3-(2-(tert-Butoxycarbonyl)-1,2,3,4-tetrahydroisoquinolin-6-yl)propanoic Acid, CAS: 1158756-02-5, stock: 6.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₃NO₄.

3-​Hydroxyisoquinoline, CAS: 7651-81-2, stock: 1.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇NO.

3-Benzyloxy-4-methoxyphenylethylamine, CAS: 36455-21-7, stock: 9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₉NO₂.

3-Bromo-7-chloroisoquinoline, CAS: 1246552-90-8, stock: 1.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₅NClBr.

3-Bromoisoquinoline, CAS: 34784-02-6, stock: 2.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₆NBr.

3-Butyl-1-chloro-5,10-dihydro-8-(2-cyanophenyl)imidazol-[1,5-b]isoquinoline, CAS: 1246814-77-6, stock: 6.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₀ClN₃.

3-Chloro-6-fluoroisoquinoline, CAS: 1041423-28-2, stock: 7.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₅NFCl.

3-Chloro-7-methylisoquinoline, CAS: 1033201-77-2, stock: 2.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈NCl.

3-Chlorobenzoyl Chloride, CAS: 618-46-2, stock: 6.8g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₄Cl₂O.

3-Chloroisoquinoline, CAS: 19493-45-9, stock: 7.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₆NCl.

3-Chloroisoquinoline-4-carbaldehyde, CAS: 120285-29-2, stock: 9.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₆ClNO.

3-Cyano-4-methylpyridine, CAS: 09/01/5444, stock: 6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆N₂.

3-Ethyl-1,2,3,4-tetrahydroisoquinoline, CAS: 111422-13-0, stock: 4.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅N.

3-Fluoroisoquinoline-6-boronic Acid, CAS: 1105710-34-6, stock: 10g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇BFNO₂.

3-Formyl-3,4-dihydro-1H-isoquinoline-2-carboxylic Acid tert-Butyl Ester, CAS: 104668-15-7, stock: 9.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₉NO₃.

3-Methyl-4-pyridinecarbonyl Chloride, CAS: 64915-79-3, stock: 4.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆ClNO.

3-Methylisoquinoline, CAS: 1125-80-0, stock: 7.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉N.

3-Piperidin-4-ylmethyl-isoquinoline Dihydrochloride, CAS: 1187928-64-8, stock: 4.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₈N₂ • 2HCl.

3-[(1,2,3,4-Tetrahydroisoquinoline-2-carbonyl)amino]propanoic Acid, CAS: 1017667-47-8, stock: 8.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆N₂O₃.

3-{trans-1,2,3,4-Tetrahydro-6,7-dimethoxy-2-(methyl-13C)-1-[(3,4,5-trimethoxyphenyl)methyl]-2-isoquinolinio}propyl-1-sulfate, CAS: /, stock: 2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄¹³CH₃₅NO₉S.

4-(2-Cyclohexenyl)isoquinoline, CAS: 111678-37-6, stock: 7.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₅N.

4-(3-Bromophenyl)-6,8-dichloro-2-methyl-1,2,3,4-tetrahydroisoquinoline, CAS: 543737-10-6, stock: 7.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄NCl₂Br.

4-(3-Thienyl)isoquinoline, CAS: 112370-12-4, stock: 7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₉NS.

4-(4-Methylbenzenesulfonate)-4-isoquinolinol, CAS: 1532-82-7, stock: 7.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₃NO₃S.

4-(Benzyloxy)-1,2-dimethoxybenzene, CAS: 42138-42-1, stock: 2.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₆O₃.

4-(Trifluoromethyl)benzenepropanol, CAS: 180635-74-9, stock: 9.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁F₃O.

4-Amino Isoquinoline, CAS: 23687-25-4, stock: 3.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈N₂.

4-Amino-1,8-naphthalimide, CAS: 1742-95-6, stock: 8.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₈N₂O₂.

4-Amino-3-bromoisoquinoline, CAS: 40073-37-8, stock: 4.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇BrN₂.

4-Amino-5,6,7,8-tetrahydro Isoquinoline, CAS: 130831-67-3, stock: 1.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₂.

4-Amino-5-(3-methoxyphenyl)pentan-1-ol, CAS: 82590-42-9, stock: 5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₉NO₂.

4-Azido-N-ethyl-1,8-naphthalimide, CAS: 912921-27-8, stock: 8.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₀N₄O₂.

4-​Bromo-​1-​methylisoquinoline, CAS: 104704-40-7, stock: 3.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈BrN.

4-​Isoquinolinol, CAS: 3336-49-0, stock: 1.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇NO.

4-Bromo-1,7-dichloro-isoquinoline, CAS: 953421-74-4, stock: 3.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₄BrCl₂N.

4-Bromo-1-chloro-6-nitro-isoquinoline, CAS: 1369199-81-4, stock: 1.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₄BrClN₂O₂.

4-Bromo-1-chloroisoquinoline, CAS: 66728-98-1, stock: 7.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₅BrClN.

4-Bromo-1-methoxyisoquinoline, CAS: 746668-73-5, stock: 5.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈BrNO.

4-Bromo-2,6-dimethylpyridine, CAS: 5093-70-9, stock: 8.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈BrN.

4-Bromo-6-methylisoquinoline, CAS: 1204298-52-1, stock: 5.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈BrN.

4-Bromoisoquinoline, CAS: 1532-97-4, stock: 9.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₆BrN.

4-Bromoisoquinoline-1-carboxylic Acid, CAS: 1179149-25-7, stock: 8.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₆NO₂Br.

4-Chloro-1-hydroxy-7-isoquinolinesulfonyl Chloride, CAS: 223671-81-6, stock: 4.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₅Cl₂NO₃S.

4-Chloroisoquinoline, CAS: 1532-91-8, stock: 9.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₆NCl.

4-Cyano-3-methylpyridine, CAS: 06/05/7584, stock: 6.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆N₂.

4-Ethynyl-N-ethyl-1,8-napthalamide, CAS: 912921-26-7, stock: 1.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₁NO₂.

4-Fluoroisoquinoline, CAS: 394-67-2, stock: 9.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₆FN.

4-Isopropoxypiperidine, CAS: 43139-18-0, stock: 1.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₇NO.

4-Methoxy-3-buten-2-one, CAS: 4652-27-1, stock: 4.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₈O₂.

4-Methoxyisoquinoline, CAS: 36034-54-5, stock: 8.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉NO.

4-Methyl-1,2,3,4-tetrahydroisoquinoline, CAS: 110841-71-9, stock: 7.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃N.

4-Methyl-5-nitroisoquinoline, CAS: 194032-17-2, stock: 5.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈N₂O₂.

4-Methylisoquinoline, CAS: 1196-39-0, stock: 8.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉N.

4-Phenyl-1,2,3,4-tetrahydroisoquinoline, CAS: 75626-12-9, stock: 8.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₆ClN.

4-Phenyl-1,2,3,4-tetrahydroisoquinoline Hydrochloride, CAS: 6109-35-9, stock: 6.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₆ClN.

5,6,7,8-Tetrahydro-[1,3]dioxolo[4,5-g]isoquinoline, CAS: 94143-83-6, stock: 9.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁NO₂.

5,6,7,8-Tetrahydroisoquinoline, CAS: 36556-06-6, stock: 3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁N.

5,7-Dichloro-1,2,3,4-tetrahydro-2-(triphenylmethyl)-6-isoquinolinecarboxylic Acid, CAS: 1194550-56-5, stock: 6.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₃Cl₂NO₂.

5,7-Dimethoxyindan-1-one, CAS: 880-87-5, stock: 2.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂O₃.

5,8-Dibromoisoquinoline, CAS: 81045-39-8, stock: 1.6g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₅NBr₂.

5,8-Difluoro-1,2,3,4-tetrahydroisoquinoline Hydrochloride, CAS: 1093064-83-5, stock: 2.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉NF₂ • HCl.

5,​6,​7,​8-​Tetrahydro-1,​3-​Dioxolo[4,​5-​g]​isoquinoline Hydrochloride, CAS: 15052-05-8, stock: 5.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉NO₂ •  (HCl).

5-(Bromomethyl)isoquinoline hydrobromide, CAS: 586373-76-4, stock: 6.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈BrN.

5-(Trifluoromethyl)isoquinoline, CAS: 120568-09-4, stock: 9.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₆NF₃.

5-Acetamidoisoquinoline, CAS: 27461-33-2, stock: 7.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀N₂O.

(11β)-21-Chloro-9-fluoro-11-hydroxy-17-(1-oxopropoxy)pregna-1,4-diene-3,20-dione, CAS: 68791-68-4, stock: 4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₀ClFO₅.

5-Amino Isoquinoline, CAS: 1125-60-6, stock: 9.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈N₂.

5-Amino-6-(dimethylamino)-1,3-dimethyl-1,3-dihydro-2H-benzimidazol-2-one Dihydrochloride, CAS: 1047652-16-3, stock: 9.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆N₄O • 2 HCl.

21-(1-Ethoxyethoxy)-isoflupredone, CAS: /, stock: 8.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₅FO₆.

5-Aminoboronphthalide, CAS: 117098-94-9, stock: 5.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈BNO₂.

5-Aminoisoquinoline Hydrochloride, CAS: 152814-23-8, stock: 5.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈N₂ • HCl.

21-Dehydro Isoflupredone, CAS: 805-14-1, stock: 8.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₅FO₅.

6α,​9α-​Difluoroprednisolone, CAS: 806-29-1, stock: 8.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₆F₂O₅.

5-Bromo-1,2,3,4-tetrahydro-isoquinoline hydrochloride, CAS: 923591-51-9, stock: 7.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁BrClN.

9-Fluoro-11β-hydroxy-17,20:20,21-bis(methylenedioxy)-pregna-1,4-dien-3-one, CAS: 3800-34-8, stock: 9.1g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₉FO₆.

9-Fluoro-11β-hydroxy-17,20:20,21-bis(methylenedioxy)-pregna-1,4-dien-3-one-d3, CAS: /, stock: 1.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₆D₃FO₆.

5-Bromo-1,2,3,4-tetrahydroisoquinoline, CAS: 81237-69-6, stock: 6.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀BrN.

5-Bromo-1,3-dichloroisoquinoline, CAS: 1215767-89-7, stock: 1.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₄NCl₂Br.

Isoflupredone 21-Phosphate Ester Disodium Salt, CAS: 94088-00-3, stock: 9.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₆FNa₂O₈P.

5-Bromo-1-chloro-6-methyl-isoquinoline, CAS: 1245647-25-9, stock: 3.5g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₇BrClN.

5-Bromo-1-chloroisoquinoline, CAS: 34551-41-2, stock: 1.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₅BrClN.

Isoflupredone Acetate, CAS: 338-98-7, stock: 2.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₉FO₆.

5-Bromo-1-methyl-1,2,3,4-tetrahydroisoquinoline, CAS: 1176414-91-7, stock: 8.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂NBr.

5-Bromo-3,4-dihydro-1H-isoquinoline-2-carboxylic Acid tert-Butyl Ester, CAS: 215184-78-4, stock: 3.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈BrNO₂.

5-Bromo-3-chloroisoquinoline, CAS: 1029720-67-9, stock: 3.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₅BrClN.

5-Bromo-3-methyl-1,2-benzisoxazole, CAS: 66033-76-9, stock: 1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₆BrNO.

5-Bromo-6-fluoroisoquinoline, CAS: 1239463-43-4, stock: 4.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₅NFBr.

5-Bromo-6-methylisoquinoline, CAS: 1146298-61-4, stock: 1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈BrN.

5-Bromo-8-nitroisoquinoline, CAS: 63927-23-1, stock: 8.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₅BrN₂O₂.

5-Bromo-norlaudanosoline Hydrobromide, CAS: /, stock: 3.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇Br₂NO₄.

5-Bromoisoquinolin, CAS: 34784-04-8, stock: 8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₆BrN.

5-Chloro-norlaudanosoline Hydrobromide, CAS: /, stock: 8.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇BrClNO₄.

5-Chloroisoquinoline, CAS: 5430-45-5, stock: 5.5g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₆ClN.

5-Chlorosulfonyl-4-methylisoquinoline, CAS: 194032-16-1, stock: 2.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈ClNO₂S.

5-Cyanoisoquinoline, CAS: 27655-41-0, stock: 4.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₆N₂.

5-Ethynylisoquinoline, CAS: 1203579-37-6, stock: 6.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₇N.

5-Fluoro-4-hydroxyquinoline PB-22, CAS: 1797132-65-0, stock: 1.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₁FN₂O₂.

5-Fluoro-norlaudanosoline Hydrobromide, CAS: /, stock: 1.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇BrFNO₄.

5-Hydrazinylisoquinoline Dihydrochloride, CAS: 102852-56-2, stock: 4.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉N₃ • 2HCl.

5-Hydroxy Debrisoquin, CAS: 70746-05-3, stock: 5.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃N₃O.

5-Hydroxyisoquinoline, CAS: 05/04/2439, stock: 3.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇NO.

5-Hydroxyisoquinoline, CAS: 05/04/2439, stock: 2.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇NO.

5-Methyl-1,2,3,4-tetrahydroisoquinoline, CAS: 123593-99-7, stock: 4.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃N.

5-Methyl-7,8-dihydro-[1,3]dioxolo[4,5-g]isoquinoline, CAS: 17104-27-7, stock: 8.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁NO₂.

5-Methylisoquinoline-6-carboxylic Acid Methyl Ester, CAS: /, stock: 4.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₁NO₂.

5-N,5-N-Diethylisoquinoline-5,8-diamine, CAS: 1154275-79-2, stock: 5.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇N₃.

5-N-(4-Fluorophenyl)isoquinoline-5,8-diamine, CAS: 1153123-20-6, stock: 9.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂N₃F.

5-Nitro-1,2,3,4-tetrahydroisoquinoline Hydrochloride, CAS: 1187932-31-5, stock: 4.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀N₂O₂ • HCl.

5-Nitroisoquinoline, CAS: 607-32-9, stock: 7.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₆N₂O₂.

5-Nitroisoquinoline-3-carbaldehyde, CAS: 102312-47-0, stock: 2.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₆N₂O₃.

5’-Bromo-norlaudanosoline Hydrobromide, CAS: /, stock: 1.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇Br₂NO₄.

5’-Chloro-norlaudanosoline, CAS: /, stock: 2.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇BrClNO₄.

5’-Fluoronorlaudonosoline Hydrobromide, CAS: /, stock: 4.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇BrFNO₄.

5’-Methoxylaudanosine, CAS: 24734-71-2, stock: 2.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₉NO₅.

5’-Methoxylaudanosine-13C, CAS: 1216692-65-7, stock: 9.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁¹³CH₂₉NO₅.

6,7,8,9-Tetrahydro-1H-imidazo[4,5-h]isoquinoline Hydrochloride, CAS: 1794760-42-1, stock: 7.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂ClN₃.

6,7,8,9-Tetrahydrothiazolo[4,5-h]isoquinoline, CAS: 120546-67-0, stock: 5.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀N₂S.

6,7-Dichloro-1,2,3,4-tetrahydro-isoquinoline Hydrochloride, CAS: 73075-49-7, stock: 5.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉Cl₂N • HCl.

6,7-Diethoxy-1-methyl-1,2,3,4-tetrahydroisoquinoline Hydrochloride, CAS: 336185-27-4, stock: 3.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₂ClNO₂.

6,7-Diethoxy-3,4-dihydro-1H-isoquinoline-1,2-dicarboxylic Acid 2-tert-Butyl Ester, CAS: 1214645-14-3, stock: 1.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₇NO₆.

6,7-Difluoroisoquinoline, CAS: 1202006-80-1, stock: 8.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₅NF₂.

6,7-Dimethoxy-1,2,3,4-tetrahydroisoquinoline, CAS: 1745-07-9, stock: 6.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅NO₂.

6,7-Dimethoxy-1,2,3,4-tetrahydroisoquinoline-2-sulfonamide, CAS: 1094222-85-1, stock: 10g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆N₂O₄S.

6,7-Dimethoxy-1-methyl-3,4-dihydroisoquinoline, CAS: 4721-98-6, stock: 3.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅NO₂.

6,7-Dimethoxy-1-phenyl-1,2,3,4-tetrahydro-isoquinoline, CAS: 4118-36-9, stock: 7.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉NO₂.

6,7-Dimethoxy-3,4-dihydroisoquinoline, CAS: 3382-18-1, stock: 7.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃NO₂.

6,7-Dimethoxy-3-(trimethylstannyl)-isoquinoline, CAS: 1245284-29-0, stock: 2.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉NO₂Sn.

6,7-Dimethoxy-3-methyl-1,2,3,4-tetrahydroisoquinoline Hydrochloride, CAS: 6266-97-3, stock: 8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈ClNO₂.

6,7-Dimethoxyisoquinoline, CAS: 15248-39-2, stock: 9.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁NO₂.

6,8-Difluoro-1,2,3,4-tetrahydroisoquinoline Hydrochloride, CAS: 1203684-62-1, stock: 7.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉NF₂.HCl.

6,​6’-​Methylenebis[5,​6,​7,​8-​tetrahydro-1,​3-​dioxolo[4,​5-​g]​isoquinoline, CAS: 1005328-62-0, stock: 1.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₂N₂O₄.

6-(4-Acetamido-1,8-naphthalamido)hexanoic acid, CAS: 172227-59-7, stock: 8.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₀N₂O₅.

6-(Bromomethyl)isoquinoline hydrobromide, CAS: 188861-57-6, stock: 5.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉Br₂N.

6-Amino-1,2,3,4-tetrahydroisoquinoline Hydrochloride, CAS: 175871-42-8, stock: 2.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₃ClN₂.

6-Amino-2-N-Boc-1,2,3,4-tetrahydroisoquinoline, CAS: 164148-92-9, stock: 5.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₀N₂O₂.

6-Amino-7-fluoro-3,4-dihydro-2(1H)-Isoquinolinecarboxylic Acid 1,1-Dimethylethyl Ester, CAS: 912846-68-5, stock: 7.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉FN₂O₂.

6-Aminoisoquinoline, CAS: 23687-26-5, stock: 2.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈N₂.

6-​Benzyloxy-​7-​methoxy-​3,​4-​dihydro-​isoquinoline, CAS: 68360-22-5, stock: 1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇NO₂.

6-Bromo-1,2,3,4-tetrahydroisoquinoline, CAS: 226942-29-6, stock: 3.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀NBr.

6-Bromo-1,3-dichloroisoquinoline, CAS: 552331-05-2, stock: 7.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₄BrCl₂N.

6-Bromo-1-isoquinolinecarboxylic Acid, CAS: 1256806-36-6, stock: 7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₆BrNO₂.

6-Bromo-2-ethylbenzo[de]isoquinoline-1,3-dione, CAS: 100874-09-7, stock: 9.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₀NO₂Br.

6-Bromo-3-hydroxyisoquinoline, CAS: 1031927-91-9, stock: 1.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₆BrNO.

6-Bromo-5-nitro-isoquinoline, CAS: 850197-72-7, stock: 1.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₅BrN₂O₂.

6-Bromoisoquinoline, CAS: 34784-05-9, stock: 5.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₆BrN.

6-Bromoisoquinoline 2-oxide, CAS: 223671-16-7, stock: 6.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₆BrNO.

6-Bromoisoquinoline-1-carbonitrile, CAS: 1082674-24-5, stock: 1.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₅BrN₂.

6-Chloro-1,2,3,4-tetrahydroisoquinoline, CAS: 33537-99-4, stock: 4.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀ClN.

6-Chloro-2-(4-pyridinylmethyl)-1H-benz[de]isoquinoline-1,3(2H)-dione, CAS: 353262-80-3, stock: 9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₁ClN₂O₂.

6-Chloroisoquinoline, CAS: 62882-02-4, stock: 4.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₆NCl.

6-Chloroisoquinoline-1-carboxylic Acid, CAS: 1179149-30-4, stock: 5.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₆NO₂Cl.

6-Cyanoisoquinoline, CAS: 106778-42-1, stock: 7.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₆N₂.

6-Demethyl 6-O-Benzyl Papaverine, CAS: 18813-62-2, stock: 6.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₅NO₄.

6-Desaminoethyl Pixantrone, CAS: 1430561-04-8, stock: 2.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄N₄O₂.

6-Fluoro-1-undecyl-3,4-dihydroisoquinoline, CAS: 914381-28-5, stock: 5.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₀FN.

6-Fluoro-3-methylisoquinoline, CAS: 1221445-02-8, stock: 5.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈FN.

6-Fluoroisoquinoline, CAS: 1075-11-2, stock: 8.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₆FN.

6-Hydroxy Debrisoquin, CAS: 61911-79-3, stock: 5g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃N₃O.

6-Hydroxy-1,2,3,4-tetrahydro-isoquinoline-1-carboxylic Acid, CAS: 91523-50-1, stock: 3.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁NO₃.

6-Hydroxyisoquinoline, CAS: 7651-82-3, stock: 3.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇NO.

6-Methoxy Isoquinoline, CAS: 52986-70-6, stock: 1.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉NO.

6-Methoxy-1,2,3,4-tetrahydro-isoquinoline-1-carboxylic Acid, CAS: 1161833-78-8, stock: 2.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃NO₃.

6-Methoxy-1,2,3,4-tetrahydroisoquinoline Hydrochloride, CAS: 57196-62-0, stock: 5.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃NO • HCl.

6-Methoxy-5-nitroisoquinoline, CAS: 72677-92-0, stock: 2.2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈N₂O₃.

6-Methyl-1,2,3,4-tetrahydroisoquinoline, CAS: 42923-76-2, stock: 5.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃N.

6-Methyl-3-isoquinolinemethanol, CAS: 412010-13-0, stock: 3.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁NO.

6-Methyl-5-nitroisoquinoline, CAS: 188121-31-5, stock: 2.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈N₂O₂.

6-Methylisoquinoline, CAS: 42398-73-2, stock: 8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉N.

6-Nitro-1,2,3,4-tetrahydro-isoquinoline Hydrobromide, CAS: 1187932-26-8, stock: 1.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀N₂O₂ • HBr.

2,4-Dichloro-β-[(2,6-dichlorophenyl)methoxy]benzeneethanamine, CAS: 1305320-62-0, stock: 8.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₃Cl₄NO.

6-O-Methylnorlaudanosoline Hydrochloride, CAS: 72072-58-3, stock: 9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₀ClNO₄.

6-Oxo-(S,S)-Palonosetron, CAS: 848074-10-2, stock: 9.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₂N₂O₂.

Chlorfenvinphos-D10 (Z/E ~ 1/2) (E Major), CAS: /, stock: 9.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₄D₁₀Cl₃O₄P.

6’-Bromo-norlaudanosoline Hydrobromide, CAS: 72258-95-8, stock: 6.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆Br₂NO₄.

6’-Chloro-norlaudanosoline Hydrobromide, CAS: /, stock: 5.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇BrClNO₄.

α,2,6-Trichloro-toluene, CAS: 2014-83-7, stock: 6.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅Cl₃.

6’-Fluoronorlaudonosoline Hydrobromide, CAS: /, stock: 4.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇BrFNO₄.

6’-Methoxy-2’,3’-dihydro-1’H-spiro[cyclohexane-1,4’-isoquinoline], CAS: 1142-80-9, stock: 5.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₁NO.

α,α,2,6-Tetrachloro-toluene, CAS: 81-19-6, stock: 6.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₄Cl₄.

7,8-Dihydro-1,3-dioxolo[4,5-g]isoquinoline, CAS: 6882-28-6, stock: 5.5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉NO₂.

7-(4,4,5,5-Tetramethyl-[1,3,2]dioxaborolan-2-yl)-3,4-dihydro-1H-isoquinoline-2-carboxylic Acid tert-Butyl Ester, CAS: 937048-76-5, stock: 2.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₀BNO₄.

7-(Benzyloxy)-1-[3-(benzyloxy)-4-methoxybenzyl]-3,4-dihydro-6-methoxyisoquinoline, CAS: 20323-85-7, stock: 8.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₁NO₄.

7-(Bromomethyl)isoquinoline, CAS: 158654-75-2, stock: 8.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈BrN.

7-(Bromomethyl)isoquinoline Hydrobromide, CAS: 1203372-02-4, stock: 8.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈NBr • HBr.

7-(Difluoromethoxy)-1,2,3,4-tetrahydroisoquinoline, CAS: 1209300-05-9, stock: 8.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁NOF₂.

7-(Trifluoromethyl)-1,2,3,4-tetrahydroisoquinoline-5-carbonitrile Hydrochloride, CAS: 1187830-66-5, stock: 1.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀ClF₃N₂.

7-(Trifluoromethyl)-3-isoquinolinecarboxylic Acid Hydrochloride, CAS: 1391052-93-9, stock: 5.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₇ClF₃NO₂.

7-Benzyloxy-1-(4-benzyloxy-3-ethoxycarbonyloxybenzyl)-6-methoxy-3,4-dihydroisoquinoline Hydrochloride, CAS: 62744-14-3, stock: 5.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₃₄ClNO₆.

7-Benzyloxy-1-(4-benzyloxy-3-hydroxybenzyl)-6-methoxy-1,2,3,4-tetrahydroisoquinoline, CAS: 62744-15-4, stock: 4.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₁NO₄.

7-Bromo-1,2,3,4-tetrahydroisoquinoline Hydrochloride, CAS: 220247-73-4, stock: 6.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀NBr • HCl.

7-Bromo-1,3-dichloroisoquinoline, CAS: 924271-40-9, stock: 2.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₄NCl₂Br.

7-Bromo-1-chloroisoquinoline, CAS: 215453-51-3, stock: 4.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₅BrClN.

7-Bromo-3-chloroisoquinoline, CAS: 1029720-65-7, stock: 7.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₅NClBr.

7-Bromo-3-hydroxyisoquinoline, CAS: 662139-46-0, stock: 7.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₆BrNO.

7-Bromo-3-isoquinolinemethanol, CAS: 1318897-45-8, stock: 2.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈BrNO.

7-Bromo-4,4-dimethyl-1,2,3,4-tetrahydroisoquinoline Hydrochloride, CAS: 1203684-66-5, stock: 1.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄NBr • HCl.

7-Bromoisoquinoline, CAS: 58794-09-5, stock: 8.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₆BrN.

7-Bromoisoquinoline-1,3(2H,4H)-dione, CAS: 1033330-27-6, stock: 8.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₆NO₂Br.

7-Chloro-1,2,3,4-tetrahydroisoquinoline, CAS: 82771-60-6, stock: 8.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀ClN.

7-Chloro-1-iodoisoquinoline, CAS: 1203579-27-4, stock: 8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₅NClI.

7-Chloro-3-isoquinolinecarboxylic Acid Hydrochloride, CAS: 365998-39-6, stock: 4.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₇Cl₂NO₂.

7-Chloro-3-isoquinolinemethanol, CAS: 1079652-66-6, stock: 3.8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈ClNO.

7-Chloroisoquinolin-1(2H)-one, CAS: 24188-74-7, stock: 8.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₆ClNO.

7-Ethoxy-1,2,3,4-tetrahydroisoquinoline Hydrochloride, CAS: 1221723-15-4, stock: 7.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅NO.HCl.

7-Fluoro-1-(propan-2-yl)-1,2,3,4-tetrahydroisoquinoline Hydrochloride, CAS: 1085542-79-5, stock: 6.5g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆NF.HCl.

7-Fluoro-1-iodoisoquinoline, CAS: 1207448-25-6, stock: 4.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₅NFI.

7-Hydroxy Debrisoquin, CAS: 70746-06-4, stock: 8.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃N₃O.

7-Hydroxy-6-methoxy-3,4-dihydroisoquinoline (~90% by HPLC), CAS: 4602-73-7, stock: 4.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁NO₂.

7-Methoxy-1-[[3-methoxy-4-(phenylmethoxy)phenyl]methyl]-6-(phenylmethoxy)isoquinoline, CAS: 29973-94-2, stock: 7.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₂₉NO₄.

7-Methoxy-2-methyl-1,2,3,4-tetrahydroisoquinoline, CAS: 54893-23-1, stock: 3.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅NO.

7-Methoxy-8-nitroisoquinoline, CAS: 63485-75-6, stock: 3.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈N₂O₃.

7-Methoxyisoquinoline, CAS: 39989-39-4, stock: 3.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉NO.

7-Methoxyisoquinoline Hydrochloride, CAS: 1211234-64-8, stock: 5.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉NO  •  HCl.

7-Nitro-1,2,3,4-tetrahydroisoquinoline, CAS: 42923-79-5, stock: 2.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀N₂O₂.

7-Nitro-1,2,3,4-tetrahydroisoquinoline Hydrochloride, CAS: 99365-69-2, stock: 7.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀N₂O₂ • HCl.

7-Trimethylstannylisoquinoline, CAS: 1032315-16-4, stock: 6.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅NSn.

7-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]-1,2,3,4-tetrahydro-2-methyl-isoquinoline, CAS: 1187948-66-8, stock: 9.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₇NOSi.

7’-Aminospiro[cyclopropane-1,4’(1’H)-isoquinoline]-2’(3’H)carboxylic Acid 1,1-Dimethyl Ester, CAS: 561297-88-9, stock: 9.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₂N₂O₂.

8-(Bromomethyl)isoquinoline, CAS: 942579-56-8, stock: 7.5g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈BrN.

8-(Bromomethyl)isoquinoline Hydrobromide, CAS: 1215541-16-4, stock: 1.1g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈NBr • HBr.

8-(Tributylstannyl)isoquinoline, CAS: 1245816-24-3, stock: 3.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₃NSn.

8-Amino-5-bromoisoquinoline, CAS: 90721-35-0, stock: 7.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇BrN₂.

8-Aminoisoquinoline, CAS: 23687-27-6, stock: 8.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈N₂.

8-​Methoxyisoquinoline, CAS: 1723-70-2, stock: 6.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉NO.

8-Bromo-1,2,3,4-tetrahydroisoquinoline, CAS: 75416-51-2, stock: 3.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀NBr.

8-Bromo-1,2,3,4-tetrahydroisoquinoline Hydrochloride, CAS: 1159813-53-2, stock: 6.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀NBr • HCl.

8-Bromo-1-chloroisoquinoline, CAS: 1233025-78-9, stock: 2.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₅NClBr.

8-Bromo-3-butyl-1-chloro-5,10-dihydroimidazo[1,5-b]isoquinoline, CAS: 1246820-05-2, stock: 7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₆BrClN₂.

8-Bromo-3-chloroisoquinoline, CAS: 1029720-63-5, stock: 5.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₅NClBr.

8-Bromo-5-nitroisoquinoline, CAS: 252861-41-9, stock: 6.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₅BrN₂O₂.

8-Bromo-norlaudanosoline Hydrobromide, CAS: /, stock: 6.7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇Br₂NO₄.

8-Bromoisoquinolin-3-ol, CAS: 608515-49-7, stock: 2.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₆BrNO.

8-Bromoisoquinoline, CAS: 63927-22-0, stock: 2.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₆BrN.

8-Chloro-5-isoquinolinesulfonic Acid, CAS: 1246816-17-0, stock: 5.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₆ClNO₃S.

8-Chloro-5-isoquinolinesulfonyl Chloride, CAS: 1246817-00-4, stock: 9.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₅Cl₂NO₂S.

8-Chloro-norlaudanosoline Hydrobromide, CAS: /, stock: 7.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇BrClNO₄.

8-Chloroisoquinoline, CAS: 34784-07-1, stock: 9.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₆ClN.

8-Fluoro-1,2,3,4-tetrahydroisoquinoline, CAS: 123594-01-4, stock: 8.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀NF.

8-Fluoro-1-methyl-1,2,3,4-tetrahydroisoquinoline, CAS: 1176414-86-0, stock: 1.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂NF.

8-Fluoro-5-isoquinolinecarboxylic Acid Methyl Ester, CAS: 1540628-23-6, stock: 3.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₈FNO₂.

8-Fluoroisoquinoline, CAS: 1075-00-9, stock: 6.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₆FN.

8-Fluoronorlaudanosoline Hydrobromide, CAS: /, stock: 4.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇BrFNO₄.

(2R,3R)-3-(2,5-Difluorophenyl)-3-hydroxy-2-methyl-4-(1H-1,2,4-triazol-1-yl)thiobutyramide, CAS: 368421-58-3, stock: 8.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₄F₂N₄OS.

8-Hydroxy Debrisoquin, CAS: 46286-45-7, stock: 8.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃N₃O.

8-Hydroxy Debrisoquin-13C,15N2, CAS: 1189975-64-1, stock: 2.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉¹³CH₁₃N¹⁵N₂O.

(3R,4R)-4-(2,5-Difluorophenyl)-3-methyl-4-(1H-1,2,4-triazol-1-ylmethyl)-2-oxetanone, CAS: 483340-20-1, stock: 3.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₁F₂N₃O₂.

(αR,βR)-β-(2,5-Difluorophenyl)-β-hydroxy-α-methyl-1H-1,2,4-triazole-1-butanamide, CAS: 241479-75-4, stock: 4.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₄F₂N₄O₂.

8-Isoquinolineboronic acid, CAS: 721401-43-0, stock: 8.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈BNO₂.

ACT 335827, CAS: 1354039-86-3, stock: 5.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₈N₂O₅.

(αS,βR)-β-(2,5-Difluorophenyl)-β-hydroxy-α-methyl-1H-1,2,4-triazole-1-butanenitrile, CAS: 241479-74-3, stock: 1.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₂F₂N₄O.

Albofungin, CAS: 37895-35-5, stock: 7.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₄N₂O₉.

Almorexant, CAS: 871224-64-5, stock: 7.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₁F₃N₂O₃.

1-(2,5-Difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethanone, CAS: 1157938-97-0, stock: 9.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₇F₂N₃O.

2,5-Difluorophenacyl Bromide, CAS: 258513-41-6, stock: 4.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₅BrF₂O.

Almorexant Hydrochloride, CAS: 913358-93-7, stock: 1.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₂ClF₃N₂O₃.

Alrestatin, CAS: 51411-04-2, stock: 7.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₉NO₄.

Isavuconazole, CAS: 241479-67-4, stock: 9.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₇F₂N₅OS.

Isavuconazole-d4, CAS: 1346598-58-0, stock: 9.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₃D₄F₂N₅OS.

Amonafide, CAS: 69408-81-7, stock: 3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇N₃O₂.

Amonafide N-Oxide, CAS: 112726-97-3, stock: 8.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇N₃O₃.

Amonafide-d6, CAS: 1217039-92-3, stock: 6.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₁D₆N₃O₂.

BAY 299, CAS: 2080306-23-4, stock: 2.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₃N₃O₄.

Benzyl (S)-(-)-1,2,3,4-Tetrahydro-3-isoquinolinecarboxylate p-Toluenesulfonic Acid Salt, CAS: 77497-97-3, stock: 2.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇NO₂.C₇H₈O₃S.

Benzyl 7-bromo-3,4-dihydroisoquinoline-2(1h)-carboxylate, CAS: 625127-09-5, stock: 4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₆BrNO₂.

Boc-7-Hydroxy-D-tic-OH, CAS: 214630-00-9, stock: 9.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₉NO₅.

Boc-H-Tic(OH)-OH, CAS: 142335-42-0, stock: 2.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₉NO₅.

Boc-Tic-OH, CAS: 78879-20-6, stock: 7.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₉NO₄.

BRD-8899, CAS: 1404437-50-8, stock: 3.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₂N₄O₃S.

Brilliant Sulfaflavine, CAS: 2391-30-2, stock: 7.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₃N₂NaO₅S.

BU 226 Hydrochloride, CAS: 1186195-56-1, stock: 5.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₁N₃ • HCl.

BYK 204165, CAS: 1104546-89-5, stock: 9.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₂N₂O₂.

CeMMEC1, CAS: 440662-09-9, stock: 7.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₆N₂O₄.

cis-Decahydroisoquinoline, CAS: 03/08/2744, stock: 2.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₇N.

cis-Hydroxy Solifenacin (Mixture of Diastereomers), CAS: /, stock: 1.8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₆N₂O₃.

cis-Hydroxy Solifenacin N-Oxide(Mixture of Diastereomers), CAS: /, stock: 6.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₆N₂O₄.

cis-Hydroxy Solifenacin-d5 N-Oxide(Mixture of Diastereomers), CAS: /, stock: 7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₁D₅N₂O₄.

Cocsulin, CAS: 26279-88-9, stock: 6.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₃₄N₂O₅.

Copper (II) Acetate Monohydrate, CAS: 6046-93-1, stock: 7.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂H₈O₄•0.5Cu•0.5H₂O.

Cort108297, CAS: 1018679-79-2, stock: 4.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₅F₄N₃O₃S.

Corynoline, CAS: 18797-79-0, stock: 3.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₁NO₅.

Crispine A, CAS: 15889-93-7, stock: 4.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉NO₂.

Cyclohexanecarboxylic-d11 Acid, CAS: 93131-16-9, stock: 7.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇HD₁₁O₂.

Cyclopent-3-enecarboxamide, CAS: 50494-42-3, stock: 7.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉NO.

Cyclopropyl isothiocyanate, CAS: 56601-42-4, stock: 9.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₅NS.

D-7-Hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic Acid, CAS: 152286-30-1, stock: 8.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁NO₃.

Dauricine, CAS: 524-17-4, stock: 8.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₄₄N₂O₆.

Daurisoline, CAS: 70553-76-3, stock: 4.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₄₂N₂O₆.

Debrisoquin Hemisulfate, CAS: 581-88-4, stock: 6.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃N₃•1/2H₂SO₄.

Debrisoquin-13C,15N2 Hemisulfate, CAS: 1246814-89-0, stock: 2.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉¹³CH₁₃N¹⁵N₂•1/2H₂SO₄.

Decahydroisoquinoline, CAS: 6329-61-9, stock: 1.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₇N.

Dehydrocorybulbine Chloride Salt, CAS: /, stock: 9.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₂ClNO₄.

Desmethyl-5’-methoxylaudanosine, CAS: 61349-11-9, stock: 7.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₅NO₅.

Dimethisoquin Hydrochloride, CAS: 2773-92-4, stock: 7.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₅ClN₂O.

DL-Tetrahydropalmatine, CAS: 2934-97-6, stock: 7.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₅NO₄.

DL-Tetrahydropalmatine Hydrochloride, CAS: 6024-85-7, stock: 8.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₆ClNO₄.

Drotaverine Hydrochloride, CAS: 985-12-6, stock: 7.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₂ClNO₄.

Drotaverine-d10 Hydrochloride, CAS: /, stock: 7.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₂D₁₀ClNO₄.

Ethaverine, CAS: 486-47-5, stock: 8.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₉NO₄.

Ethaverine Hydrobromide, CAS: 855701-63-2, stock: 8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₉NO₄ • (HBr).

Ethyl (S)-1-Phenyl-1,2,3,4-tetrahydro-2-isoquinolinecarboxylate, CAS: 180468-42-2, stock: 8.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₉NO₂.

Ethyl 3-Methyl-5-pyrazolecarboxylate, CAS: 4027-57-0, stock: 6.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₀N₂O₂.

Ethyl Isoquinoline-3-carboxylate, CAS: 50458-79-2, stock: 7.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₁NO₂.

Fmoc-(3S)-1,2,3,4-tetrahydroisoquinoline-3-acetic acid, CAS: 270062-99-2, stock: 8.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₃NO₄.

Fmoc-7-hydroxy-(r)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic Acid, CAS: 178432-50-3, stock: 3.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₁NO₅.

Fmoc-7-hydroxy-(s)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid, CAS: 178432-49-0, stock: 1.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₁NO₅.

Fmoc-D-Tic-OH, CAS: 130309-33-0, stock: 7.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₁NO₄.

Heliamine Hydrochloride, CAS: 03/12/2328, stock: 3.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₆ClNO₂.

Higenamine Hydrochloride, CAS: 11041-94-4, stock: 1.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇NO₃ • HCl.

Hydrocotarnine Hydrochloride, CAS: 5985-55-7, stock: 2.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆ClNO₃.

Hydrocotarnine Hydrochloride-d3, CAS: /, stock: 4.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₃D₃ClNO₃.

Hydrohydrastinine, CAS: 494-55-3, stock: 7.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃NO₂.

Isoboldine, CAS: 3019-51-0, stock: 6.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₁NO₄.

Isoquinoline, CAS: 119-65-3, stock: 8.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇N.

Isoquinoline N-Oxide, CAS: 1532-72-5, stock: 5.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇NO.

Isoquinoline-1,3(2H,4H)-dione, CAS: 4456-77-3, stock: 7.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇NO₂.

Isoquinoline-1,6-diamine, CAS: 1147347-51-0, stock: 3.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉N₃.

Isoquinoline-1-carbonitrile, CAS: 1198-30-7, stock: 7.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₆N₂.

Isoquinoline-1-carboxylic acid, CAS: 486-73-7, stock: 2.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₇NO₂.

Isoquinoline-3-carbaldehyde, CAS: 5470-80-4, stock: 7.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₇NO.

Isoquinoline-3-carboximidamide Hydrochloride, CAS: 1179362-42-5, stock: 9.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉N₃.HCl.

Isoquinoline-3-carboxylic Acid, CAS: 6624-49-3, stock: 5.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₇NO₂.

Isoquinoline-3-carboxylic acid hydrate, CAS: 203626-75-9, stock: 8.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₇NO₂ • H ₂O.

Isoquinoline-4-boronic acid, CAS: 192182-56-2, stock: 3.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈BNO₂.

Isoquinoline-4-boronic acid, neopentyl glycol ester, CAS: 844891-01-6, stock: 4.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₆BNO₂.

Isoquinoline-4-boronic acid, pinacol ester, CAS: 685103-98-4, stock: 5.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₈BNO₂.

Isoquinoline-4-carbaldehyde, CAS: 22960-16-3, stock: 6.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₇NO.

Isoquinoline-4-carbonitrile, CAS: 34846-65-6, stock: 9.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₆N₂.

Isoquinoline-4-carboxylic acid, CAS: 7159-36-6, stock: 6.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₇NO₂.

Isoquinoline-5,6-diamine, CAS: 140192-89-8, stock: 6.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉N₃.

Isoquinoline-5-boronic acid, CAS: 371766-08-4, stock: 1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈BNO₂.

Isoquinoline-5-boronic acid, hydrochloride, CAS: 1256345-46-6, stock: 4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉BClNO₂.

Isoquinoline-5-carbaldehyde, CAS: 80278-67-7, stock: 3.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₇NO.

Isoquinoline-5-carboxylic Acid, CAS: 27810-64-6, stock: 6.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₇NO₂.

Isoquinoline-5-sulfonamide, CAS: 109547-31-1, stock: 5.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈N₂O₂S.

Isoquinoline-5-sulfonic Acid, CAS: 27655-40-9, stock: 9.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇NO₃S.

Isoquinoline-5-sulfonyl Chloride, Hydrochloride, CAS: 105627-79-0, stock: 2.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇Cl₂NO₂S.

Isoquinoline-5-thiocarboxamide, CAS: 885272-56-0, stock: 1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈N₂S.

Isoquinoline-6-carboxamide, CAS: 1158754-94-9, stock: 2.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈N₂O.

Isoquinoline-6-carboxylic acid, CAS: 106778-43-2, stock: 4.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₇NO₂.

Isoquinoline-7-boronic Acid, CAS: 1092790-21-0, stock: 4.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈BNO₂.

Isoquinoline-8-carbaldehyde, CAS: 787615-01-4, stock: 8.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₇NO.

Isoquinoline-8-carbonitrile, CAS: 362606-11-9, stock: 7.8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₆N₂.

Itrocainide, CAS: 90828-99-2, stock: 3.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₇N₃O.

α-(3,4-Diethoxyphenyl)-6,7-diethoxy-1-isoquinolinemethanol, CAS: 1394077-64-5, stock: 2.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₉NO₅.

JDTic, CAS: 361444-66-8, stock: 2g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₉N₃O₃.

Kibdelone A, CAS: 934464-77-4, stock: 6.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₄ClNO₁₀.

Kibdelone B, CAS: 934464-78-5, stock: 1.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₆ClNO₁₀.

Kibdelone C, CAS: 934464-79-6, stock: 6.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₈ClNO₁₀.

Kigamicin C, CAS: 680571-51-1, stock: 2.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₁H₄₇NO₁₆.

KN-62, CAS: 127191-97-3, stock: 4.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₃₅N₅O₆S₂.

L-7-Hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic Acid, CAS: 128502-56-7, stock: 7.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁NO₃.

Liensinine, CAS: 2586-96-1, stock: 4.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₄₂N₂O₆.

Liensinine Perchlorate, CAS: 2385-63-9, stock: 1.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₄₃ClN₂O₁₀.

Liriodenine, CAS: 475-75-2, stock: 8.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₉NO₃.

LOE 908 Hydrochloride, CAS: 143482-60-4, stock: 8.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₁H₄₈N₂O₉•HCl.

Losartan Imidazo[1,5-b]isoquinoline Impurity, CAS: 165276-38-0, stock: 3.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₁ClN₆.

Lucifer Yellow CH Dilithium Salt, CAS: 67769-47-5, stock: 4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₁N₅O₉S₂ •2Li.

Lucifer Yellow CH Dipotassium Salt (Technical Grade), CAS: 71206-95-6, stock: 4.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₉K₂N₅O₉S₂.

Lucifer Yellow VS Dilithium Salt, CAS: 71231-14-6, stock: 3.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₄N₂O₁₀S₃ •2Li.

Lysolipin I, CAS: 59113-57-4, stock: 2.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₄ClNO₁₁.

Methyl (1S)-3,4-Dihydro-1-phenyl-2(1H)-isoquinolinecarboxylate, CAS: 1251905-45-9, stock: 6.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇NO₂.

Methyl 1,2,3,4-Tetrahydro-1-oxoisoquinoline-7-carboxylate, CAS: 1245798-40-6, stock: 2.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁NO₃.

Methyl 1,2,3,4-Tetrahydroisoquinoline-3-carboxylate, CAS: 57060-86-3, stock: 7.5g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃NO₂.

Methyl 1,2,3,4-tetrahydroisoquinoline-3-carboxylate hydrochloride, CAS: 57060-88-5, stock: 8.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃NO₂ • HCl.

Methyl 1,2,3,4-Tetrahydroisoquinoline-5-carboxylate Hydrochloride, CAS: 1035700-06-1, stock: 5.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃NO₂ • HCl.

Methyl 1,2,3,4-Tetrahydroisoquinoline-8-carboxylate Hydrochloride, CAS: 1029689-82-4, stock: 3.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃NO₂ • HCl.

Methyl 1-Chloro-4-hydroxyisoquinoline-3-carboxylate, CAS: 223388-20-3, stock: 4.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₈NO₃Cl.

Methyl 1-Chloroisoquinoline-7-carboxylate, CAS: 1206975-02-1, stock: 4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₈NO₂Cl.

Methyl 2-(2-Chloroacetyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylate, CAS: 1008996-86-8, stock: 2.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₄NO₃Cl.

Methyl 2-Boc-1,2,3,4-tetrahydro-isoquinoline-6-carboxylate, CAS: 170097-66-2, stock: 8.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₁NO₄.

Methyl 4-Formamidobenzoate, CAS: 53405-05-3, stock: 5.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉NO₃.

Methyl 4-Hydroxyisoquinoline-3-carboxylate, CAS: 1108146-90-2, stock: 4.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₉NO₃.

Methyl 6-Isoquinolinecarboxylate, CAS: 173089-82-2, stock: 6.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₉NO₂.

Methyl 7-Chloroisoquinoline-3-carboxylate, CAS: 365998-38-5, stock: 7.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₈ClNO₂.

Methyl Isoquinoline-3-carboxylate, CAS: 27104-73-0, stock: 9.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₉NO₂.

Mitonafide, CAS: 54824-17-8, stock: 4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₅N₃O₄.

MMP 8-I, CAS: 236403-25-1, stock: 8.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₈N₂O₅S.

Moexipril Acyl-β-D-glucuronide, CAS: /, stock: 4.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₄₂N₂O₁₃.

Moexipril Cyclohexyl Analogue Hydrochloride, CAS: 1356019-89-0, stock: 5.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₁ClN₂O₇.

Moexipril Diketopiperazine, CAS: 103733-51-3, stock: 2.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₂N₂O₆.

Moexipril Hydrochloride, CAS: 82586-52-5, stock: 6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₅ClN₂O₇.

Moexipril Methyl Benzyl Ester Maleate, CAS: 1356019-99-2, stock: 9.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₄₂N₂O₁₁.

Moexipril Methyl Ester Analog Hydrochloride Salt, CAS: 1356841-17-2, stock: 4.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₃ClN₂O₇.

Moexipril tert-Butyl Ester Maleic Acid Salt, CAS: 103733-40-0, stock: 4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₄₆N₂O₁₁.

Moexipril-d3 Hydrochloride, CAS: /, stock: 4.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₂D₃ClN₂O₇.

Moexipril-d4 Hydrochloride, CAS: /, stock: 2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₁D₄ClN₂O₇.

Moexipril-d5, CAS: 1356929-49-1, stock: 3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₉D₅N₂O₇.

Moexiprilat, CAS: 103775-14-0, stock: 1.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₀N₂O₇.

Moexiprilat Acyl-β-D-glucuronide, >65%, CAS: 1260613-88-4, stock: 4.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₈N₂O₁₃.

Moexiprilat Hydrochloride, CAS: 82586-57-0, stock: 6.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₁ClN₂O₇.

Moexiprilat-d5, CAS: 1356840-08-8, stock: 8.4g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₅D₅N₂O₇.

N,N-Dimethyl-1-phenyl-3,4-dihydroisoquinoline-2(1H)-carboxamide, CAS: /, stock: 2.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₀N₂O.

N,N’-Bis(4-methoxyphenyl)-3,4,9,10-perylenetetracarboxylic Diimide, CAS: 6424-77-7, stock: 6.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₂₂N₂O₆.

N-(2-Aminoethyl)-5-chloroisoquinoline-8-sulfonamide, CAS: 120615-25-0, stock: 5.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₂ClN₃O₂S.

N-(2-Aminoethyl)-5-chloroisoquinoline-8-sulfonamide Dihydrochloride, CAS: 1177141-67-1, stock: 5.2g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄Cl₃N₃O₂S.

N-(2-Aminoethyl)-5-isoquinolinesulfonamide, CAS: 84468-17-7, stock: 3.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃N₃O₂S.

N-(2-Aminoethyl)-5-isoquinolinesulfonamide Hydrochloride, CAS: 116970-50-4, stock: 8.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄ClN₃O₂S.

N-(2-Aminoethyl)-8-isoquinolinesulfonamide Dihydrochloride, CAS: 127371-16-8, stock: 7.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃N₃O₂S • 2(HCl).

N-(4-Hydroxy-3-methoxyphenethyl)-2-(3-hydroxy-4-methoxyphenyl)acetamide, CAS: 21411-19-8, stock: 7.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₁NO₅.

N-Boc-1,2,3,4-Tetrahydroisoquinoline-6-carboxylic Acid, CAS: 170097-67-3, stock: 6.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₉NO₄.

N-Boc-3-aminopropanol, CAS: 58885-58-8, stock: 4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₇NO₃.

N-Boc-6,8-Dichloro-1,2,3,4-tetrahydroisoquinoline, CAS: /, stock: 4.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₇Cl₂NO₂.

N-Boc-6-hydroxymethyl-1,2,3,4-tetrahydroisoquinoline, CAS: 622867-52-1, stock: 2.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₁NO₃.

N-Boc-6-iodo-3,4-dihydroisoquinoline, CAS: 1008517-84-7, stock: 4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈NO₂I.

N-Desmethyl (-)-Canadalisol N-Carboxylic Acid Ethyl Ester, CAS: 123878-18-2, stock: 6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₇NO₇.

N-Formyl Octabase, CAS: 51773-23-0, stock: 2.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₃NO₂.

N-Formyl Octabase-d3, CAS: 1795785-83-9, stock: 9.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₀D₃NO₂.

N-Methyl-5-nitro-6-isoquinolinamine, CAS: 147293-17-2, stock: 8.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉N₃O₂.

N-Methyl-8-nitro-7-isoquinolinamine, CAS: 148556-87-0, stock: 7.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉N₃O₂.

N-Methyleneaniline Hydrochloride, CAS: 273933-66-7, stock: 4.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇N  •  HCl.

N-[2-(2-Thienyl)ethyl]formamide, CAS: 28783-49-5, stock: 8.5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₉NOS.

N-[2-(4-Fluorophenyl)ethyl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide, CAS: 1105059-12-8, stock: 5.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₉N₂OF.

N-[2-(4-Hydroxy-3-methoxyphenyl)ethyl]-3,4-bis(phenylmethoxy)benzeneacetamide, CAS: 138645-00-8, stock: 7.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₁NO₅.

N-[2-(Dimethylamino)ethyl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide Dihydrochloride, CAS: 1214014-55-7, stock: 6.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₁N₃O • 2HCl.

N-[2-(Methylamino)ethyl]-5-isoquinolinesulfonamide Dihydrochloride, CAS: 113276-94-1, stock: 9.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇Cl₂N₃O₂S.

N-[2-(Propylamino)ethyl]isoquinoline-5-sulfonamide, CAS: 116970-90-2, stock: 5.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉N₃O₂S.

N-[2-(Thiophen-2-yl)ethyl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide, CAS: 1101919-44-1, stock: 7.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈N₂OS.

N-[3-(Benzyloxy)-4-methoxyphenethyl]-2-[3-(benzyloxy)-4-methoxyphenyl]acetamide, CAS: 21411-26-7, stock: 7.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₃NO₅.

N-[4-(Benzyloxy)-3-methoxyphenethyl]-2-[3-(benzyloxy)-4-methoxyphenyl]acetamide, CAS: 1699-40-7, stock: 3.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₃NO₅.

Naftalofos, CAS: 1491-41-4, stock: 7.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₆NO₆P.

Naltriben, CAS: 111555-58-9, stock: 8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₅NO₄.

Narcotolinogendiol, CAS: 5876-41-5, stock: 3.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₅NO₇.

N’-Desmethyl Amonafide, CAS: 114991-16-1, stock: 8.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₅N₃O₂.

N’-Desmethyl Amonafide-d5, CAS: 1215400-25-1, stock: 5.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₀D₅N₃O₂.

Neferine, CAS: 2292-16-2, stock: 5.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₈H₄₄N₂O₆.

Nelfinavir Hydroxy-tert-butylamide, CAS: 213135-56-9, stock: 5.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₅N₃O₅S.

Nelfinavir Mesylate, CAS: 159989-65-8, stock: 7.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₄₉N₃O₇S₂.

Nelfinavir Sulfone, CAS: 1041389-29-0, stock: 7.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₅N₃O₆S.

Nelfinavir Sulfoxide, CAS: 1041389-28-9, stock: 9.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₅N₃O₅S.

Nelfinavir-d3, CAS: 1217629-70-3, stock: 4.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₂D₃N₃O₄S.

Nomifensine Maleic Acid Salt, CAS: 32795-47-4, stock: 7.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₂N₂O₄.

Nomifensine-d3 Maleic Acid Salt, CAS: 1795140-41-8, stock: 5.8g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₉D₃N₂O₄.

Norlaudanosoline Hydrobromide, CAS: 16659-88-4, stock: 3.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇NO₄•HBr.

O-Desethyl-O-isopropyl Quinapril, CAS: 955034-25-0, stock: 8.1g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₂N₂O₅.

Octaverine Hydrochloride, CAS: 6775-26-4, stock: 6.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₈ClNO₅.

Olodanrigan, CAS: 1316755-16-4, stock: 1.7g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₂₉NO₅.

Papaveraldine, CAS: 522-57-6, stock: 7.9g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₉NO₅.

Papaverine, CAS: 58-74-2, stock: 1.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₁NO₄.

Papaverine Hydrochloride, CAS: 61-25-6, stock: 4.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₂ClNO₄.

Papaverine-d3 Hydrochloride, CAS: /, stock: 4.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₉D₃ClNO₄.

PF 06650833, CAS: 1817626-54-2, stock: 8.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₀FN₃O₄.

PFI-2, CAS: 1627676-59-8, stock: 8.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₅F₄N₃O₃S.

Phenyl (S)-1-Phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate, CAS: 1203447-95-3, stock: 5.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₉NO₂.

Pigment Red 123 (Perylene Scarlet S-5761), CAS: 24108-89-2, stock: 5.3g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₂₆N₂O₆.

(+)-Irinotecan, CAS: 97682-44-5, stock: 4.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₈N₄O₆.

Pixantrone Bismaleinamide, CAS: /, stock: 9.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₃N₅O₈.

(4S)-4,11-Diethyl-3,4,12,14-tetrahydro-3,14-dioxo-1H-pyrano[3’,4’:6,7]indolizino[1,2-b]quinoline-4,9-diyl bis(2-methylpropyl) Ester Carbonic Acid, CAS: 848078-06-8, stock: 2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₆N₂O₉.

Pixantrone Dimaleate, CAS: 144675-97-8, stock: 8.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₇N₅O₁₀.

Pixantrone-bis-(2’-N-BOC), CAS: 144510-94-1, stock: 1.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₅N₅O₆.

(4S)-4-Ethyl-4-hydroxy-11-(1-hydroxypropyl)-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3’,4’:6,7]indolizino[1,2-b]quinolin-9-yl [1,4’-bipiperidine]-1’-carboxylate, CAS: /, stock: 9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₄₀N₄O₇.

(4S)-4-Ethyl-7,8-dihydro-4-hydroxy-1H-pyrano[3,4-f]indolizine-3,6,10(4H)-trione, CAS: 110351-94-5, stock: 6.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₃NO₅.

Pixantrone-N7-desethanamine Dihydrochloride, CAS: /, stock: 4.2g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄N₄O₂.

Pixantrone-N7-desethanamine Dihydrochloride and Pixantrone-N4-desethanamine Dihydrochloride Mixture, CAS: /, stock: 2.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₂Cl₄N₈O₄.

(R)-4-Hydroxy-4-methyl-7,8-dihydro-1H-pyrano[3,4-f]-indolizine-3,6,10(4H)-trione, CAS: /, stock: 9.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₁NO₅.

(R)-Irinotecan Hydrochloride Trihydrate, CAS: /, stock: 1g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₄₅ClN₄O₉•3H₂O.

PK 11195, CAS: 85532-75-8, stock: 2.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₁ClN₂O.

Potassium Isoquinoline-4-trifluoroborate, CAS: 1111733-07-3, stock: 4.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₆BF₃KN.

(R)-Irinotecan Hydrochloride-d10 Trihydrate, CAS: /, stock: 8.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₂₉D₁₀ClN₄O₆.

(S)-4,11-Diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3’,4’:6,7]indolizino[1,2-b]quinolin-9-yl Isobutyl Carbonate, CAS: /, stock: 7.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₈N₂O₇.

Quinapril Cyclohexyl Analogue, CAS: /, stock: 9.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₆N₂O₅.

(S)-4-Hydroxy-4-methyl-7,8-dihydro-1H-pyrano[3,4-f]-indolizine-3,6,10(4H)-trione, CAS: 1332605-57-8, stock: 2.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₁NO₅.

Quinapril Diketopiperazine, CAS: 103733-49-9, stock: 9.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₈N₂O₄.

Quinapril Ethyl Ester Maleic Acid Salt, CAS: 103733-36-4, stock: 2.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₈N₂O₉.

1-(2-Amino-5-hydroxyphenyl)propan-1-one, CAS: 35364-15-9, stock: 6.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁NO₂.

10,20-Di-O-methoxymethyl SN-38, CAS: 1246820-40-5, stock: 7.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₈N₂O₇.

Quinapril Hydrochloride, CAS: 82586-55-8, stock: 7.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₁ClN₂O₅.

Quinapril N-Oxide, CAS: /, stock: 2.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₀N₂O₆.

10-Hydroxy Camptothecin, CAS: 19685-09-7, stock: 7.8g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₆N₂O₅.

10-O-Acetyl SN-38, CAS: 946821-59-6, stock: 9.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₂N₂O₆.

Quinapril-d5 Benzyl Ester, CAS: /, stock: 6.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₁D₅N₂O₅.

Quinaprilat, CAS: 82768-85-2, stock: 8.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₆N₂O₅.

10-O-Acetyl SN-38-d3, CAS: /, stock: 8.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₁₉D₃N₂O₆.

10-O-Methoxymethyl SN-38, CAS: 1246815-54-2, stock: 7.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₄N₂O₆.

Quinaprilat-d4 Hydrate, CAS: /, stock: 8.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₄D₄N₂O₆.

Quinaprilat-d5, CAS: 1279034-23-9, stock: 3.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₁D₅N₂O₅.

11-Desethyl Irinotecan, CAS: 103816-16-6, stock: 4.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₄N₄O₆.

11-Desethyl Irinotecan-d10, CAS: /, stock: 9.1g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₂₄D₁₀N₄O₆.

R-(+)-N-Norlaudanosine, CAS: 50896-90-7, stock: 9.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₅NO₄.

12-Hydroxy Irinotecan (Mixture of Diastereomers), CAS: 185336-12-3, stock: 2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₈N₄O₇.

2-Hydroxy Irinotecan, CAS: 1346597-39-4, stock: 6.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₈N₄O₇.

rac 1,2,3,4-Tetrahydroisoquinoline-3-carboxylic Acid, CAS: 67123-97-1, stock: 1.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁NO₂.

rac 1,2,3,4-Tetrahydroisoquinoline-3-methanol, CAS: 63006-93-9, stock: 4.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃NO.

2-Hydroxy Irinotecan-d10, CAS: 1346597-30-5, stock: 5.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₂₈D₁₀N₄O₇.

2-Hydroxy-2-(6’-(hydroxymethyl)-5’-oxo-3’,5’,8’,8a’-tetrahydro-2’H-spiro[[1,3]dioxolane-2,1’-indolizin]-7’-yl)-N-((S)-1-phenylethyl)propanamide, CAS: /, stock: 7.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₈N₂O₆.

rac 1-Phenyl-1,2,3,4-tetrahydroisoquinoline, CAS: 22990-19-8, stock: 1.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₅N.

rac 4-Hydroxydebrisoquine Hemisulfate, CAS: 62580-84-1, stock: 7.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃N₃O•1/2H₂SO₄.

20-Desethyl-20-methyl-10-hydroxy-7-ethylcamptothecin, CAS: /, stock: 2.2g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₈N₂O₅.

3,10-Diethyl-11,13-dihydro-3-hydroxy-13-oxo-1H,3H-furo[3’,4’:6,7]indolizino[1,2-b]quinolin-8-yl Ester [1,4’-Bipiperidine]-1’-carboxylic Acid, CAS: 143490-54-4, stock: 7.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₈N₄O₅.

rac 4-Hydroxydebrisoquine-13C,15N2 Hemisulfate, CAS: 59333-79-8, stock: 9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉¹³CH₁₃N¹⁵N₂O•1/2H₂SO₄.

rac N-Acetyl Norlaudanosine-d3, CAS: 1216654-63-5, stock: 5.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₄D₃NO₅.

4-Benzyloxycarbonylaminopiperidine, CAS: 182223-54-7, stock: 8.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₈N₂O₂.

4-Hydroxy-4-methyl-7,8-dihydro-1H-pyrano[3,4-f]-indolizine-3,6,10(4H)-trione, CAS: /, stock: 7.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₁NO₅.

4-Methyl Irinotecan, CAS: /, stock: 6.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₄₀N₄O₆.

4-Piperidinopiperidine-1-carbonyl Chloride, CAS: 103816-19-9, stock: 5.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₉ClN₂O.

rac-(4R)-4,6-Dihydroxy-2-methyl-1,2,3,4-tetrahydroisoquinoline-1-carboxylic Acid-D3 (Impurity), CAS: /, stock: 1.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀D₃NO₄.

rac-4-Oxo Solifenacin, CAS: /, stock: 6.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₄N₂O₃.

4-[[5-Oxo-5-(phenylmethoxy)pentyl][(phenylmethoxy)carbonyl]amino]-1-piperidine, CAS: 1798021-74-5, stock: 6.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₂N₂O₄.

7,11-Diethyl-10-hydroxycamptothecin, CAS: 947687-01-6, stock: 7.8g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₄N₂O₅.

rac-Nor Laudanosine Hydrochloride, CAS: 05/04/6429, stock: 4.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₆ClNO₄.

S-(-)-Tretoquinol Hydrochloride, CAS: 18559-59-6, stock: 3.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₄ClNO₅.

7-Ethyl Camptothecin, CAS: 78287-27-1, stock: 6.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₀N₂O₄.

7-Ethyl-10-(4-amino-1-piperidino)carbonyloxycamptothecin, CAS: 185304-42-1, stock: 4.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₀N₄O₆.

S-(-)-Tretoquinol-d9 Hydrochloride, CAS: /, stock: 6.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₅D₉ClNO₅.

SB 205607 Dihydrobromide, CAS: 1217628-73-3, stock: 8.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₄N₂O • 2(HBr).

7-Ethyl-10-(4-amino-1-piperidino)carbonyloxycamptothecin Dihydrochloride, CAS: /, stock: 2.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₂Cl₂N₄O₆.

7-Ethyl-10-(4-amino-1-piperidino)carbonyloxycamptothecin-d3, CAS: 1217625-98-3, stock: 2.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₇D₃N₄O₆.

Scriptide, CAS: 287383-59-9, stock: 3.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₈N₂O₄.

Solifenacin Hydrochloride, CAS: 180468-39-7, stock: 8.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₇ClN₂O₂.

7-Ethyl-10-(4-N-aminopentanoic acid)-1-piperidino)carbonyloxycamptothecin, CAS: 181467-56-1, stock: 4.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₈N₄O₈.

7-Ethyl-10-(4-N-aminopentanoic acid)-1-piperidino)carbonyloxycamptothecin Hydrochloride, CAS: 181629-47-0, stock: 2.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₉ClN₄O₈.

Solifenacin N-Oxide, CAS: 180272-28-0, stock: 5.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₆N₂O₃.

Solifenacin Succinate, CAS: 242478-38-2, stock: 4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₂N₂O₆.

7-Ethyl-10-(4-N-aminopentanoic acid)-1-piperidino)carbonyloxycamptothecin-d3, CAS: 1217816-76-6, stock: 7.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₅D₃N₄O₈.

8-Ethyl Irinotecan, CAS: 947687-02-7, stock: 7.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₄₂N₄O₆.

Solifenacin-13C6 Succinate, CAS: /, stock: 8.8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁¹³C₆H₃₂N₂O₆.

Solifenacin-d5 Hydrochloride, CAS: 1426174-05-1, stock: 1.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₂D₅ClN₂O₂.

9-Methoxy Irinotecan Hydrochloride Trihydrate, CAS: /, stock: 7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₄H₄₀N₄O₇ • (HCl) • 3(H ₂O).

Solifenacin-d7 Hydrochloride, CAS: /, stock: 5.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₀D₇ClN₂O₂.

Solvent Yellow 98, Tech., CAS: 12671-74-8, stock: 5.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₄₅NO₂S.

SR 8278, CAS: 1254944-66-5, stock: 3.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₉NO₃S₂.

SR 8278-d3, CAS: /, stock: 1.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₆D₃NO₃S₂.

Desmethyl Irinotecan Hydrochloride-d3, CAS: /, stock: 1.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₄D₃ClN₄O₆.

Irinotecan Carboxylate Sodium Salt, CAS: 1329502-92-2, stock: 1.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₃₉N₄NaO₇.

SR 8278-d5, CAS: /, stock: 6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₄D₅NO₃S₂.

Irinotecan Hydrochloride Trihydrate, CAS: 136572-09-3, stock: 1.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₄₅ClN₄O₉.

Irinotecan Lactone Impurity, CAS: 143490-53-3, stock: 8.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₆N₄O₅.

TC-I 2000, CAS: 1159996-20-9, stock: 3.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₈F₄N₂O.

TCS OX2 29, CAS: 372523-75-6, stock: 5.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₃₁N₃O₃ • HCl.

Irinotecan-d10 Hydrochloride (Major), CAS: 718612-62-5, stock: 4.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₂₉D₁₀ClN₄O₆.

rac-Desmethyl Irinotecan Hydrochloride, CAS: /, stock: 6.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₇ClN₄O₆.

tert-​Butyl 6-​(4,​4,​5,​5-​tetramethyl-​1,​3,​2-​dioxaborolan-​2-​yl)​-​3,​4-​dihydroisoquinoline-​2(1H)​-​carboxylate, CAS: 893566-72-8, stock: 4.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₀BNO₄.

tert-Butyl 1-(Aminomethyl)-3,4-dihydroisoquinoline-2(1H)-carboxylate, CAS: 1207175-15-2, stock: 5.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₂N₂O₂.

SN-38, CAS: 86639-52-3, stock: 3.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₀N₂O₅.

SN-38 Carboxylate Disodium Salt, CAS: /, stock: 6.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₀N₂Na₂O₆.

tert-Butyl 1-Oxospiro[2,3-dihydroisoquinoline-4,4’-piperidine]-1’-carboxylate, CAS: 1032143-15-9, stock: 4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₄N₂O₃.

tert-Butyl 4-Oxo-1,2,3,4-tetrahydroisoquinoline-2-carboxylate, CAS: 1134327-89-1, stock: 4.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₇NO₃.

SN-38 Glucuronide, CAS: 121080-63-5, stock: 5.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₈N₂O₁₁.

SN-38 Glucuronide-13C3, CAS: /, stock: 9.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅¹³C₃H₂₈N₂O₁₁.

tert-Butyl 5-(Aminomethyl)-1,2,3,4-tetrahydroisoquinoline-2-carboxylate, CAS: 1196156-49-6, stock: 8.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₂N₂O₂.

tert-Butyl 5-methyl-1,4-diazepane-1-carboxylate, CAS: 194032-42-3, stock: 1.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₂N₂O₂.

SN-38 Glucuronide-d5, CAS: /, stock: 4.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₃D₅N₂O₁₁.

SN-38 Tri-O-acetyl-β-D-glucuronic Acid Methyl Ester, CAS: 121098-77-9, stock: 6.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₃₆N₂O₁₄.

tert-Butyl 6-(Aminomethyl)-3,4-dihydroisoquinoline-2(1H)-carboxylate, CAS: 1196154-55-8, stock: 3.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₂N₂O₂.

tert-Butyl 6-Bromo-1-oxo-3,4-dihydroisoquinoline-2(1H)-carboxylate, CAS: 1214900-33-0, stock: 5.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₆BrNO₃.

SN-38 Tri-O-acetyl-β-D-glucuronic Acid Methyl Ester-d3, CAS: /, stock: 7.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₃₃D₃N₂O₁₁.

SN-38-d3, CAS: 718612-49-8, stock: 8.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₇D₃N₂O₅.

tert-Butyl 6-Fluoro-1,4-diazepane-1-carboxylate, CAS: 1261297-63-5, stock: 6.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₉FN₂O₂.

tert-Butyl 6-hydroxy-3,4-dihydroisoquinoline-2(1H)-carboxylate, CAS: 158984-83-9, stock: 9.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉NO₃.

SN-38-d3 Glucuronide, CAS: /, stock: 2.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₅D₃N₂O₁₁.

SN-38-d3 Glucuronide (0.1 mg/mL in DMSO), CAS: /, stock: 6.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₅D₃N₂O₁₁.

tert-Butyl 6-Hydroxy-5-methyl-3,4-dihydroisoquinoline-2(1h)-carboxylate, CAS: 1165923-89-6, stock: 9.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₁NO₃.

SN-38-d3 Glucuronide (1 mg/mL in DMSO), CAS: /, stock: 1.2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₅D₃N₂O₁₁.

SN-38-d5, CAS: /, stock: 3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₅D₅N₂O₅.

tert-Butyl 6’-Bromo-2’,3’-dihydro-1’H-spiro[cyclopropane-1,4’-isoquinoline]-2’-carboxylate, CAS: 1203682-77-2, stock: 4.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₀NO₂Br.

tert-Butyl 7-Amino-3,4-dihydroisoquinoline-2(1H)-carboxylate, CAS: 171049-41-5, stock: 4.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₀N₂O₂.

[1,4’-Bipiperidine]-1’-carboxylic Acid 12-ethyl-9,11-dihydro-8-methyl-9-oxo-7-(1-oxopropyl)indolizino[1,2-b]quinolin-2-yl Ester, CAS: 176515-52-9, stock: 5.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₈N₄O₄.

tert-Butyl 7-Bromo-3,4-dihydroisoquinoline-2(1H)-carboxylate, CAS: 258515-65-0, stock: 4.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈NO₂Br.

tert-Butyl 7-Methoxy-3,4-dihydro-2h-spiro[isoquinoline-1,4’-piperidine]-1’-carboxylate, CAS: 1160247-66-4, stock: 3.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₈N₂O₃.

tert-Butyl Spiro[3,4-dihydro-2H-isoquinoline-1,4’-piperidine]-1’-carboxylate, CAS: 1160247-65-3, stock: 6.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₆N₂O₂.

tert-Butylamine, CAS: 75-64-9, stock: 9.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₁₁N.

Tetrabutylammonium cyanide, CAS: 10442-39-4, stock: 9.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₃₆N  • CN.

Trabectedin, CAS: 114899-77-3, stock: 8.9g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₉H₄₃N₃O₁₁S.

Tributylphenyltin, CAS: 960-16-7, stock: 6.3g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₂Sn.

Tylophorinidine, CAS: 32523-69-6, stock: 9.2g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₃NO₄.

WIKI4, CAS: 838818-26-1, stock: 10g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₃N₅O₃S.

Yohimbine-O-TBS, CAS: /, stock: 6.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₀N₂O₃Si.

[3S-(3R,4aR,8aR,2’S,3’S)]-2-[3’-N-t-Boc-amino-2’-hydroxy-4’-(phenyl)thio]butyldecahydroisoquinoline-3-N-t-butylcarboxamide, CAS: 1217629-57-6, stock: 7.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₄₇N₃O₄S.

[3S-(3S,4aS,8aS,2’R,3’R)]-2-[3’-N-CBz-amino-2’-hydroxy-4’-(phenyl)thio]butyldecahydroisoquinoline-3-N-t-butylcarboxamide, CAS: 159878-04-3, stock: 3.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₅N₃O₄S.

[S-(R*,R*)]-2-[2-tert-Butyloxycarbonylamino-1-oxopropyl]-1,2,3,4-tetrahydro-3-isoquinolinecarboxylic Acid Phenylmethyl Ester, CAS: 92829-12-4, stock: 3.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₀N₂O₅.

1-Amino-1-cyanocyclopentane Hydrochloride, CAS: 16195-83-8, stock: 5.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁ClN₂.

1-Amino-1-cyanocyclopentane-d4 Hydrochloride, CAS: 1346603-70-0, stock: 7.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₇D₄ClN₂.

2-Butyl-1,3-diazaspiro[4.4]non-1-en-4-one Hydrochloride, CAS: 151257-01-1, stock: 3.8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₉ClN₂O.

2-n-Butyl-d7-1,3-diazaspiro[4.4]non-1-en-4-one, CAS: 1794891-89-6, stock: 5.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁D₇N₂O.

Iproniazid-1-oxide, CAS: 36781-38-1, stock: 9.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₃N₃O₂.

Iprodione, CAS: 36734-19-7, stock: 4.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₃Cl₂N₃O₃.

Iprodione-d5, CAS: 1215631-57-4, stock: 9.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₈D₅Cl₂N₃O₃.

3-exo-Ipratropium Bromide Monohydrate, CAS: 922491-06-3, stock: 1.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₀BrNO₃•H₂O.

Ipidacrine, CAS: 62732-44-9, stock: 2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆N₂.

Ipidacrine-d9 (Major), CAS: /, stock: 3.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₈D₉N₂.

5-Acetamido-2,4,6-triiodoisophthaloyl Dichloride, CAS: 31122-75-5, stock: 4.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₄Cl₂I₃NO₃.

5-Amino-N,N’-bis[2,3-bis(acetyloxy)propyl]-2,4,6-triiodo-N-methyl-1,3-benzenedicarboxamide, CAS: 76350-09-9, stock: 5.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₈I₃N₃O₁₀.

5-Amino-N’-[2,3-bis(acetyloxy)propyl]-N-(2,3-dihydroxypropy)-2,4,6-triiodo-N-methyl-1,3-benzenedicarboxamide, CAS: 1391051-75-4, stock: 6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₄I₃N₃O₈.

Desmethoxy Iopromide, CAS: 76350-28-2, stock: 4.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₂I₃N₃O₇.

Iopromide, CAS: 73334-07-3, stock: 6.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₄I₃N₃O₈.

Iopromide-d3, CAS: 1189947-73-6, stock: 5.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₁D₃I₃N₃O₈.

N-Desmethoxyacetyl Iopromide, CAS: 154361-51-0, stock: 4.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₀I₃N₃O₆.

Tetra-O-acetyl Iopromide, CAS: 1246820-70-1, stock: 8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₂I₃N₃O₁₂.

Tetra-O-acetyl Iopromide-d3, CAS: 1246818-05-2, stock: 6.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₉D₃I₃N₃O₁₂.

(S)-2-Acetoxypropanoic Acid-d3, CAS: /, stock: 1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₅D₃O₄.

(S)-2-Acetoxypropionoyl Chloride-d3, CAS: /, stock: 5.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₄D₃ClO₃.

(S)-N1,N3-bis(1,3-dihydroxypropan-2-yl)-5-(2-hydroxypropanamido)-2,4-diiodoisophthalamide, CAS: 1788899-70-6, stock: 6.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₃I₂N₃O₈.

(S)-N1-(1,3-dihydroxypropan-2-yl)-5-(2-hydroxypropanamido)-2,4,6-triido-N3, N3-dimethylisophthalamide(Iopamidol EP Impurity F), CAS: 1869069-71-5, stock: 4.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₀I₃N₃O₆.

(S)-N1-(1,3-Dihydroxypropan-2-yl)-N3-(2-hydroxyethyl)-5-(2-hydroxypropanamide)-2,4,6-triiodisophthalamide, CAS: 77868-44-1, stock: 10g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₀I₃N₃O₇.

2-Desiodo-2-chloroiopmamidol, CAS: /, stock: 6.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₂ClI₂N₃O₈.

2-[Bis(phenylmethyl)amino]-1,3-propanediol Diethyl Ester, CAS: /, stock: 3.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₅NO₄.

2-[Bis(phenylmethyl)amino]-1,3-propanediol-d4, CAS: /, stock: 5.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇D₄NO₂.

4-Desiodo 4-Chloroiopmamidol, CAS: /, stock: 1.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₂ClI₂N₃O₈.

5-Amino-N,N’-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-2,4,6-triiodo-1,3-benzenedicarboxamide, CAS: 60166-98-5, stock: 8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈I₃N₃O₆.

5-Amino-N,N’-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-2,4,6-triiodo-1,3-benzenedicarboxamide-d8, CAS: /, stock: 5.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₀D₈I₃N₃O₆.

5-​(Acetylamino)​-​N1,​N3-​bis[2-​hydroxy-​1-​(hydroxymethyl)​ethyl]​-​2,​4,​6-​triiodo-1,​3-​benzenedicarboxamide(Iopamidol EP Impurity C), CAS: 87932-07-8, stock: 7.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₀I₃N₃O₇.

5-​[[(2S)​-​2-​(Acetyloxy)​-​1-​oxopropyl]​amino]​-​N,​N’-​bis[2-​hydroxy-​1-​(hydroxymethyl)​ethyl]​-​2,​4,​6-​triiodo-1,​3-​benzenedicarboxamide​(Iopamidol EP Impurity E), CAS: 60166-92-9, stock: 7.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₄I₃N₃O₉.

Desmethyl Iopamidol, CAS: 77868-41-8, stock: 9.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₀I₃N₃O₈.

Iopamidol, CAS: 60208-45-9, stock: 5.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₂I₃N₃O₈.

Iopamidol-d3 Tetraacetate, CAS: /, stock: 4.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₉D₃I₃N₃O₁₃.

Iosarcol, CAS: 97702-82-4, stock: 5.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₉I₃N₄O₉.

Iosarcol-d6, CAS: /, stock: 1.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₀D₆I₃N₄O₉.

N,N’-Bis[2-(acetyloxy)-1-[(acetyloxy)methyl]ethyl]-5-amino-2,4,6-triiodo-1,3-benzenedicarboxamide, CAS: 148051-08-5, stock: 6.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₆I₃N₃O₁₀.

N,N’-Bis[2-(acetyloxy)-1-[(acetyloxy)methyl]ethyl]-5-amino-2,4,6-triiodo-1,3-benzenedicarboxamide-d8, CAS: /, stock: 4.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₈D₈I₃N₃O₁₀.

N1-​(2,​3-​Dihydroxypropyl)​-​N3-​[2-​hydroxy-​1-​(hydroxymethyl)​ethyl]​-​5-​[[(2S)​-​2-​hydroxy-​1-​oxopropyl]​amino]​-​2,​4,​6-​triiodoisophthalamide(Iopamidol EP Impurity G), CAS: 1869069-72-6, stock: 9.6g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₂I₃N₃O₈.

Penta-O-acetyl Iopamidol, CAS: 289890-55-7, stock: 9.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₃₂I₃N₃O₁₃.

Penta-O-acetyl Iopamidol-d8, CAS: /, stock: 5.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₄D₈I₃N₃O₁₃.

Iomeprol, CAS: 78649-41-9, stock: 4.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₂I₃N₃O₈.

Iomeprol-d3, CAS: 1185146-41-1, stock: 5.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉D₃I₃N₃O₈.

N-Desmethyl Iomeprol, CAS: 77868-40-7, stock: 8.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₀I₃N₃O₈.

N-Desmethyl Iomeprol Pentaacetate, CAS: 87785-51-1, stock: 5.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₀I₃N₃O₁₃.

1-(3-(N-(2,3-Dihydroxypropyl)acetamido) Iohexol, CAS: /, stock: 6.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₈I₃N₃O₁₀.

3-(3-(N-(2,3-Dihydroxypropyl)acetamido) Iohexol, CAS: /, stock: 1.2g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₈I₃N₃O₁₀.

5-(Acetylamino)-N,N’-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide, CAS: 31127-80-7, stock: 8.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₀I₃N₃O₇.

5-(N-(2-(2,3-Dihydroxypropoxy)-3-hydroxypropyl)acetamido) Iohexol, CAS: /, stock: 6.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₂I₃N₃O₁₁.

5-(N-(3-(2,3-Dihydroxypropoxy)-3-hydroxypropyl)acetamido) Iohexol, CAS: /, stock: 2.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₂I₃N₃O₁₁.

5-Amino-2,4,6-triiodoisophthalic Acid, CAS: 35453-19-1, stock: 3.7g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₄I₃NO₄.

5-Amino-N,N’-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide, CAS: 76801-93-9, stock: 8.4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈I₃N₃O₆.

5-Amino-N,N’-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide Tetraacetate, CAS: 76801-94-0, stock: 2.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₆I₃N₃O₁₀.

Iohexol, CAS: 66108-95-0, stock: 1.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₆I₃N₃O₉.

Iohexol-d3, CAS: /, stock: 7.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₃D₃I₃N₃O₉.

Iohexol-d5, CAS: 928623-33-0, stock: 3.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₁D₅I₃N₃O₉.

N,N’-Bis(2,3-dihydroxypropyl)-5-nitro-1,3-benzenedicarboxamide, CAS: 76820-34-3, stock: 5.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉N₃O₈.

N1-(2-(2,3-Dihydroxypropoxy)-3-hydroxypropyl Iohexol, CAS: /, stock: 6.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₂I₃N₃O₁₁.

N1-(3-(2,3-Dihydroxypropoxy)-2-hydroxypropyl) Iohexol, CAS: /, stock: 9.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₂I₃N₃O₁₁.

Cyclic Iodixanol (90%), CAS: 171897-73-7, stock: 9.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₄₁I₅N₆O₁₄.

Deacetyl Iodixanol, CAS: 171897-74-8, stock: 8.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₄₂I₆N₆O₁₄.

Des(2,3-dihydroxypropyl) Iodixanol, CAS: 255376-57-9, stock: 1.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₈I₆N₆O₁₃.

Iodixanol, CAS: 92339-11-2, stock: 3.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₄₄I₆N₆O₁₅.

N-Acetyl Cyclized Iodixanol, CAS: 171897-72-6, stock: 1.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₄₃I₅N₆O₁₅.

(+)-Loline Dihydrochloride, CAS: 25161-92-6, stock: 1.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₆Cl₂N₂O.

(+)-Loline-d3 Dihydrochloride, CAS: /, stock: 7.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₃D₃Cl₂N₂O.

(+)-trans-Allethrin, CAS: 28434-00-6, stock: 5.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₆O₃.

(+/-)-1,2-Propylene-d6 Oxide, CAS: 202468-69-7, stock: 7.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃D₆O.

(1,1-Dimethylethyl)dimethyl[[(1R)-1-methyl-3-butyn-1-yl]oxy]silane, CAS: 193544-52-4, stock: 5.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₂OSi.

(2-Methyl-d3)fluoranthene, CAS: /, stock: 8.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₉D₃.

(2R)-4-Pentyn-2-ol, CAS: 159407-28-0, stock: 3.4g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₈O.

(4-​Chloro-​2-​methylphenoxy-​2,​3,​5-​d3)​acetic Acid, CAS: 352431-14-2, stock: 5.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₆ClD₃O₃.

(4-Chloro-2-methylphenoxy)acetic Acid, CAS: 94-74-6, stock: 5.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉ClO₃.

(7α,8β,9α,10α)-7,8,9,10-Tetrahydrobenzo[a]pyrene-7,8,9,10-tetrol (>90%), CAS: 61490-69-5, stock: 3.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₆O₄.

(7α,8β,9α,10α)-7,8,9,10-Tetrahydrobenzo[a]pyrene-7,8,9,10-tetrol-13C, CAS: /, stock: 7.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆¹³C₄H₁₆O₄.

(7α,8β,9α,10α)-7,8,9,10-Tetrahydrobenzo[a]pyrene-7,8,9,10-tetrol-d8, CAS: /, stock: 3.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₈D₈O₄.

(7R,8S,9R,10S)-rel-7,8,9,10-Tetrahydrobenzo[a]pyrene-7,8,9,10-tetrol, CAS: 61490-66-2, stock: 7.1g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₆O₄.

(7R,8S,9R,10S)-rel-7,8,9,10-Tetrahydrobenzo[a]pyrene-7,8,9,10-tetrol-13C4, CAS: /, stock: 9.1g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆¹³C₄H₁₆O₄.

(7R,8S,9R,10S)-rel-7,8,9,10-Tetrahydrobenzo[a]pyrene-7,8,9,10-tetrol-d8, CAS: /, stock: 5.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₈D₈O₄.

(7R,​8S,​8aR,​9aS)​-7,​8,​8a,​9a-​Tetrahydrobenzo[10,​11]​chryseno[3,​4-​b]​oxirene-​7,​8-​diol, CAS: 58917-91-2, stock: 3.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₄O₃.

(7R,​8S,​9R,​10S)​-​9-​Bromo-​7,​8,​9,​10-​tetrahydrobenzo[a]​pyrene-​7,​8,​10-​triol, CAS: 64681-68-1, stock: 5.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₅BrO₃.

(7R,​8S,​9S,​10R)​-​7,​8,​9,​10-​Tetrahydrobenzo[a]​pyrene-​7,​8,​9,​10-​tetrol 7,8,9,10-Tetraacetate, CAS: 62697-18-1, stock: 9.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₄O₈.

(7R,​8S,​9S,​10S)​-7,​8,​9,​10-​Tetrahydrobenzo[a]​pyrene-​7,​8,​9,​10-​tetrol 7,​8,​9,​10-​Tetraacetate, CAS: 1004551-26-1, stock: 6.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₄O₈.

(±)-1-Octen-3-ol, CAS: 3391-86-4, stock: 8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₆O.

(±)-Propylene Oxide, CAS: 75-56-9, stock: 8.9g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₆O.

(Heptadecafluorooctyl)(tridecafluorohexyl) Phosphinic Acid Sodium Salt, CAS: /, stock: 2.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄F₃₀NaO₂P.

(R)-5-Chloro-8-methoxy-3-methyl-1-oxo-3,4-dihydro-1H-isochromene-7-carboxylic Acid, CAS: 1421840-16-5, stock: 8.5g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₁ClO₅.

(S)-2-Amino-2,3-dimethylbutanamide, CAS: 90377-00-7, stock: 2.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₄N₂O.

1,1,1,11-Tetrachloroundecane, CAS: 3922-34-7, stock: 1.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₀Cl₄.

1,1,1,2-Tetrachloroethane, CAS: 630-20-6, stock: 8.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂H₂Cl₄.

1,1,1,3,10,11-Hexachloroundecane, CAS: 601523-28-8, stock: 4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₈Cl₆.

1,1,1,3,10,12,12,12-Octachlorododecane, CAS: 601523-21-1, stock: 9.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈Cl₈.

1,1,1,3,12,13-Hexachlorotridecane, CAS: 865306-23-6, stock: 4.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₂Cl₆.

1,1,1,3,8,10,10,10-Octachlorodecane, CAS: 601523-23-3, stock: 8.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄Cl₈.

1,1,1,3-Tetrachlorodecane, CAS: 51755-60-3, stock: 6.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₈Cl₄.

1,1,1,3-Tetrachlorododecane, CAS: 14983-60-9, stock: 8.3g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₂Cl₄.

1,1,1,3-Tetrachlorotridecane, CAS: 67095-50-5, stock: 2.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₄Cl₄.

1,1,1,3-Tetrachloroundecane, CAS: 56686-55-6, stock: 6.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₀Cl₄.

1,1,1-Trichloro-3,5-dimethyloctane, CAS: 13275-21-3, stock: 1.6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₉Cl₃.

1,1,1-Trichlorodecane, CAS: 62108-56-9, stock: 4.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₉Cl₃.

1,1,1-Trichlorododcane, CAS: 62108-57-0, stock: 5.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₃Cl₃.

1,1,1-Trichlorotridecane, CAS: 3922-24-5, stock: 1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₅Cl₃.

1,1,1-Trichloroundecane, CAS: 3922-25-6, stock: 9.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₂₁Cl₃.

1,1,14,14-Tetrachlorotetradecane, CAS: 32905-57-0, stock: 9.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₆Cl₄.

1,1,2,2-Tetrahydroperfluoro-1-tetradecanol, CAS: 39239-77-5, stock: 8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₅F₂₅O.

1,1-Dioctadecyl-3,3,3,3-tetramethylindotricarbocyanine Iodide (>90%), CAS: 100068-60-8, stock: 4.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₃H₁₀₁IN₂.

1,10-Dichlorodecane, CAS: 2162-98-3, stock: 2.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₂₀Cl₂.

1,10b-Dihydro-2-methyl-3(2H)-fluoranthenone, CAS: 858258-61-4, stock: 7.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₄O.

1,1’,2,2’,3,3’,4,4’,5,5’-Decamethylferrocene, CAS: 12126-50-0, stock: 4.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₀Fe.

1,1’-(1,2-Ethanediyl)bis[1-methyl-silane], CAS: 4405-22-5, stock: 3.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₁₄Si₂.

1,1’-Dimethylferrocene, CAS: 1291-47-0, stock: 7.1g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄Fe.

1,2,3,10b-Tetrahydro-2-methylfluoranthene, CAS: 872302-23-3, stock: 1.1g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₆.

1,2,3,4,5-Pentachlorobenzene, CAS: 608-93-5, stock: 3.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆HCl₅.

1,2,3,4,5-Pentachlorobenzene-13C6, CAS: /, stock: 8.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₆HCl₅.

1,2,3,4-Tetrachloro-5-nitrobenzene, CAS: 879-39-0, stock: 3.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆HCl₄NO₂.

1,2,4,5-Tetrachlorobenzene-13C6, CAS: /, stock: 2.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₆H₂Cl₄.

1,2,4-Tribromo-5-ethylbenzene-13C6, CAS: /, stock: 1.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂¹³C₆H₇Br₃.

1,2,4-Tributyl Phosphorotrithioate, CAS: 78-48-8, stock: 1.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₇OPS₃.

1,2,5,6-Tetrabromocyclooctane, CAS: 3194-57-8, stock: 7.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₂Br₄.

1,2,7,8-Tetrachlorodibenzo-p-dioxin, CAS: 34816-53-0, stock: 3.1g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₄Cl₄O₂.

1,2-Dibromo-3-chloropropane, CAS: 96-12-8, stock: 7.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₅Br₂Cl.

1,2-Dichloro-1,1-difluoroethane, CAS: 1649-08-7, stock: 5.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂H₂Cl₂F₂.

1,2-Dichloroethylene (Mixture of cis and trans), CAS: 540-59-0, stock: 4.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂H₂Cl₂.

1,2-Dimethyl-4-nitrobenzene, CAS: 99-51-4, stock: 3.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₉NO₂.

1,2-Dimethylnaphthalene, CAS: 573-98-8, stock: 2.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₂.

1,2-Phenylenediamine, CAS: 95-54-5, stock: 2.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₈N₂.

1,3,6-Trichloropyrene, CAS: 33070-25-6, stock: 2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₇Cl₃.

1,3-Butadiene (~15% by weight in Toluene), CAS: 106-99-0, stock: 9.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₆.

1,3-Dichlorobenzene, CAS: 541-73-1, stock: 5.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄Cl₂.

1,3-Dinitrobenzene, CAS: 99-65-0, stock: 5.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄N₂O₄.

1,3-Oxathiolan-2-one, CAS: 3326-89-4, stock: 1.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₄O₂S.

1,4-Dithiane, CAS: 505-29-3, stock: 6.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₈S₂.

1,5,5,6,6,10-Hexachlorodecane, CAS: 90943-97-8, stock: 2.1g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆Cl₆.

1,6-Dichloropyrene, CAS: 89315-21-9, stock: 2.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₈Cl₂.

1,6-Dihydro-5H-pyrazolo[3,4-c]pyridin-5-one, CAS: 1049672-77-6, stock: 4.8g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₅N₃O.

1,6-Dimethyl-phenanthrene, CAS: 20291-74-1, stock: 5.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄.

1,7,7,8,8,14-Hexachlorotetradecane, CAS: 96949-61-0, stock: 9.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₄Cl₆.

1,7-Dimethyl-phenanthrene, CAS: 483-87-4, stock: 5.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₄.

1,7-Naphthalenedisulfonic Acid, CAS: 5724-16-3, stock: 5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈O₆S₂.

1,​1-​Dichloro-​1-​fluoroethane, CAS: 1717-00-6, stock: 7.2g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂H₃Cl₂F.

1,​2-​Dichloro-​1,​1,​3,​3,​3-​pentafluoropropane, CAS: 431-86-7, stock: 7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃HCl₂F₅.

1,​3-​Bis(isocyanatomethyl​)​cyclohexane (Mixture of Cis and Trans), CAS: 38661-72-2, stock: 4.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄N₂O₂.

1,​3-​Phenylene Diisocyanate, CAS: 123-61-5, stock: 2.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₄N₂O₂.

1-(2,5-Dichlorophenyl)ethanone-d3, CAS: /, stock: 8.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₃D₃Cl₂O.

1-(2-Hydroxyethyl)-2-imidazolidinone, CAS: 3699-54-5, stock: 1.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀N₂O₂.

1-(2-Methoxyphenyl)-2-methyl-naphthalene (Mixture), CAS: 910784-96-2, stock: 8.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₆O.

1-Bromopentane, CAS: 110-53-2, stock: 7.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₁Br.

1-Bromopentane-d11, CAS: 126840-21-9, stock: 7.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅D₁₁Br.

1-Butyl-3-methylimidazolium Hexafluorophosphate, CAS: 174501-64-5, stock: 1.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₅FN₂P₆.

1-Chloropyrene, CAS: 34244-14-9, stock: 8g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₉Cl.

1-Ethyl-3-hydroxy-2-methyl-4-pyridinone, CAS: 30652-12-1, stock: 1.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₁NO₂.

1-Ethylchrysene, CAS: 09/11/6705, stock: 2.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₆.

1-Hexadecyl-3-methylimidazolium Chloride, CAS: 61546-01-8, stock: 1.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₃₉ClN₂.

1-Hexyl-3-methylimidazolium Bromide, CAS: 85100-78-3, stock: 6.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₂₀BrN₂.

1-Methoxy-2-propanone-d5, CAS: 89922-02-1, stock: 3.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₃D₅O₂.

1-Methyldibenzothiophene, CAS: 31317-07-4, stock: 4.1g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₀S.

1-Methylfluoranthene, CAS: 25889-60-5, stock: 8.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₂.

1-Methylfluoranthene-d3, CAS: /, stock: 2.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₉D₃.

1-Nitrosopyrrolidine, CAS: 930-55-2, stock: 8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₈N₂O.

1-Nitrosopyrrolidine-d4, CAS: 57371-40-1, stock: 5.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₄D₄N₂O.

1-Octyne, CAS: 629-05-0, stock: 3.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₄.

1-Phenazinecarboxylic Acid, CAS: 2538-68-3, stock: 10g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₈N₂O₂.

1-Propenylmagnesium bromide, CAS: 14092-04-7, stock: 9.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₅BrMg.

1-[5-Chloro-2-(2,4-dichlorophenoxy-13C6)phenyl]ethanone, CAS: /, stock: 4.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈¹³C₆H₉Cl₃O₂.

13C2-PFHxA (50μg/mL in Methanol), CAS: 960315-47-3, stock: 3.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆HF₁₁O₂.

14-Azido-3,6,9,12-tetraoxatetradecanol, CAS: 86770-68-5, stock: 8.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₂₁N₃O₅.

15-Acetyl Deoxynivalenol (~90%), CAS: 88337-96-6, stock: 5.2g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₂O₇.

(2S)-N1-[4-Methyl-5-[2-(2,2,2-trifluoro-1,1-dimethylethyl)-4-pyridinyl]-2-thiazolyl]-1,2-pyrrolidinedicarboxamide, CAS: 1217486-61-7, stock: 5.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₂F₃N₅O₂S.

(1S,2S,3R,4S,5S)-2,3,4-Tris(benzyloxy)-5-(((R)-1-(benzyloxy)-3-hydroxypropan-2-yl)amino)-1-((benzyloxy)methyl)cyclohexanol, CAS: /, stock: 4.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₅H₅₁NO₇.

(R)-D-myo-Inositol-1-(2,3-didecanoyloxy-propyl-hydrogenphosphate)-3,4-diphosphate Triammonium Salt, CAS: /, stock: 9.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₆₆N₃O₁₉P₃.

(R)-D-myo-Inositol-1-(2,3-dilauroyloxy-propyl-hydrogenphosphate)-3,4-diphosphate Triammonium Salt, CAS: /, stock: 2.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₃H₇₄N₃O₁₉P₃.

(R)-D-myo-Inositol-1-(2,3-dipalmitoyloxy-propyl-hydrogenphosphate)-3,4-diphosphate Triammonium Salt, CAS: /, stock: 9.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₇H₈₂N₃O₁₉P₃.

(-)-Inosine Dehydroxy-N-(6-iminohexyl)-2,2,2-trifluoroacetamide, CAS: /, stock: 6.9g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₅F₃N₆O₅.

(-)-Inosine Dehydroxy-N-(6-iminohexyl)-2,2,2-trifluoroacetamide Phosphate, CAS: /, stock: 1.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₆F₃N₆O₈P.

2,2,4-Trichlorodecane, CAS: 39185-78-9, stock: 2.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₉Cl₃.

2,2,6,6-Tetramethyl-1-hydroxypiperidine, CAS: 7031-93-8, stock: 5.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₉NO.

(-)-Inosine Dehydroxy-N-(6-iminohexyl)-2,2,2-trifluoroacetamide Phospho-morpholine, CAS: /, stock: 4.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₃₃F₃N₇O₉P.

(2R,​3S,​4S,​5S) -5-Hydroxy-2,3,4-tris(phenylmethoxy)-5-[(phenylmethoxy)methyl]-cyclohexamine, CAS: /, stock: 4.9g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₃₉NO₅.

(2R,​3S,​4S,​5S) -5-Hydroxy-2,3,4-tris(phenylmethoxy)-5-[(phenylmethoxy)methyl]-cyclohexanol-(S)-amino-3-phenoxypropan-2-yl, CAS: /, stock: 1.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₄₉NO₇.

1,2-Cyclohexylidene Tetra-O-acetyl myo-Inositol, CAS: 39110-61-7, stock: 1.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₈O₁₀.

1,2-Dipalmitoyl-L-alpha-phosphatidyl-D-myo-inositol 4,5-bisphosphate, CAS: 120595-88-2, stock: 4.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₁H₈₁O₁₉P₃.

2,2-Didecyl-1,3-propanediol, CAS: 170025-81-7, stock: 2.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₄₈O₂.

2,2-Diethylhexanoic Acid, CAS: 4528-37-4, stock: 1.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₂₀O₂.

(-)-Lentiginosine, CAS: 125279-72-3, stock: 2.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₅NO₂.

(2R,​3S,​4S,​5S) -5-Hydroxy-2,3,4-tris(phenylmethoxy)-5-[(phenylmethoxy)methyl]-cyclohexyl-(R)-amino-3-phenoxypropanal, CAS: /, stock: 2.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₄H₄₇NO₇.

1,2-Isopropylidene D,L-myo-Inositol, CAS: 26276-97-1, stock: 1.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₆O₆.

1,2-Isopropylidene D,L-myo-Inositol Tetraacetate, CAS: 26276-98-2, stock: 4.2g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₄O₁₀.

2,2-Diethylhexanoic Acid-d9, CAS: /, stock: 1.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁D₉O₂.

2,2-Difluoro[1,1,2,2-tetrafluoro-2-(pentafluoroethoxy)ethoxy]acetic Acid Ammonium Salt, CAS: 908020-52-0, stock: 10g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆HF₁₁O₄ • x(NH ₃).

(2R,5R)-4-Iodo-2-(6-oxo-1H-purin-9(6H)-yl)-5-(((2,4,4-trimethyl-5-oxo-1,3-dioxolan-2-yl)oxy)methyl)tetrahydrofuran-3-yl Acetate, CAS: /, stock: 4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₁IN₄O₈.

(3S,4S)-(+)-1-Benzyl-3,4-pyrrolidinediol, CAS: 90365-74-5, stock: 7.2g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅NO₂.

(3R,6S,9S,12E,16S)-9-(4-Aminobutyl)-3-[(4-benzoylphenyl)methyl]-6-(cyclohexylmethyl)-2,5,8,11,14-pentaoxo-1,4,7,10,15-pentaazacycloeicos-12-ene-16-carboxamide, CAS: 1774353-12-6, stock: 7g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₁H₅₅N₇O₇.

1,2-Isopropylidene-D,L-myo-inositol, CAS: 26276-97-1, stock: 4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₆O₆.

1,2-O-Cyclohexylidene myo-Inositol, CAS: 6763-47-9, stock: 3.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₀O₆.

(R)-Indoxacarb, CAS: 185608-75-7, stock: 7.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₇ClF₃N₃O₇.

(5E)-5-(4-Hydroxybenzylidene)-1,3-thiazolidine-2,4-dione, CAS: 103788-60-9, stock: 6.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₇NO₃S.

(5Z)-Rosiglitazone, CAS: 160596-25-8, stock: 6.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₇N₃O₃S.

1,2-O-Cyclohexylidene-4-O-(phenylmethyl)-D-myo-inositol, CAS: 116839-47-5, stock: 6.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₆O₆.

(S)-Indoxacarb, CAS: 173584-44-6, stock: 4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₇ClF₃N₃O₇.

1,2,3,5-Tetra-O-acetyl β-D-Ribofuranose-13C5, CAS: /, stock: 6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈¹³C₅H₁₈O₉.

1-​(2,​3,​5-​Tri-​O-​acetyl-​β-​D-​xylofuranosyl)​-​1H-​1,​2,​4-​triazole-​3-​carboxylic Acid Methyl Ester-13C5, CAS: /, stock: 2.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀¹³C₅H₁₉N₃O₉.

1,2:4,5-Bis-O-(Isopropylidene-3,6-bis-O-(phenylmethyl) DL-myo-Inositol, CAS: 176200-07-0, stock: 4.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₂O₆.

4a-Des(methylcarboxy), 4a(S)-carboxyethyl Indoxacarb, CAS: /, stock: 3.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₉ClF₃N₃O₇.

(±)-α-Lipoamide, CAS: 940-69-2, stock: 8.5g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₅NOS₂.

1,2:4,5-Biscyclohexylidene D-myo-Inositol, CAS: 55123-26-7, stock: 4.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₈O₆.

1,2:4,5-Biscyclohexylidene DL-myo-Inositol, CAS: 104873-71-4, stock: 7.1g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₈O₆.

7-Chloro-2-((4-methoxyphenyl)carbamoyl)-2,3,4a,5-tetrahydroindeno[1,2-e][1,3,4]oxadiazine-4a-carboxylic Acid Methyl Ester, CAS: /, stock: 7.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₈ClN₃O₅.

7-Chloro-4a,5-dihydroindeno[1,2-e][1,3,4]oxadiazine-2,4a(3H)-dicarboxylic Acid Dimethyl Ester, CAS: /, stock: 6.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₃ClN₂O₅.

1-Methyl-Inosine, CAS: 2140-73-0, stock: 8.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄N₄O₅.

1-Methyl-Inosine-d3, CAS: /, stock: 5.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁D₃N₄O₅.

(E)-5-(4-(2-(Benzyl(pyridin-2-yl)amino)ethoxy)benzylidene)thiazolidine-2,4-dione, CAS: /, stock: 5.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₁N₃O₃S.

(Hydroxy-2-naphthalenylmethyl)phosphonic Acid Bis(1,1-Dimethylethyl) Ester, CAS: 132541-51-6, stock: 1.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₇O₄P.

1,2:4,5-Biscyclohexylidene L-myo-Inositol, CAS: /, stock: 9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₈O₆.

Deschloro Indoxacarb, CAS: /, stock: 1.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₈F₃N₃O₇.

(R)-(-)-1,2,3,4-Tetrahydro-1-naphthol, CAS: 23357-45-1, stock: 7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂O.

1,2:4,5-Diisopropylidene D,L-myo-Inositol, CAS: 98974-89-1, stock: 9.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₀O₆.

1,2:5,6-Di-O-cyclohexylidene-myo-inositol, CAS: 34711-26-7, stock: 3.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₈O₆.

Deschloro Indoxacarb-d3, CAS: /, stock: 6.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₅D₃F₃N₃O₇.

Deschloro-destrifluoromethyl Indoxacarb, CAS: /, stock: 7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₉N₃O₇.

2-Acetoxyisobutyryl Bromide, CAS: 40635-67-4, stock: 1.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉BrO₃.

2-Amino Adenosine, CAS: 08/10/2096, stock: 1.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄N₆O₄.

1,3-Diazido-4-O-[(2S,3R)-3-azido-6-(azidomethyl)-3,4-dihydro-2H-pyran-2-yl]-1,2,3-trideoxy-6-O-[3-deoxy-4-C-methyl-3-(methylamino)-β-L-arabinopyranosyl]-D-myo-inositol, CAS: 1225277-47-3, stock: 4.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₉N₁₃O₇.

1,6-O-[(1R,2R)-1,2-Dimethoxy-1,2-dimethyl-1,2-ethanediyl]-3,4-O-[(1S,2S)-1,2-dimethoxy-1,2-dimethyl-1,2-ethanediyl]-5-benzoate-myo-inositol, CAS: 1068088-78-7, stock: 5.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₆O₁₁.

Deschloro-destrifluoromethyl Indoxacarb-d3, CAS: /, stock: 2.4g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₆D₃N₃O₇.

Indoxacarb, CAS: 144171-61-9, stock: 2.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₇ClF₃N₃O₇.

2-Azainosine, CAS: 36519-16-1, stock: 1.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁N₅O₅.

2-Bromo-2’,3’,5’-tri-O-acetylinosine, CAS: 41623-91-0, stock: 7.9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇BrN₄O₈.

(R)-Valiolamine Voglibose Dihydrochloride, CAS: /, stock: 8.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₃₆Cl₂N₂O₁₁.

1,6:3,4-Bis-[O-(2,3-dimethoxybutane-2,3-diyl)]-2-O-trifluoromethanesulphonyl-5-O-benzolyl-myo-inositol, CAS: 1068089-34-8, stock: 7.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₅F₃O₁₃S.

1,​3,​5-​O-​Methylidyne-​myo-​inositol, CAS: 98510-20-4, stock: 7.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₀O₆.

2,2’-[[3-Chloro-4-[2-(4-nitrophenyl)diazenyl]phenyl]imino]bis[ethanol], CAS: 4540-00-5, stock: 4.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇ClN₄O₄.

Indoxacarb-d3, CAS: /, stock: 1.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₁₄D₃ClF₃N₃O₇.

2-Chloro-6-O-methyl-inosine, CAS: 15465-92-6, stock: 2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃ClN₄O₅.

2-Chloroinosine, CAS: 13276-43-2, stock: 1.4g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁ClN₄O₅.

1-Bromooctadecane, CAS: 112-89-0, stock: 9.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₇Br.

1-D-4-O-Methyl-myo-inositol, CAS: 6090-97-7, stock: 1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₄O₆.

rac-Desmethoxycarbonyl Indoxacarb, CAS: /, stock: 5.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₅ClF₃N₃O₅.

[4-(Trifluoromethoxy)phenyl]carbamic Acid Methyl Ester, CAS: 177905-10-1, stock: 8.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₈F₃NO₃.

2-Chloroinosine 3’,4’,6’-Triacetate, CAS: 41623-86-3, stock: 5.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇ClN₄O₈.

2’,3’,5’-Tri-O-acetylinosine, CAS: 3181-38-2, stock: 9.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈N₄O₈.

(S)-Valiolamine Voglibose Dihydrochloride, CAS: /, stock: 3.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₃₆Cl₂N₂O₁₁.

1-Palmitoyl-2-(L-α-phosphatidylinositol) Sodium Salt, CAS: 383907-36-6, stock: 1.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₃H₇₈NaO₁₃P.

2,2-Dimethyl-1,3-dioxolane-13C3-4-methanol Dibenzyl Phosphate, CAS: /, stock: 1.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇¹³C₃H₂₅O₆P.

2’,3’-Anhydroinosine, CAS: 31766-13-9, stock: 6.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀N₄O₄.

(S)-Valiolamine-2,3,4-tris(phenylmethoxy)-5-[(phenylmethoxy)methyl] Voglibose-2,3,4-tris(phenylmethoxy)-5-[(phenylmethoxy)methyl], CAS: /, stock: 3.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈₀H₈₈N₂O₁₁.

(S)​-​(+)​-​1,​2,​3,​4-​Tetrahydro-​1-​naphthol, CAS: 53732-47-1, stock: 6.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂O.

2,2-Dimethyl-1,3-dioxolane-4-methanol Dibenzyl Phosphate, CAS: 13879-76-0, stock: 6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₅O₆P.

2,3-O-Cyclohexylidene-1,6-bis-O-(phenylmethyl)-D-myo-inositol, CAS: 152697-26-2, stock: 7.1g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₂O₆.

2,3-Dichloro-1,1,1,2,3-pentafluoropropane, CAS: 422-48-0, stock: 2.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃HCl₂F₅.

2’,3’-Dideoxyinosine-13C2,15N, CAS: /, stock: 1.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈¹³C₂H₁₂N₃¹⁵NO₃.

Indobufen, CAS: 63610-08-2, stock: 8.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₇NO₃.

(S)​-​(+)​-​1-​Indanol, CAS: 25501-32-0, stock: 9.7g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₀O.

2,3-Dichlorodibenzo-p-dioxin, CAS: 29446-15-9, stock: 9.5g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₆Cl₂O₂.

2’,3’-O-(1-Methoxyethylidene)-inosine, CAS: 65870-99-7, stock: 9.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆N₄O₆.

2’,3’-O-(1-Methylethylidene)-6-thio-5’-inosinic Acid Bis(1,1-Dimethylethyl) Ester, CAS: 1375103-71-1, stock: 1.4g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₃N₄O₇PS.

1-Hydroxy Mitiglinide, CAS: /, stock: 3.5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₅NO₄.

2,4:3,5-Di-O-benzylidene L-Iditol, CAS: /, stock: 5.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₂O₆.

2’,3’-O-Isopropylidene-6-thioinosine, CAS: 5856-48-4, stock: 8.8g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆N₄O₄S.

10-Shogaol, CAS: 36752-54-2, stock: 6.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₃₂O₃.

2,6-Difluoro-N-[4-[(4-fluorophenyl)methoxy]-2-pyridinyl]-benzeneacetamide, CAS: 1415834-68-2, stock: 7.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₁₅F₃N₂O₂.

2-(4-((3-Amino-6-bromoquinolin-4-yl)amino)-phenyl)-2-methylpropanenitrile, CAS: 915019-52-2, stock: 6.8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₇BrN₄.

2,4,5-Trichlorophenol, CAS: 95-95-4, stock: 6.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃Cl₃O.

2’,3’-O-Isopropylideneinosine, CAS: 06/11/2140, stock: 7.5g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆N₄O₅.

2’,3’-O-Isopropylideneinosine, CAS: 06/11/2140, stock: 9.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆N₄O₅.

2,4,5-Trichlorophenol-13C6, CAS: /, stock: 4.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₆H₃Cl₃O.

2,4,5-Trichlorophenol-d2, CAS: 93951-82-7, stock: 5.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆HD₂Cl₃O.

2’-Amino-2’-deoxyinosine, CAS: 75763-51-8, stock: 2.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃N₅O₄.

2,3,4,6-Tetra-O-acetyl-α-D-mannopyranosyl-Fmoc Serine, CAS: 118358-80-8, stock: 9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₅NO₁₄.

2-​Amino-​6-​methylpyridine, CAS: 1824-81-3, stock: 6.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₈N₂.

2-Bromoethyl-1-[2-Fmoc-3-O-tert-butyldimethylsilyl]-D-erythro-sphingosylphosphate, CAS: /, stock: 3.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₁H₆₅BrNO₇PSi.

2’-Deoxyinosine 5’-Monophosphate Disodium Salt, CAS: 14999-52-1, stock: 7.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁N₄Na₂O₇P.

2’-Fluoro-2’-deoxyinosine, CAS: 80049-87-2, stock: 1.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁FN₄O₄.

2-(Benzyloxy)isonicotinaldehyde, CAS: 467236-27-7, stock: 4.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₁NO₂.

2,4,6-Trichlorophen-3,5-d2-ol, CAS: 93951-80-5, stock: 1.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆HD₂Cl₃O.

2’-O-Methylinosine, CAS: 3881-21-8, stock: 5.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄N₄O₅.

3-Oxo-(-)-lentiginosine, CAS: 160169-49-3, stock: 7.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₃NO₃.

3,4,5,6-Tetra-O-acetyl myo-Inositol, CAS: 90366-30-6, stock: 6.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₀O₁₀.

3,4,5,6-Tetra-O-acetyl myo-Inositol-1,2-thiocarbonate, CAS: 25348-62-3, stock: 1.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₈O₁₀S.

2,4,6-Trichlorophenol, CAS: 88-06-2, stock: 7.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃Cl₃O.

2,4,6-Trichlorophenol-13C6, CAS: 208461-28-3, stock: 7.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₆H₃Cl₃O.

3’-Deoxy-4’-bromo-inosine 2’,5’-Diacetate, CAS: /, stock: 5.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₅BrN₄O₆.

3’-Deoxyinosine, CAS: 13146-72-0, stock: 8.9g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₄O₄.

3,4-O-[(1R,2R)-1,2-Dimethoxy-1,2-dimethyl-1,2-ethanediyl]-1,6-O-[(1S,2S)-1,2-dimethoxy-1,2-dimethyl-1,2-ethanediyl]-D-myo-inositol, CAS: 176798-27-9, stock: 1.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₃₂O₁₀.

3,6-Bis-O-benzyl-D,L-myo-inositol, CAS: 111408-68-5, stock: 3.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₄O₆.

2,4-D Butyl Ester, CAS: 94-80-4, stock: 3.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄Cl₂O₃.

3’-Deoxyinosine 2’,5’-Diacetate, CAS: 204978-87-0, stock: 5.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₆N₄O₆.

4-Amino-2-chlorobenzonitrile, CAS: 20925-27-3, stock: 2.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅ClN₂.

3-Cyanomethylpiperidine, CAS: 5562-22-1, stock: 9.4g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₂N₂.

3-Deoxy-3-fluoro-D-myo-inositol, CAS: 120444-24-8, stock: 3.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁FO₅.

2,4-Diiodopyridine, CAS: 83674-71-9, stock: 5.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₃I₂N.

2-Methyl-2-pyridylaminoethanol, CAS: 122321-04-4, stock: 1.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₂N₂O.

3-Methyl Adenine, CAS: 5142-23-4, stock: 4.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₇N₅.

3-Methyl Adenine-d3, CAS: 110953-39-4, stock: 9.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄D₃N₅.

2,4-Dimethyldecane, CAS: 2801-84-5, stock: 9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₆.

2-Methylenecyclopropaneacetic Acid, CAS: 1073-00-3, stock: 6.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₈O₂.

2-Phenyl-4-(hydroxymethyl)-2-oxazoline, CAS: 15263-48-6, stock: 4.3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁NO₂.

1-(Benzo[b]thiophen-3-yl)-2-bromoethanone, CAS: 26167-45-3, stock: 2.3g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₇OSBr.

3-O-[(t-Butyldiphenylsilyl]-1,2:4,5-bis-O-(1-methylethylidene) D,L-myo-Inositol, CAS: 119874-35-0, stock: 2.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₈O₆Si.

2,5-Dimethyl-2-ethylhexanoic Acid, CAS: 24353-79-5, stock: 3.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₂₀O₂.

2,5-Dimethyl-2-ethylhexanoic Acid-d3, CAS: /, stock: 5.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₇D₃O₂.

5-Cyano-2-methylpyridine, CAS: 3222-48-8, stock: 3.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆N₂.

5’-O-(4,4’-Dimethoxytrityl)-2’-deoxyinosine, CAS: 93778-57-5, stock: 3.2g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₀N₄O₆.

2-Phenyloxazoline-4-carboxylic Acid Methyl Ester, CAS: 55044-06-9, stock: 5.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁NO₃.

2-sec-Butylphenol, CAS: 89-72-5, stock: 9.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄O.

3-Chloroindomethacin, CAS: 402849-26-7, stock: 7.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₅Cl₂NO₄.

3-O-[(tert-Butyldiphenylsilyl]-6-O-(D,L-1-Ethoxyethyl)-1,2:4,5-bis-O-(1-methylethylidene)-D,L-myo-inositol, CAS: 197848-72-9, stock: 6.7g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₆O₇Si.

2,6-Di(methyl-d3)-naphthalene, CAS: 51209-51-9, stock: 2.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₆D₆.

2,6-Dimethylnaphthalene, CAS: 581-42-0, stock: 5.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₂.

5’-O-DMT-2’-O-methyl-iosine, CAS: 128219-84-1, stock: 9.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₂N₄O₇.

5’-O-Tritylinosine, CAS: 4152-77-6, stock: 7.3g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₂₆N₄O₅.

2-[[2-(4-Bromophenyl)-6-methyl-4-pyrinidinyl]amino]ethanol, CAS: 330981-72-1, stock: 7.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₄BrN₃O.

3,4,5-Trichloronitrobenzene, CAS: 20098-48-0, stock: 2.6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₂Cl₃NO₂.

4-Acetylbutyric Acid, CAS: 01/06/3128, stock: 2.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₀O₃.

4,5-O-Isopropylidene-3,6-bis-O-(phenylmethyl)-1-O-(triphenylmethyl) DL-myo-Inositol, CAS: 114218-25-6, stock: 1.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₂H₄₂O₆.

2,7-Diaminophenazine, CAS: 120209-97-4, stock: 8.9g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₀N₄.

2,7-Dibromophenanthrene, CAS: 62325-30-8, stock: 5.7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₈Br₂.

6-(Hydroxymethyl)nicotinonitrile, CAS: 31795-61-6, stock: 2.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆N₂O.

6-Chloropurine-9-β-D-ribofuranoside, CAS: 5399-87-1, stock: 4.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁ClN₄O₄.

4-Amino-1-(tetrahydropyranyl)-1H-indazole, CAS: 1053655-57-4, stock: 2.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₅N₃O.

2,7-Dichloronaphthalene, CAS: 2198-77-8, stock: 9.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₆Cl₂.

6-Mercaptopurine-9-β-D-ribofuranoside (~90%), CAS: 574-25-4, stock: 6.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₄O₄S.

6-Mercaptopurine-9-β-D-ribofuranoside 2’,3’,5’-Triacetate, CAS: 3021-21-4, stock: 7.6g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈N₄O₇S.

4-Dechloro-2-chloroindomethacin, CAS: /, stock: 8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₆ClNO₄.

4-Amino-3.4-dideoxy-2-C-(hydroxymethyl)-D-epi-inositol, CAS: 83465-22-9, stock: 7.6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₅NO₅.

4-Deoxy-4-fluoro-D-myo-inositol, CAS: 136315-50-9, stock: 9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁FO₅.

2,7-Dimethylundecane, CAS: 17301-24-5, stock: 9g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₈.

2,8,14-Tris[4-(3,7-dimethyloctyl)phenyl]-5,11,17-tris(4’-ethylacetatephenyl)-hexa-peri-hexabenzocoronene, CAS: 1018967-72-0, stock: 1.5g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂₀H₁₂₀O₆.

6-Methylmercaptopurine Riboside, CAS: 342-69-8, stock: 2.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₄N₄O₄S.

6-Methylmercaptopurine Riboside-d3, CAS: /, stock: 6.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁D₃N₄O₄S.

5,5,5-Trifluoro-4-oxopentanoic Acid, CAS: 684-76-4, stock: 6.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₅F₃O₃.

4-Methylumbelliferyl myo-Inositol 1-Phosphate Lithium Salt, CAS: 244145-22-0, stock: 2.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₈LiO₁₁P.

4-Methylumbelliferyl Phosphate, Dilithium Salt, CAS: 125328-83-8, stock: 9.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉O₆P  •2Li.

2,​2,​3,​4,​4,​5,​5,​6,​6,​7,​8,​8,​8-​Tridecafluoro-​3,​7-​bis(trifluoromethyl)​-octanoic Acid, CAS: 172155-07-6, stock: 5.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀HF₁₉O₂.

6-Methylmercaptopurine Riboside-d3 (Major), CAS: /, stock: 4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁D₃N₄O₄S.

3-Bromo-4-pyridinecarboxaldehyde, CAS: 70201-43-3, stock: 8.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄BrNO.

ATB-343, CAS: 1000700-26-4, stock: 8.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₂₀ClNO₄S₃.

4-Pyridazinamine, CAS: 20744-39-2, stock: 7.5g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₅N₃.

5,6-Dichloro-2,4-Pyrimidinediamine, CAS: 89033-89-6, stock: 4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₄Cl₂N₄.

2,​3-​Dichloro-​1-​propene, CAS: 78-88-6, stock: 8.7g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₄Cl₂.

2,​4-​D-Butylglycol Ester, CAS: 1929-73-3, stock: 1.2g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈Cl₂O₄.

6-Methylthioinosine Diphosphate-13C2,15N, CAS: /, stock: 8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉¹³C₂H₁₆N₃¹⁵NO₁₀P₂S.

6-Methylthioinosine Monophosphate-13C2,15N, CAS: /, stock: 4.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉¹³C₂H₁₅N₃¹⁵NO₇PS.

(1S,2R)-(-)-cis-1-Amino-2-indanol, CAS: 126456-43-7, stock: 1.8g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₁NO.

3-Guanidinopropionic Acid, CAS: 353-09-3, stock: 1.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₉N₃O₂.

3-Methyl-2-oxo-valeric-d9 Acid Ethyl Ester, CAS: /, stock: 9.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₅D₉O₃.

5,6-O-Isopropylidene-1,4-bis-O-(phenylmethyl)-DL-myo-Inositol, CAS: 173828-64-3, stock: 3.5g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₈O₆.

5-Deoxy-5-fluoro-D-myo-inositol, CAS: /, stock: 3.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₁FO₅.

6-Methylthioinosine Triphosphate-13C2,15N, CAS: /, stock: 6.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉¹³C₂H₁₇N₃¹⁵NO₁₃P₃S.

6-S-(2,4-Dinitrophenyl)-2’,3’-O-(1-methylethylidene)-6-thioinosine, CAS: 52545-08-1, stock: 5.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₈N₆O₈S.

(S)-2-tert-Butylcarboxamide-4-tert-butoxycarbonylpiperazine, CAS: 150323-35-6, stock: 1.8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₇N₃O₃.

2-Benzyl-1-(2,2-dimethyl-8,8α-dihydro-3α,H-indeno[1,2-d]oxazol-3yl)-3-oxiranyl-propan-1-one, CAS: 158512-24-4, stock: 8.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₇NO₃.

3-Methyl-2-oxovaleric Acid Sodium Salt, CAS: 3715-31-9, stock: 2.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉NaO₃.

6-S-(4-Chlorophenyl)-6-thio-inosine, CAS: 132089-81-7, stock: 6.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₅ClN₄O₄S.

6-S-(4-Chlorophenyl)-6-thio-inosine 2’,3’,5’-Triacetate, CAS: 132089-80-6, stock: 9.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₁ClN₄O₇S.

Des(3-pyridylmethyl tert-Butylaminocarbonyl) Indinavir Hydrochloride, CAS: 1391053-70-5, stock: 7g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₄ClN₃O₃.

Des-3-pyridylmethyl Indinavir (>90%), CAS: 150323-38-9, stock: 8.1g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₄₂N₄O₄.

3-Methyl-2-oxovaleric Acid-13C3 Sodium Salt, CAS: 1391052-48-4, stock: 3.4g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃¹³C₃H₉NaO₃.

3-Methyl-2-oxovaleric Acid-d8 Sodium Salt, CAS: 1795037-03-4, stock: 8.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆HD₈NaO₃.

Indomethacin Acyl-β-D-glucopyranuronic Acid Phenyl Ester, CAS: /, stock: 2.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₀ClNO₁₀.

6-Chloro-2-methylpyrimidine-4,5-diamine, CAS: 933-80-2, stock: 4.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₇ClN₄.

2-(2-Methyl-1-naphthalenyl)-phenol, CAS: 188688-12-2, stock: 9.6g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₄O.

2-(2-Methylnaphthalen-1-yl)phenyl Trifluoromethanesulfonate, CAS: /, stock: 5.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₃F₃O₃S.

6-Thioinosine Phosphate, CAS: 53-83-8, stock: 6.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃N₄O₇PS.

Indinavir, CAS: 150378-17-9, stock: 3.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₄₉N₅O₈S.

3-Methyl-2-oxovaleric Acid-d8 Sodium Salt (Major), CAS: 1795037-03-4, stock: 2.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆HD₈NaO₃.

4,5-Dihydro-2-phenyl-4-[(phenylmethoxy)methyl]-oxazole, CAS: /, stock: 6.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇NO₂.

6-Fluoro-3-pyridinecarboxaldehyde, CAS: 677728-92-6, stock: 6.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄FNO.

6-O-(D,L-1-Ethoxyethyl)-1,2:4,5-bis-O-(1-methylethylidene) D,L-myo-Inositol, CAS: 197848-74-1, stock: 3.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₈O₇.

2-(2H-Benzotriazol-2-yl)-4-(tert-butyl)-6-(sec-butyl)phenol, CAS: 36437-37-3, stock: 2.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₅N₃O.

2-(3-Hydroxyquinolin-2-yl)-1H-indene-1,3(2H)-dione, CAS: 7576-65-0, stock: 6.9g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₁NO₃.

6-Thioinosine Phosphate-13C2,15N, CAS: /, stock: 8.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈¹³C₂H₁₃N₃¹⁵NO₇PS.

6-[(4-Nitrobenzyl)thio]-9-β-D-ribofuranosylpurine-5’-monophosphate, Disodium Salt, CAS: /, stock: 6.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₆N₅Na₂O₉PS.

Indinavir Sulfate, CAS: 157810-81-6, stock: 5.5g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₄₉N₅O₈S.

Indinavir-d6, CAS: 185897-02-3, stock: 4.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₆H₄₁D₆N₅O₄.

Indomethacin Ester, 4-Methoxyphenyl-, CAS: 261766-24-9, stock: 3.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₂₂ClNO₅.

8-Aminoadenine, CAS: 28128-33-8, stock: 2.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₆N₆.

2-(5-tert-Butyl-2-hydroxyphenyl)benzotriazole, CAS: 3147-76-0, stock: 9.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇N₃O.

2-(5-tert-Butyl-2-hydroxyphenyl)benzotriazole-d9, CAS: /, stock: 3.2g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₈D₉N₃O.

7-Deaza-2’-deoxyinosine, CAS: 97224-58-3, stock: 1.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃N₃O₄.

4-Amino-3,4-dideoxy-2-C-[(phenylmethoxy)methyl]-1,5,6-tris-O-(phenylmethyl)-D-epi-inositol, CAS: 140926-94-9, stock: 9.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₅H₃₉NO₅.

Indomethacin sodium, CAS: 7681-54-1, stock: 3.7g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₅ClNNaO₄.

2-(Hydroxyphenyl)-4H-1,3-benzoxazin-4-one, CAS: /, stock: 1.8g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₁₃NO₅.

8-Amino-Inosine, CAS: 13389-16-7, stock: 2.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃N₅O₅.

8-Aminoguanosine, CAS: 3868-32-4, stock: 4.6g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄N₆O₅.

APY29, CAS: 1216665-49-4, stock: 2.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₆N₈.

APY29 Hydrochloride Salt, CAS: /, stock: 9.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₆N₈ • x(HCl).

2-Acetyl-3-methoxybenzeneacetic Acid, CAS: 120714-35-4, stock: 7.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₃₁NO₃Si₃.

2-​(2-​Hydroxyphenyl)​-​4,​5-​dihydro-​1,​3-​thiazole-​4-​carboxylic Acid, CAS: 49608-51-7, stock: 8.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉NO₃S.

1-(1H-Inden-4-yloxy)-3-[(1-methylethyl)amino]-2-propanol, CAS: 106656-86-4, stock: 7.8g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₁NO₂.

8-Aminoguanosine-13C2,15N, CAS: /, stock: 9.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈¹³C₂H₁₄N₅¹⁵NO₅.

4-Chloro-2-methoxypyridine-3-carbaldehyde, CAS: 1008451-58-8, stock: 2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆ClNO₂.

m-Carborane-1-carboxylic Acid, CAS: 18581-81-2, stock: 1.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₁₂B₁₀O₂.

Azetidine-2-carboxamide, CAS: 130973-78-3, stock: 3.1g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₈N₂O.

2-​Chloro-​6-​(trichloromethyl)​pyridine, CAS: 1929-82-4, stock: 3.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃Cl₄N.

2-​Ethyl-​N-​(2-​methoxy-​1-​methylethyl)​-​6-​methyl-benzenamine, CAS: /, stock: 4.2g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₁NO.

7-(2-Hydroxy-3-isopropylaminopropoxy)indene, CAS: 30190-86-4, stock: 8.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₁NO₂.

Indenolol, CAS: 60607-68-3, stock: 8.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₂₁NO₂.

8-Chloroinosine, CAS: 116285-77-9, stock: 7.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁ClN₄O₅.

B-[2-(4-methyl-1-piperazinyl)-5-pyrimidinyl]boronic Acid, CAS: 1256355-29-9, stock: 1.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₅BN₄O₂.

Benzyl 3-(Chlorosulfonyl)pyrrolidine-1-carboxylate, CAS: 1035173-74-0, stock: 5.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄ClNO₄S.

2-​Ethyl-​N-​(2-​methoxy-​1-​methylethyl)​-​6-​methyl-benzenamine-d6, CAS: /, stock: 1.7g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₅D₆NO.

Indenolol-d5, CAS: /, stock: 2.3g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₆D₅NO₂.

AVN-944, CAS: 297730-17-7, stock: 3.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₇N₅O₅.

4-Hydroxy-4-Piperidinepropanol Hydrochloride, CAS: 884535-06-2, stock: 4.6g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₇NO₂•HCl.

Bovine GPLD1 (Phosphatidylinositol-glycan-specific phospholipase D) ELISA Kit (96T), CAS: /, stock: 9.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

2-Bromo-1-(2,4-dichlorophenyl)ethenyldi(ethyl-1,1,2,2,2-d5) Ester Phosphoric Acid, CAS: 1316117-64-2, stock: 4.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₄D₁₀BrCl₂O₂P.

2-Bromo-5-(trifluoromethyl)thiophene, CAS: 143469-22-1, stock: 7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₂BrF₃S.

4-Iodo-2-methoxy-3-pyridinecarboxaldehyde, CAS: 158669-26-2, stock: 1.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₆IN0₂.

4-Methoxy-1-cyclohexenyl Trifluoromethanesulfonate, CAS: 1092938-89-0, stock: 2.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₁F₃O₄S.

Bovine IMPAD1 (Inositol monophosphatase 3) ELISA Kit (96T), CAS: /, stock: 6.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Bovine ISYNA1 (Inositol-3-phosphate synthase 1) ELISA Kit (96T), CAS: /, stock: 9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

2,3-Dihydro-2-methyl-1H-indol-1-amine Hydrochloride, CAS: 102789-79-7, stock: 9.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₂ xHCl.

2-Bromoisobutyric Acid, CAS: 09/01/2052, stock: 4.2g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₇BrO₂.

Bovine ITPK1 (Inositol-tetrakisphosphate 1-kinase) ELISA Kit (96T), CAS: /, stock: 2.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Bovine PIGW (Phosphatidylinositol-glycan biosynthesis class W protein) ELISA Kit (96T), CAS: /, stock: 9.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

2-Methyl-N-(propan-2-ylidene)indolin-1-amine, CAS: /, stock: 5.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₆N₂.

2-Bromoisobutyric-d6 Acid, CAS: 1219795-23-9, stock: 9.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄HD₆BrO₂.

2-Butyn-1-ol, CAS: 764-01-2, stock: 8.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₆O.

Diphosphoryl Chloride 90%, CAS: 13498-14-1, stock: 10g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  Cl₄O₃P₂.

Ethyl N-Benzyloxycarbonyl-3-[(2R)-piperidinyl)]-(2R,3S)-dihydroxrpropanoate, CAS: 160169-48-2, stock: 2.6g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₅NO₆.

4-Methoxycyclohexene-1-boronic Acid Pinacol Ester, CAS: 1092938-92-5, stock: 9.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₂₃BO₃.

NO-Indomethacin, CAS: 301838-28-8, stock: 1.7g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₀ClN₃O₉S.

o-Carborane-1-carboxylic Acid, CAS: 18178-04-6, stock: 1.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₁₂B₁₀O₂.

Bovine PIK3R3 (Phosphatidylinositol 3-kinase regulatory subunit gamma) ELISA Kit (96T), CAS: /, stock: 3.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

2-C-Methyl-2,3-O-isopropylidene-D-ribono-1,4-lactone, CAS: 23709-41-3, stock: 7.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₄O₅.

Ethyl N-Benzyloxycarbonyl-3-[(2R)-piperidinyl)]-2(E)-propenoate, CAS: 160169-47-1, stock: 8.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₃NO₄.

4-Methyl-2-oxovaleric Acid Sodium Salt, CAS: 4502-00-5, stock: 8.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉NaO₃.

4-Methyl-2-oxovaleric Acid-13C3 Sodium Salt, CAS: /, stock: 1.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃¹³C₃H₉NaO₃.

Chicken ITPK1 (Inositol-tetrakisphosphate 1-kinase) ELISA Kit (96T), CAS: /, stock: 2.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

4-Chloro-3-sulfamoylbenzoyl Chloride, CAS: 70049-77-3, stock: 8.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₅Cl₂NO₃S.

2-Chloro-4-methyl-quinoline, CAS: 634-47-9, stock: 8.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₈ClN.

4-Methyl-2-oxovaleric Acid-d7 Sodium Salt, CAS: 1795020-84-6, stock: 5.8g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₂D₇NaO₃.

5-(Methoxycarbonyl)picolinic Acid, CAS: 17874-79-2, stock: 5.1g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇NO₄.

Chicken MDGA1 (MAM domain-containing glycosylphosphatidylinositol anchor protein 1) ELISA Kit (96T), CAS: /, stock: 2.5g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Conduritol B Epoxide, CAS: 6090-95-5, stock: 6.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₀O₅.

2-Cyclohexyl-4,6-dinitrophenol, CAS: 131-89-5, stock: 2.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₄N₂O₅.

5-Fluoroisatoic Anhydride, CAS: 321-69-7, stock: 8.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₄FNO₃.

5-Iodopicolinic Acid, CAS: 32046-43-8, stock: 1.2g, assay: 99%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₄INO₂.

D,L-myo-Inositol-1-(n-butylfluoresceinylphosphate) Lithium Salt, CAS: /, stock: 9.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₀H₃₀LiO₁₃P.

D-chiro Inositol, CAS: 643-12-9, stock: 5.1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂O₆.

(R)-8-(Benzyloxy)-5-(oxiran-2-yl)quinolin-2(1H)-one, CAS: 173140-90-4, stock: 2.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₅NO₃.

N-(4-Chloro-3-sulfamoylbenzoyl)-2-methylindoline, CAS: /, stock: 4.2g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₅ClN₂O₃S.

2-Ethoxyphenylacetic Acid, CAS: 70289-12-2, stock: 8.6g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂O₃.

2-Ethyl-2-methylpentanoic Acid, CAS: 5343-52-2, stock: 9.6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₆O₂.

1,4-Diethylbenzene, CAS: 105-05-5, stock: 5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₄.

5,6-Diethyl-2,3-dihydro-1H-inden-2-amine, CAS: 312753-70-1, stock: 3.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₉N.

6-(Methylthio)-1-hexanamine, CAS: 62580-22-7, stock: 8.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₇NS.

6-Aminohexyl β-D-Glucopyranoside, CAS: 56981-41-0, stock: 6g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₂₅NO₆.

D-myo-Inositol 1,4,5-Trisphosphate Hexaammonium Salt, CAS: 112571-69-4, stock: 5.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₅O₁₅P₃ • 6(NH ₃).

D-myo-Inositol 1,4,5-Trisphosphate Trilithium Salt, CAS: 129828-69-9, stock: 1.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂Li₃O₁₅P₃.

N-(4-Chloro-3-sulfamoylbenzoyl)-2-methylindoline-d3, CAS: /, stock: 10g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₂D₃ClN₂O₃S.

2-Ethyl-2-methylpentanoic Acid-d3, CAS: /, stock: 2.9g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₃D₃O₂.

2-Hydrazino-ethan-1,1,2,2-d4-ol, CAS: 701906-28-7, stock: 2.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂H₄D₄N₂O.

5-[(1R)-2-[(5,6-Diethyl-2,3-dihydro-1H-inden-2-yl)amino]-1-hydroxyethyl]-8-(phenylmethoxy)-2(1H)-quinolinone, CAS: 435273-75-9, stock: 4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₄N₂O₃.

5-[(1R)-2-[(5-Ethyl-2,3-dihydro-1H-inden-2-yl)amino]-1-hydroxyethyl]-8-hydroxy-2(1H)-quinolinone, CAS: 1026461-20-0, stock: 3.4g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₄N₂O₃.

Human IMPDH2(Inosine 5’-Monophosphate Dehydrogenase 2) ELISA Kit (96T), CAS: /, stock: 9.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

2-Hydroxy Imiquimod, CAS: 112668-45-8, stock: 6.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₆N₄O.

D-myo-Inositol 1,4,5-trisphosphate Trisodium Salt, CAS: 141611-10-1, stock: 6.4g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂Na₃O₁₅P₃.

ent-Indacaterol Hydrochloride, CAS: 1384188-70-8, stock: 6.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₈N₂O₃•HCl.

Indacaterol, CAS: 312753-06-3, stock: 5.4g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₈N₂O₃.

Human ITPA(Inosine triphosphate pyrophosphatase) ELISA Kit (96T), CAS: /, stock: 5.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Indolizine-2-carboxylic Acid, CAS: 3189-48-8, stock: 6.7g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₇NO₂.

D-Myo-Inositol-1,3,4,5-tetrakisphosphate Octapotassium Salt, CAS: 145843-69-2, stock: 2.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₈K₈O₁₈P₄.

2-Imidazolidinethione-4,5-d4, CAS: 352431-28-8, stock: 8.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₂D₄N₂S.

Indacaterol Impurity A, CAS: 773895-24-2, stock: 8.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₃₄N₂O₃.

Indacaterol Impurity B, CAS: 1207760-24-4, stock: 4.5g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₉H₄₉N₃O₆.

Inosine 5’ Triphosphate Trisodium Salt, CAS: 35908-31-7, stock: 1.6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₅N₄Na₃O₁₄P₃.

Inosine 5’-​(Trihydrogen Diphosphate) Monohydrate Trisodium Salt, CAS: 81012-88-6, stock: 2.5g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁N₄Na₃O₁₁P₂ • H ₂O.

Adrenocorticotropic Hormone Fragment 18-39 human, CAS: 53917-42-3, stock: 4.3g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁₂H₁₆₅N₂₇O₃₆.

4-Isobutylamino-3-aminoquinoline, CAS: 99010-09-0, stock: 7.3g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇N₃.

Desamino Chloroimiquimod, CAS: 99010-64-7, stock: 7.4g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₄ClN₃.

D-myo-Inositol-1,4,5-trisphosphate Hexapotassium Salt, CAS: 103476-24-0, stock: 2.3g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉K₆O₁₅P₃.

Demethoxyviridiol, CAS: 56617-66-4, stock: 9.6g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₆O₅.

rac Indapamide-N-sulfonamido-β-D-glucuronide(Mixture of Diastereomers), CAS: /, stock: 7.3g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₂H₂₄ClN₃O₉S.

Indacaterol Maleic Acid Salt, CAS: 753498-25-8, stock: 6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₂N₂O₇.

Inosine-13C5 5’-Monophosphate (Triethylammonium Salt), CAS: /, stock: 9.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁¹³C₅H₂₈N₅O₈P.

Ammonium Vanadium Oxide, CAS: 7803-55-6, stock: 9.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  H₄NO₃V.

Desamino Imiquimod, CAS: 99010-24-9, stock: 8.1g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₅N₃.

Desamino Imiquimod N-Oxide, CAS: 99010-63-6, stock: 4.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₅N₃O.

Despentamino Pentazido Tobramycin, CAS: 468065-22-7, stock: 8.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₇N₁₅O₉.

Dimethyl Phosphate Sodium Salt, CAS: 32586-82-6, stock: 2.1g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂H₆NaO₄P.

(3-Methylaminopropyl)-5H-dibenz[b,f]azepine, CAS: 2010-13-1, stock: 8.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₀N₂.

Inosine-5-diphosphoric Acid Disodium Salt, CAS: 54735-61-4, stock: 1.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₄Na₂O₁₁P₂.

Inosine-5’-monophosphate Disodium Salt Hydrate, CAS: 352195-40-5, stock: 9.6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁N₄Na₂O₈P•xH₂O.

Amylin TFA salt (human), CAS: /, stock: 4.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆₅H₂₆₁N₅₁O₅₅S₂ . x( C₂HF₃O₂).

anti- Insulin antibody, CAS: /, stock: 3g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Desmethyl-N-propyl Imiquimod, CAS: 853792-81-1, stock: 8.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₄N₄.

Imiquimod, CAS: 99011-02-6, stock: 6g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₆N₄.

Dimethyl Phosphate-13C2 Sodium Salt, CAS: 157487-95-1, stock: 7.2g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₂H₆NaO₄P.

Dimethyl Phosphate-d6 (Major) Sodium Salt, CAS: 157487-94-0, stock: 1.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂D₆NaO₄P.

2-Methyl-3-nitroaniline, CAS: 603-83-8, stock: 7g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈N₂O₂.

2-Methyl-4-nitroaniline, CAS: 99-52-5, stock: 8.1g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈N₂O₂.

Inosine-5’-monophosphate Sodium Salt Hydrate, CAS: 20813-76-7, stock: 6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁N₄O₈PNa₂ • 8(H ₂O).

anti- Insulin antibody, CAS: /, stock: 4.3g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Imiquimod-d6, CAS: /, stock: 1.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₀D₆N₄.

N-Formyl Imiquimod, CAS: 910644-52-9, stock: 5.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₆N₄O.

DL-myo-Inositol 1,4,5-Trisphosphate Hexaammonium Salt, CAS: 112571-68-3, stock: 6.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₃₃N₆O₁₅P₃.

epi-Inositol, CAS: 488-58-4, stock: 1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂O₆.

10-[3-(Dimethylamino)propyl]-9-methyl-acridinum Iodide, CAS: /, stock: 5.6g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₃IN₂.

10-[3-(Dimethylamino)propyl]-9-methyl-acridinum-d6 Iodide, CAS: /, stock: 6.2g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₇D₆IN₂.

Methyl β-D-Ribofuranoside 2,3,5-Triacetate-13C4, CAS: /, stock: 1.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈¹³C₄H₁₈O₈.

ET-18-OCH3, CAS: 77286-66-9, stock: 1g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₅₈NO₆P.

ETP 45658, CAS: 1198357-79-7, stock: 4.4g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₇N₅O₂.

2-Methyl-6-nitroaniline, CAS: 570-24-1, stock: 4.2g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈N₂O₂.

2-Methyldibenzothiophene, CAS: 20928-02-3, stock: 4g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₀S.

Azoramide, CAS: 932986-18-0, stock: 6.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₇ClN₂OS.

Delactamimipenem Monosodium (Mixture of Diastereomers), CAS: /, stock: 8.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₈N₃NaO₅S.

2-Formyl Trimipramine-d3, CAS: 1794938-94-5, stock: 6g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₃D₃N₂O.

2-Hydroxy Desipramine, CAS: 1977-15-7, stock: 3.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₂N₂O.

2-Methylfluoranthene, CAS: 33543-31-6, stock: 7.3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₂.

Mycophenolic Acid Methyl Ester 6-Methyl β-D-Glucuronate, CAS: /, stock: 5.3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₂O₁₂.

Mycophenolic Acid Methyl Ester-d6 6-(β-D-glucuronic Acid Methyl Ester), CAS: /, stock: 9.1g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₆D₆O₁₂.

Imipenem, Monohydrate, CAS: 74431-23-5, stock: 8.8g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₉N₃O₅S.

GDC-0941 Bimesylate, CAS: 957054-33-0, stock: 1.1g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₅N₇O₉S₄.

2-Hydroxy Desipramine β-D-Glucuronide, CAS: 25521-31-7, stock: 8.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₀N₂O₇.

2-Hydroxy Desipramine-d3, CAS: 1189998-63-7, stock: 9.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₉D₃N₂O.

Bis(2-ethylhexyl) Phthalate, CAS: 117-81-7, stock: 8.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₈O₄.

Bis(2-ethylhexyl) Phthalate (Phenyl-13C6, D4), CAS: /, stock: 4.8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈¹³C₆H₃₄D₄O₄.

δ1-Imipenem, CAS: /, stock: 9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₁₇N₃O₄S.

Human  IP6K1(Inositol hexakisphosphate kinase 1) ELISA Kit (96T), CAS: /, stock: 6.2g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

2-Hydroxy Desipramine-d3 β-D-Glucuronide, CAS: /, stock: 9.8g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₇D₃N₂O₇.

2-Hydroxy Desipramine-d6 Hydrochloride, CAS: /, stock: 9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₇D₆ClN₂O.

2-Methylthio-trans-zeatin Riboside (2MeStZR), CAS: 53274-45-6, stock: 8.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₃N₅O₅S.

Mycophenolic Acid-d3 Methyl Ester 6-Methyl β-D-Glucuronate, CAS: /, stock: 5.7g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₉D₃O₁₂.

N-Des-1-β-D-ribofuranosyl Ribavirin, CAS: 05/08/3641, stock: 1.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₄N₄O.

Bisindolylmaleimide II, CAS: 137592-45-1, stock: 6.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₂₆N₄O₂.

1-(3-Chlorophenyl)-5-isopropyl Biguanide Hydrochloride, CAS: 1071546-52-5, stock: 2.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₇Cl₂N₅.

Human GPI(Glycophosphatidylinositol) ELISA Kit (96T), CAS: /, stock: 5.5g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human GPIHBP1 (Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1) ELISA Kit (96T), CAS: /, stock: 5.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

2-Hydroxy Imipramine, CAS: 303-70-8, stock: 1.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₄N₂O.

2-Hydroxy Imipramine 2,3,4-Triacetate-β-D-glucopyranuronic Acid Methyl Ester, CAS: 1053632-53-3, stock: 3.2g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₄₀N₂O₁₀.

N6-Benzoyl-3’-O-tert-butyldimethylsilyl-5’-O-DMT-adenosine 2’-CE Phosphoramidite, CAS: 129451-75-8, stock: 6.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₃H₆₆N₇O₈PSi.

Bisindolylmaleimide III Hydrochloride, CAS: 683775-59-9, stock: 5.8g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₀N₄O₂  • (HCl).

BMS 536924, CAS: 468740-43-4, stock: 2.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₆ClN₅O₃.

1-(4-Chlorophenyl)biguanide Hydrochloride, CAS: 4022-81-5, stock: 9.6g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₁Cl₂N₅.

1-(4-Chlorophenyl)biguanide-d4 Hydrochloride, CAS: 1794816-89-9, stock: 5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇D₄Cl₂N₅.

Human GPLD1 (Phosphatidylinositol-glycan-specific phospholipase D) ELISA Kit (96T), CAS: /, stock: 4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human GPLD1(Phosphatidylinositol-glycan-specific phospholipase D) ELISA Kit (96T), CAS: /, stock: 2.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

2-Hydroxy Imipramine β-D-Glucuronide, CAS: 54190-76-0, stock: 5.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₂N₂O₇.

2-Hydroxy Imipramine-d6, CAS: 1189880-70-3, stock: 6.6g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₈D₆N₂O.

2-Nitrotoluene, CAS: 88-72-2, stock: 6.5g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇NO₂.

2-NP-AMOZ, CAS: 183193-59-1, stock: 4.7g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₈N₄O₅.

Nebularine, CAS: 550-33-4, stock: 6.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₄O₄.

Poly(I:C)  (~90%), CAS: 24939-03-5, stock: 8.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  (C₁₀H₁₃N₄O₈P)ₓ (C₉H₁₄N₃O₈P)ₓ.

BMS 754807, CAS: 1001350-96-4, stock: 3.9g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₄FN₉O.

1-Benzyl-1-methylbiguanide Hydrochloride, CAS: 01/07/2123, stock: 6.1g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆ClN₅.

1-Methyl Biguanide Hemisulfate Monohydrate (85%), CAS: /, stock: 3.4g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₁₁N₅O•1/2H₂SO₄.

Human IMPA1(Inositol monophosphatase 1) ELISA Kit (96T), CAS: /, stock: 7.2g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

2-Hydroxy Imipramine-d6 β-D-Glucuronide, CAS: /, stock: 9.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₂₆D₆N₂O₇.

2-Hydroxy Trimipramine, CAS: 2064-15-5, stock: 9.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₆N₂O.

2-NP-AMOZ-d5, CAS: 1173097-59-0, stock: 8.9g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₃D₅N₄O₅.

Rat IMPDH2(Inosine 5’-Monophosphate Dehydrogenase 2) ELISA Kit (96T), CAS: /, stock: 9.4g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Ribavirin, CAS: 36791-04-5, stock: 8g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₂N₄O₅.

Boc-Glu-Ofm, CAS: 133906-29-3, stock: 7.6g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₇NO₆.

Bovine IGF-1(Insulin-like growth factor 1) ELISA Kit (96T), CAS: /, stock: 7.7g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

1-Methyl Biguanide SulfateMetformin EP Impurity E Sulfate, CAS: 36801-25-9, stock: 2g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₉N₅ (H₂SO₄).

1-Methylbiguanide Hydrochloride, CAS: 1674-62-0, stock: 2.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₁₀ClN₅.

1,3-Dithietan-2-imine Hydrochloride, CAS: 25878-14-2, stock: 4.6g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂H₃NS₂•HCl.

Human IMPA2(Inositol monophosphatase 2) ELISA Kit (96T), CAS: /, stock: 2.8g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human INPP5D (Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1) ELISA Kit (96T), CAS: /, stock: 5.3g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

2-Hydroxy Trimipramine-d3, CAS: 1189647-53-7, stock: 9.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₃D₃N₂O.

2-Hydroxy-N-desmethyl Trimipramine, CAS: 2064-14-4, stock: 9.3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₄N₂O.

Ribavirin 2,3,5-Tri-O-acetyl, CAS: 40372-03-0, stock: 4.6g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₈N₄O₈.

Ribavirin-13C2, CAS: 1279035-36-7, stock: 5.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆¹³C₂H₁₂N₄O₅.

Bovine IGFBPL1 (Insulin-like growth factor-binding protein-like 1) ELISA Kit (96T), CAS: /, stock: 7.3g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Bovine INSM1 (Insulinoma-associated protein 1) ELISA Kit (96T), CAS: /, stock: 5.5g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

1-Phenylbiguanide hydrochloride, CAS: 55-57-2, stock: 9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₁N₅ •HCl.

Chlorguanide Hydrochloride, CAS: 637-32-1, stock: 7.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₇Cl₂N₅.

1,3-Dithiolan-2-imine, CAS: 4472-81-5, stock: 5.1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃H₅NS₂.

Dimethyl N-Cyanodithioiminocarbonate, CAS: 10191-60-3, stock: 9.2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₆N₂S₂.

Human INPP5D(Phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase 1) ELISA Kit (96T), CAS: /, stock: 1.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human INPPL1 (Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2) ELISA Kit (96T), CAS: /, stock: 7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

3,​7-​Dichloro-​10,​11-​dihydro-​5H-​dibenzo[b,​f]​azepine, CAS: 13080-74-5, stock: 5.7g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₁Cl₂N.

3-Chloro-N,N-diethylpropan-1-amine, CAS: 104-77-8, stock: 6.7g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₆ClN.

2-Pentyl Acetate, CAS: 626-38-0, stock: 4.9g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₄O₂.

Ribavirin-13C5, CAS: 1646818-35-0, stock: 1g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃¹³C₅H₁₂N₄O₅.

S-(4-Nitrobenzyl)-6-thioinosine, CAS: 38048-32-7, stock: 2.3g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₇N₅O₆S.

Buformin Hydrochloride, CAS: 1190-53-0, stock: 7.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₆ClN₅.

Buformin-d9 Hydrochloride, CAS: 1215700-80-3, stock: 5.3g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₇D₉ClN₅.

Chlorguanide-d4 Hydrochloride, CAS: 1189671-34-8, stock: 6.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₃D₄Cl₂N₅.

Diphenyl N-Cyanocarbonimidate, CAS: 79463-77-7, stock: 4.3g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₀N₂O₂.

Disodium Cyanodithioimidocarbamate Hydrate, CAS: /, stock: 5g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂N₂Na₂S₂ •xH₂O.

Human IPMK (Inositol polyphosphate multikinase) ELISA Kit (96T), CAS: /, stock: 9.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human MDGA1 (MAM domain-containing glycosylphosphatidylinositol anchor protein 1) ELISA Kit (96T), CAS: /, stock: 9.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

3-Chlorobalipramine Maleate, CAS: 114600-27-0, stock: 2.2g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₅ClN₂O₄.

3-Chlorobalipramine-d6 Maleate, CAS: /, stock: 8.9g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₁₉D₆ClN₂O₄.

Sodium Inosine 5’-Phosphate (2:1), CAS: 4691-65-0, stock: 6.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₁N₄Na₂O₈P.

Tiazofurin, CAS: 60084-10-8, stock: 5g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₂N₂O₅S.

C-Peptide (Proinsulin), CAS: 59112-80-0, stock: 4.2g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁₂H₁₇₉N₃₅O₄₆.

C-Peptide-d3 (Proinsulin), CAS: /, stock: 1.4g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  NA.

Chlorguanide-d6 Hydrochloride, CAS: /, stock: 1.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₁D₆Cl₂N₅.

Fosthietan, CAS: 21548-32-3, stock: 3.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂NO₃PS₂.

Imidocarb, CAS: 27885-92-3, stock: 9.7g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₀N₆O.

Human MINPP1 (Multiple inositol polyphosphate phosphatase 1) ELISA Kit (96T), CAS: /, stock: 5.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human MIOX(Inositol oxygenase) ELISA Kit (96T), CAS: /, stock: 5.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

5-(3-Chloropropyl)-10,11-dihydro-2-formyl-5H-dibenz[b,f]azepine, CAS: 1159977-20-4, stock: 6.8g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₈ClNO.

5-(3-Chloropropyl)-10,11-dihydro-2-hydroxy-5H-dibenz[b,f]azepine, CAS: 1159977-21-5, stock: 7.3g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₈ClNO.

2-Toluidine, CAS: 95-53-4, stock: 4.9g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₉N.

2-Toluidine-13C6, CAS: 1329837-29-7, stock: 1.1g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C¹³C₆H₉N.

VPC 23019, CAS: 449173-19-7, stock: 4.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₉N₂O₅P.

Chicken IGF-1(Insulin-like growth factor 1) ELISA Kit (96T), CAS: /, stock: 8.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Chlorproguanil, CAS: 537-21-3, stock: 7.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₅Cl₂N₅.

Imidocarb Dipropionate, CAS: 55750-06-6, stock: 9.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₂N₆O₅.

Imidocarb-D8, CAS: /, stock: 8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₂D₈N₆O.

Human NUDT11(Diphosphoinositol polyphosphate phosphohydrolase 3-beta) ELISA Kit (96T), CAS: /, stock: 6.1g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human PIGW (Phosphatidylinositol-glycan biosynthesis class W protein) ELISA Kit (96T), CAS: /, stock: 3.9g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

5-[3-(Methylamino)propyl]-5H-dibenz[b,f]azepine-d3, CAS: /, stock: 4.9g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₇D₃N₂.

2-Toluidine-d7, CAS: 68408-22-0, stock: 3.7g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₂D₇N.

2-[Phenyl(1H-pyrrol-2-yl)methyl]-1H-pyrrole, CAS: 107798-98-1, stock: 6.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₄N₂.

Chicken IGF-2(Insulin Like Growth Factor 2) ELISA Kit (96T), CAS: /, stock: 8.4g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Chicken IGFBP-1(Insulin Like Growth Factor Binding Protein 1) ELISA Kit (96T), CAS: /, stock: 3.8g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Metformin-d6, Hydrochloride, CAS: 1185166-01-1, stock: 5.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄H₆D₆ClN₅.

Phospholan-methyl, CAS: 5120-23-0, stock: 7.1g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₀NO₃PS₂.

Human PIK3CA(Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha isoform) ELISA Kit (96T), CAS: /, stock: 6g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human PIK3CD (Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform) ELISA Kit (96T), CAS: /, stock: 1.7g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

8-Hydroxyclomipramine, CAS: 61523-80-6, stock: 7.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₃ClN₂O.

Balipramine Hydrochloride (Impurity), CAS: 58262-51-4, stock: 2g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₃N₂Cl.

Chicken IGFBP-3(Insulin Like Growth Factor Binding Protein 3) ELISA Kit (96T), CAS: /, stock: 5.4g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Chicken IGFBP-4(Insulin Like Growth Factor Binding Protein 4) ELISA Kit (96T), CAS: /, stock: 2.4g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

N,N’-Bis(1-methylethyl)Imidodicarbonimidic Diamide Hydrochloride, CAS: 35708-82-8, stock: 4.6g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₂₀ClN₅.

Human PIK3CD(Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta isoform) ELISA Kit (96T), CAS: /, stock: 6.9g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human PIK3R3 (Phosphatidylinositol 3-kinase regulatory subunit gamma) ELISA Kit (96T), CAS: /, stock: 4.5g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Balipramine Hydrochloride-d6 (Impurity), CAS: /, stock: 2.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₇D₆N₂Cl.

Carpipramine Dihydrochloride, CAS: 08/03/7075, stock: 8.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₀Cl₂N₄O.

Human PIP4K2C(Phosphatidylinositol-5-phosphate 4-kinase type-2 gamma) ELISA Kit (96T), CAS: /, stock: 5.8g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human PITPNC1 (Cytoplasmic phosphatidylinositol transfer protein 1) ELISA Kit (96T), CAS: /, stock: 8.1g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Carpipramine-d10 Dihydrochloride, CAS: /, stock: 3.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₃₀D₁₀Cl₂N₄O.

Clomipramine Hydrochloride, CAS: 17321-77-6, stock: 7.7g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₄Cl₂N₂.

(4S)-1-(Methyl-d3)-2-oxo-4-imidazolidinecarboxylic Acid, tert-Butyl Ester, CAS: 1217704-07-8, stock: 9.6g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₃D₃N₂O₃.

Chlorpropamide, CAS: 94-20-2, stock: 6.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₃ClN₂O₃S.

Chlorpropamide-d4, CAS: 1794779-79-5, stock: 4.9g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₉D₄ClN₂O₃S.

N-Desisopropyl N-Chlorophenylchlorguanide Hydrochloride, CAS: 13590-98-2, stock: 1.8g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₄Cl₃N₅.

N-Ethyl (Metformin-d6) Hydrochloride, CAS: /, stock: 8.1g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₉D₆N₅•HCl.

Human PLCγ2(Phospholipase C Gamma 2, Phosphatidylinositol Specific) ELISA Kit (96T), CAS: /, stock: 6.7g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human PREX1 (Phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 1 protein) ELISA Kit (96T), CAS: /, stock: 5.4g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Clomipramine-d6 Hydrochloride, CAS: 1189882-28-7, stock: 1.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₈D₆Cl₂N₂.

Dehydro Trimipramine, CAS: 315-69-5, stock: 8.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₄N₂.

2H-Perfluoro-2-decenoic Acid, CAS: 70887-84-2, stock: 5.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₂F₁₆O₂.

(4S)-1-Methyl-2-oxo-4-imidazolidinecarboxylic Acid, tert-Butyl Ester, CAS: 83056-79-5, stock: 8.4g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₆N₂O₃.

Imidapril Hydrochloride, CAS: 89396-94-1, stock: 2.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₈ClN₃O₆.

CIM 0216, CAS: 1031496-06-6, stock: 7.9g, assay: 97.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₁N₃O₂.

N-Ethyl Metformin Hydrochloride, CAS: 110181-35-6, stock: 8.7g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₅N₅•HCl.

N-[4-(2-Hydroxyethyl)phenyl]imidodicarbonimidic Diamide, CAS: 102460-36-6, stock: 6.5g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₅N₅O.

Human PREX1(Phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 1 protein) ELISA Kit (96T), CAS: /, stock: 2.5g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human PREX2 (Phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 2 protein) ELISA Kit (96T), CAS: /, stock: 2.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Dichloroimipramine Hydrochloride, CAS: 115189-28-1, stock: 4.9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₃Cl₂N₂Cl.

Dichloroimipramine Hydrochloride-d6, CAS: /, stock: 8.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₇D₆Cl₂N₂Cl.

Imidapril tert-Butyl Ester, CAS: 89371-38-0, stock: 1.7g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₅N₃O₆.

Human PREX2(Phosphatidylinositol 3,4,5-trisphosphate-dependent Rac exchanger 2 protein) ELISA Kit (96T), CAS: /, stock: 7.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

2,3-Bis(1,5-dihydro-5-methyl-5-isopropyl-4H-Imadazol-4-one)-5-ethyl Pyridine, CAS: /, stock: 1.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₅N₅O₂.

Imidapril-d3 Hydrochloride, CAS: 1356017-30-5, stock: 1.3g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₅D₃ClN₃O₆.

Imidapril-d3 tert-Butyl Ester, CAS: /, stock: 2.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₂D₃N₃O₆.

Phenformin Hydrochloride, CAS: 834-28-6, stock: 6.3g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₆ClN₅.

Human PTEN(Phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN) ELISA Kit (96T), CAS: /, stock: 6.4g, assay: 98%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human PTPRQ(Phosphotidylinositol phosphatase PTPRQ) ELISA Kit (96T), CAS: /, stock: 1.9g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Imipramine Hydrochloride, CAS: 113-52-0, stock: 6.8g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₅ClN₂.

Imipramine Hydrochloride (1.0 mg/mL in Methanol), CAS: 113-52-0, stock: 6.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₅ClN₂.

2-​(5-​Ethyl-​3-​pyridinyl)​-​3,​5-​dihydro-​5-​methyl-​5-​(1-​methylethyl)​-4H-​imidazol-​4-​one, CAS: 202586-58-1, stock: 8.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉N₃O.

3-​Ethyl-​5,​7-​dihydro-​α-​methyl-​α-​(1-​methylethyl)​-​5,​7-​dioxo-6H-​pyrrolo[3,​4-​b]​pyridine-​6-​acetamide, CAS: 102268-21-3, stock: 4.6g, assay: 97.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₉N₃O₃.

Imidaprilat, CAS: 89371-44-8, stock: 6.7g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₃N₃O₆.

Imidaprilat Benzyl Ester, (Carbonylimidazolidine)tert-butyl Ester, CAS: 89460-20-8, stock: 5.9g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₇N₃O₆.

D-Fructose, CAS: 57-48-7, stock: 5.8g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₁₂O₆.

Phenformin-d5 Hydrochloride, CAS: /, stock: 9.3g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₀D₅N₅xHCl.

Human SLC2A13(Proton myo-inositol cotransporter) ELISA Kit (96T), CAS: /, stock: 7.6g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Human VPS34(Phosphatidylinositol 3-kinase catalytic subunit type 3) ELISA Kit (96T), CAS: /, stock: 6g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Imipramine N-β-D-Glucuronide, CAS: 165602-94-8, stock: 1.2g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₂N₂O₆.

Imipramine N-Oxide Hydrate, CAS: 1215681-42-7, stock: 1.5g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₄N₂O • x(H  ₂O).

3-​Ethyl-furo[3,​4-​b]​pyridin-​7(5H)​-​one, CAS: 1360885-08-0, stock: 4.5g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₉NO₂.

3-Descarboxy Imazethapyr, CAS: 89084-60-6, stock: 1.7g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉N₃O.

3,4-Dihydrocyclopenta[cd]pyren-4-ol, CAS: 80010-98-6, stock: 8.4g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₂O.

Imidaprilat Benzyl Ester, (Carbonylimidazolidine)tert-butyl Ester-d3, CAS: 1356353-73-5, stock: 7.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₉H₃₄D₃N₃O₆.

Imidaprilat-d3, CAS: 1356019-69-6, stock: 9.4g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₀D₃N₃O₆.

D-Manno-Hept-2-ulose-13C, CAS: /, stock: 7.8g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³CC₆H₁₄O₇.

D-Mannoheptulose, CAS: 3615-44-9, stock: 5.4g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₁₄O₇.

IP3(Inositol Triphosphate) ELISA Kit (96T), CAS: /, stock: 6.2g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

α-Glycerophosphoryl Inositol, CAS: 07/11/2816, stock: 6.9g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₉H₁₉O₁₁P.

Imipramine Pamoate, CAS: 10075-24-8, stock: 9.9g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆₁H₆₄N₄O₆.

Imipramine-2,4,6,8-d4 Hydrochloride, CAS: 61361-33-9, stock: 9.8g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₁D₄ClN₂.

4-Desisopropyl-4-ethyl Imazethapyr, CAS: /, stock: 8.3g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₇N₃O₃.

3,6,9,12,15,18,21,24,27,30,33,36,39,42-Tetradecaoxatetrapentacontan-1-ol, CAS: 54350-53-7, stock: 7.9g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₈₂O₁₅.

D-Mannoheptulose-13C7, CAS: /, stock: 6.7g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  ¹³C₇H₁₄O₇.

Kasugamycin Hydrochloride, CAS: /, stock: 8.3g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₅N₃O₉ • x(HCl).

Kasugamycin Hydrochloride Monohydrate, CAS: 200132-83-8, stock: 2.1g, assay: 98.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₅N₃O₉ • ( HCl) • (H ₂O).

Imipramine-d6, CAS: 65100-45-0, stock: 9.4g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₈D₆N₂.

Imipramine-d6 N-Oxide Monohydrate, CAS: 1216808-01-3, stock: 1.5g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₀D₆N₂O₂.

4-Desisopropyl-4-isobutyl Imazethapyr, CAS: /, stock: 2.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₁N₃O₃.

4-Desisopropyl-4-methyl Imazethapyr, CAS: /, stock: 8.2g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₅N₃O₃.

3,6,9,12,15,18,21,24,27,30,33,36,39,42-Tetradecaoxatetrapentacontan-1-ol-d25, CAS: /, stock: 5.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₄₀H₅₇D₂₅O₁₅.

Darglitazone, CAS: 141200-24-0, stock: 4.7g, assay: 98.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₃H₂₀N₂O₄S.

Kasugamycin(~70%), CAS: 6980-18-3, stock: 7.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₂₅N₃O₉.

Kasugamycin(~70%)-13C2,15N, CAS: /, stock: 9.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂¹³C₂H₂₅N₂¹⁵NO₉.

1-Methylpiperazine, CAS: 109-01-3, stock: 8.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅H₁₂N₂.

4-Desisopropyl-4-propyl Imazethapyr, CAS: 153232-73-6, stock: 5.4g, assay: 98.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₉N₃O₃.

4-Desisopropyl-4-tert-butyl Imazethapyr, CAS: /, stock: 5g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₁N₃O₃.

3,6-Dichloro-9H-carbazole, CAS: 5599-71-3, stock: 5.1g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₂H₇Cl₂N.

3,7,11,15-Tetramethyl-1-hexadecanol 4-Methylbenzenesulfonate, CAS: 100566-23-2, stock: 3.9g, assay: 97.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₇H₄₈O₃S.

Demethylasterriquinone B1, CAS: 78860-34-1, stock: 1.8g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₃₀N₂O₄.

Dibutyl Phthalate-13C6, CAS: /, stock: 5.9g, assay: 97.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀¹³C₆H₂₂O₄.

L-690,330, CAS: 142523-38-4, stock: 3g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₂O₈P₂.

N,N-Didemethylchlorimipramine, CAS: 62724-32-7, stock: 8.2g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₉ClN₂.

N-Demethyl Trimipramine, CAS: 2293-21-2, stock: 3.6g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₄N₂.

2-((4-Methylpiperazin-1-yl)methyl)benzonitrile, CAS: 864069-00-1, stock: 7.4g, assay: 97.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₇N₃.

4-Desmethyl-4-ethyl Imazethapyr, CAS: /, stock: 6.3g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₂₁N₃O₃.

5-(1-Hydroxyethyl) Imazapyr, CAS: 134887-87-9, stock: 6g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₉N₃O₄.

3,9,10-Trichlorophenanthrene, CAS: 800409-57-8, stock: 4.8g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₇Cl₃.

Duck IGF-1(Insulin-Like Growth Factor 1) ELISA Kit (96T), CAS: /, stock: 2.5g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

L-690,488, CAS: 142523-14-6, stock: 5.4g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₂H₅₂O₁₆P₂.

L-Idaric Acid Disodium Salt, CAS: /, stock: 3.7g, assay: 98.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₆H₈Na₂O₈.

N-Desmethyl Clomipramine Hydrochloride, CAS: 29854-14-6, stock: 1.3g, assay: 96.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₂₂Cl₂N₂.

N-Desmethyl Clomipramine-d3 Hydrochloride, CAS: 1189971-04-7, stock: 2.3g, assay: 98.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₈H₁₉D₃Cl₂N₂.

2-Methyl-4-nitrophenylguanidine Nitrate, CAS: 796738-73-3, stock: 9.6g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₁N₅O₅.

2-Methyl-5-nitroaniline, CAS: 99-55-8, stock: 5.9g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₈N₂O₂.

5-Acetyl Imazapyr, CAS: 113052-10-1, stock: 9.8g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₇N₃O₄.

5-Carboxy Imazapyr, CAS: /, stock: 6.5g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₅N₃O₅.

Duck IGF-2(Insulin-Like Growth Factor 2) ELISA Kit (96T), CAS: /, stock: 3g, assay: 96%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  /.

Ertiprotafib, CAS: 251303-04-5, stock: 1.3g, assay: 97.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₃₁H₂₇BrO₃S.

LY 294002, CAS: 154447-36-6, stock: 9.2g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₇NO₃.

LY 294002 Hydrochloride, CAS: 934389-88-5, stock: 9.6g, assay: 97.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₁₇NO₃ • (HCl).

Quinupramine, CAS: 31721-17-2, stock: 8g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₁H₂₄N₂.

Trimipramine Maleate Impurity E, CAS: /, stock: 9.9g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₇N₃  •     C₄H₄O₄.

3-(5-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)benzenamine, CAS: 641571-16-6, stock: 4.1g, assay: 96.7%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₁H₁₀F₃N₃.

3-Acetylpyridine, CAS: 350-03-8, stock: 8.3g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₇H₇NO.

5-Hydroxy Imazapyr, CAS: 102771-62-0, stock: 9.9g, assay: 96.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₅N₃O₄.

Imazethapyr, CAS: 81335-77-5, stock: 2.8g, assay: 98.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₅H₁₉N₃O₃.

3-Acetyldeoxynivalenol, CAS: 50722-38-8, stock: 8.7g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₂₂O₇.

ESI 09, CAS: 263707-16-0, stock: 6.9g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₅ClN₄O₂.

Ethyl 2-Amino-7-hydroxy-4-(pyridin-3-yl)-4H-chromene-3-carboxylate, CAS: 332164-34-8, stock: 8.4g, assay: 96.1%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₇H₁₆N₂O₄.

Trimipramine Maleate Salt, CAS: 521-78-8, stock: 5.2g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₃₀N₂O₄.

3-Dimethylamino-1-(3-pyridyl)-2-propen-1-one, CAS: 55314-16-4, stock: 5.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₀H₁₂N₂O.

N-(1-Cyano-1,2-dimethylpropyl)-5-ethyl--3-pyridinecarboxamide, CAS: /, stock: 3.5g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₄H₁₉N₃O.

Mersalyl Acid Sodium Salt, CAS: 492-18-2, stock: 6.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₃H₁₆HgNNaO₆.

MI 14, CAS: 1715934-43-2, stock: 4.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₉H₂₃ClN₆O₃S.

(-)-Corey Lactone Diol, CAS: 32233-40-2, stock: 7.6g, assay: 98.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₂O₄.

Trimipramine N-β-D-Glucuronide, CAS: 165602-84-6, stock: 3.5g, assay: 96.2%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₆H₃₄N₂O₆.

Trimipramine N-Oxide, CAS: 14171-70-1, stock: 7.1g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₀H₂₆N₂O.

Bicyclo[1.1.1]pentane-1,3-dicarboxylic Acid, 1-methyl Ester, CAS: 83249-10-9, stock: 6.4g, assay: 97.8%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₁₀O₄.

3-​Acetylphenanthrene, CAS: 2039-76-1, stock: 9g, assay: 96.3%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₁₆H₁₂O.

Ethyl α-Ketoisocaproate-d7, CAS: /, stock: 2.8g, assay: 97.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₈H₇D₇O₃.

ML-191, CAS: 931695-79-3, stock: 8.3g, assay: 96.6%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₅N₃O₃.

(1E)-1-[(3’aS,4’R,5’R,6’aR)-5’-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]hexahydro-5,5-dimethylspiro[1,3-dioxane-2,2’(1’H)-pentalen]-4’-yl]-4-methyl-1-octen-6-yn-3-one, CAS: 116896-29-8, stock: 9.8g, assay: 97%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₆O₄Si.

(1E,3R,4S)-1-[(3’aS,4’R,5’R,6’aR)-5’-[[(1,1-Dimethylethyl)dimethylsilyl]oxy]hexahydro-5,5-dimethylspiro[1,3-dioxane-2,2’(1’H)-pentalen]-4’-yl]-4-methyl-1-octen-6-yn-3-ol, CAS: 910916-95-9, stock: 7.6g, assay: 98.5%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₈H₄₈O₄Si.

Trimipramine N1,N,N,2-tetramethylpropane-1,3-diamine, CAS: /, stock: 9.1g, assay: 96.4%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₅H₃₇N₃.

Trimipramine-d3 (Major) Maleate Salt, CAS: 1185245-93-5, stock: 9.6g, assay: 96.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₂₄H₂₇D₃N₂O₄.

Des(methylpiperazinyl) Imatinib Dimer Piperazinium Chloride (90%), CAS: /, stock: 3g, assay: 98.9%, Supplying H-NMR; HRMS; IR; Purity by HPLC; TGA, MolFormula:  C₅₃H₅₁ClN₁₂O₂.